Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.154662147878177,0.00303083318402064,0.148721714837496,0.160602580918857,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42611,-0.165728302610138,0.00412460765264458,-0.173812533609321,-0.157644071610955,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.151786693394734,0.00305042567477236,0.14580785907218,0.157765527717288,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42568,-0.155049914266185,0.00399244396903465,-0.162875104445493,-0.147224724086878,1.11258874960717e-308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.149772454312397,0.00391701327260146,-0.157449800326696,-0.142095108298098,5.53154852040946e-301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,42346,-0.448161637288614,0.0120276074822145,-0.471735747953754,-0.424587526623473,5.52688557903243e-289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.0996140216794648,0.00272125656532771,0.0942803588114225,0.104947684547507,8.94230172307778e-280
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,40532,0.0766395427178648,0.00229124408482314,0.0721487043116114,0.0811303811241181,5.01105573891301e-234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.261521587875262,0.0079540447697447,-0.277111515623961,-0.245931660126562,1.6079924590379e-226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.202652623281145,0.00620608705025563,-0.214816553899646,-0.190488692662644,3.45423587772215e-225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,40539,0.217602325864786,0.0066404062564594,0.204587129602125,0.230617522127446,4.07811314043488e-225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.370200820654839,0.0116118878660124,0.347441520437455,0.392960120872223,3.75418986943047e-215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42663,0.0859596563808577,0.00273288758029096,0.0806031967234874,0.0913161160382279,1.28957790331755e-209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42618,-0.160872048653948,0.00550437026434667,-0.171660614372068,-0.150083482935829,4.26449875093099e-182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.257920143925585,0.00886575895740381,-0.275297031482097,-0.240543256369074,1.76286120593919e-180
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42754,-0.144267781892146,0.00502370774474716,-0.15411424907185,-0.134421314712441,4.0891442319114e-176
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0845380534582563,0.00296196234965,-0.0903434996635703,-0.0787326072529423,5.96291596700742e-174
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42636,0.128815980623328,0.00453466273136296,0.119928041669857,0.137703919576799,1.95311350826262e-172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,40116,-0.282554773112899,0.00994451879962846,-0.30204602996017,-0.263063516265627,2.16552727789756e-171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,40532,0.145026520243858,0.0051682099872087,0.134896828668929,0.155156211818787,1.42860573614827e-167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.138312976438141,0.00498194088874521,-0.148077580580082,-0.1285483722962,5.22410838244831e-165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.0893137938107172,0.00336102571791931,-0.095901404217839,-0.0827261834035954,1.04448714617564e-151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.10626532830852,0.00400113461756092,-0.114107552158939,-0.0984231044581004,1.62041676426546e-151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.351997541265153,0.0135144551557337,-0.378485873370391,-0.325509209159915,5.7833799633613e-146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0890481554973846,0.00343434156496463,-0.0957794649647153,-0.0823168460300539,1.07794539736246e-144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0786277043313087,0.00304769324148367,0.0726542255780007,0.0846011830846167,1.38724719196633e-142
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,42370,-0.196991677840852,0.00780869674948905,-0.21229672346985,-0.181686632211853,3.53329955654612e-137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.220889146275986,0.0087785454760041,-0.238095095408954,-0.203683197143018,5.42904667582263e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,40033,0.106708204671269,0.00425938986504521,0.0983598005357804,0.115056608806758,1.06464493322785e-134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0531433984586598,0.00213574136150685,0.0489573453901063,0.0573294515272132,1.13501710693516e-133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42636,-0.145384347202365,0.00592340760924355,-0.156994226116482,-0.133774468288247,3.59427879850562e-130
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.132341399763599,0.00538059888528804,-0.142887373578763,-0.121795425948434,3.66071178718347e-130
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.0854252557965836,0.00350914706410495,0.0785473275509379,0.0923031840422293,3.74393415889909e-128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.161887294141504,0.00671257010064667,-0.175043931538771,-0.148730656744236,8.69799317975847e-126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0791757628238793,0.0033053980662354,-0.0856543430337007,-0.0726971826140579,3.3171966273167e-124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0800398961434582,0.00334180306160818,-0.0865898301442102,-0.0734899621427061,3.75552791909659e-124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0755083012485564,0.00324496951999582,-0.0818684415077482,-0.0691481609893645,1.85594286469412e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.185501318768845,0.00799817335204746,-0.201177738538858,-0.169824898998832,1.15250484805066e-116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.181465078380544,0.00795687667746398,-0.197060556668374,-0.165869600092715,5.44220528848118e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.120343088009984,0.00527656505147819,-0.130685155510882,-0.110001020509087,5.4505206082995e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.086078285290563,0.00378040312786788,0.0786686951599419,0.093487875421184,1.23487517343739e-112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.113416581807835,0.00497336711793219,0.103668782256688,0.123164381358982,1.37075705474485e-112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.124055759406448,0.00547100772548958,-0.134778934548407,-0.113332584264488,1.06791570373477e-111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.258631849650882,0.0115042231888952,-0.281180127101117,-0.236083572200648,6.49689339421628e-110
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0792539976725518,0.00354470881479153,0.0723063683955604,0.0862016269495432,9.24234236784523e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0731683043094933,0.00331134360835782,0.066678070837112,0.0796585377818746,2.60814770991306e-106
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0799659545596798,0.00363332647875602,0.072844634661318,0.0870872744580415,3.71532363115977e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.0969347715388698,0.00442130352033147,0.0882690166390201,0.105600526438719,1.03217420039517e-104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42754,-0.0620600792592054,0.00285855524925122,-0.0676628475477378,-0.056457310970673,9.13866109162869e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.110532915713929,0.00514206670150936,-0.120611366448887,-0.100454464978971,8.04494315394346e-101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.0993150647930222,0.00463155742883915,-0.108392917353547,-0.0902372122324975,2.46838330596905e-100
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,42311,-0.110540822865345,0.00515516219713743,-0.120644940771734,-0.100436704958956,2.78505258167292e-100
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0417833246605246,0.00196143078857514,0.0379389203149174,0.0456277290061319,4.61366948430831e-99
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0631423094620229,0.0029738284066358,0.0573136057850168,0.0689710131390291,1.94154767323377e-98
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42600,-0.215604282486354,0.0102096242809698,-0.235615146077054,-0.195593418895653,2.0913985017879e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0672817406725831,0.00318149045261476,-0.073517461959708,-0.0610460193854581,2.64746696127971e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0562207027406577,0.00267323459703244,0.0509811629304741,0.0614602425508413,1.22151078589343e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.110140945515261,0.00524672097640463,0.0998573724015081,0.120424518629014,2.844676357046e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.111303237458829,0.00530602403025264,-0.121703044558124,-0.100903430359533,3.96756567509465e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,42679,-0.0666373769649248,0.00321415415902669,-0.0729371191166172,-0.0603376348132325,5.13066665234724e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0800673522155464,0.00388263299672166,0.0724573915419719,0.0876773128891209,4.82608603736022e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42659,0.109079399215229,0.00531823119416842,0.0986556660746591,0.119503132355799,4.40784291868485e-92
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.108455832785861,0.00537618471731234,-0.118993154831793,-0.0979185107399285,3.52719513792687e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42636,-0.0680000973074886,0.00337866894607998,-0.0746222884418053,-0.0613779061731718,8.77908121918167e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.161565419931162,0.00802965999534593,-0.17730355352204,-0.145827286340284,9.82914878794598e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41747,-0.0835205149381177,0.00416283661366345,-0.091679674700898,-0.0753613551753373,3.69307407801757e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.160329557659688,0.00813252051877905,-0.176269297876495,-0.144389817442881,2.59266112698549e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42611,0.0525698106956276,0.00268826089280754,0.0473008193457248,0.0578388020455304,5.46508399152252e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0594992482880341,0.00306014480617459,0.0535013644679319,0.0654971321081362,4.59325410088848e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.0894463197964156,0.00461092066236741,-0.0984837242946557,-0.0804089152981755,1.05532633272523e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42569,-0.140365086370338,0.00726764859677573,-0.154609677620018,-0.126120495120657,5.36896463596038e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0663170116535824,0.00343716088329745,-0.0730538469848454,-0.0595801763223194,7.49872175202654e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0711979930440395,0.0036872794413987,-0.0784250607491809,-0.063970925338898,9.86381296301562e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.122197614599639,0.00636020579994811,-0.134663617967537,-0.10973161123174,3.72538329940428e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.064660854688596,0.00337293437470063,0.0580499033141828,0.0712718060630093,7.58092531034276e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,42636,-0.161947738204158,0.00847533245367916,-0.178559389813369,-0.145336086594947,2.50100616524909e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.110568399720437,0.00580263763714051,-0.121941569489233,-0.0991952299516421,1.133336282374e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.104842673320371,0.00551444883106314,-0.115650993029255,-0.0940343536114877,1.49926254782307e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.151465523471886,0.00797174321820109,-0.16709014017956,-0.135840906764212,1.87519914524935e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.057179902960237,0.00303189511766002,-0.0631224173908506,-0.0512373885296233,2.51335860911939e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0609544404588559,0.00323885147031814,-0.0673025893406794,-0.0546062915770323,5.14441669081866e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.158210020005676,0.00844031196621548,-0.174753031459458,-0.141667008551893,3.1860630556036e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0491413199652408,0.00263563332281374,-0.0543071612779558,-0.0439754786525259,1.99965665814942e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,40539,-0.0367765710058651,0.00197294264138045,-0.0406435385829708,-0.0329096034287594,2.0780777598434e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42706,-0.0379844604518711,0.00207245979022579,-0.0420464816407137,-0.0339224392630286,3.89139335904675e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,40283,-0.0514044936760095,0.00281089741728157,-0.0569138526138814,-0.0458951347381377,1.24967751571524e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0567697005754607,0.00311002517424998,-0.0628653499169906,-0.0506740512339307,1.46898962814368e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42587,-0.14667578692518,0.00803553978131206,-0.162425444896552,-0.130926128953808,1.51185841767364e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0603881878988139,0.00332026645786,-0.0668959101562195,-0.0538804656414083,4.87304262057841e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42663,-0.0324040485471063,0.00178708563242109,-0.0359067363866516,-0.0289013607075609,1.29057459274232e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0554882841470479,0.00306147710338743,-0.0614887792696872,-0.0494877890244085,1.49887334012387e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,40182,-0.147123673850121,0.00811052839770258,-0.163020309509618,-0.131227038190624,1.75502419537393e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0741729531293146,0.00411319629547538,-0.0822348178684464,-0.0661110883901829,7.40927620450596e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0658780968325889,0.00365314988351206,-0.0730382706042725,-0.0587179230609052,7.44737485245593e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.104672668642786,0.00584047966150308,-0.116120008779332,-0.0932253285062402,5.54324582711444e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.0971829599221752,0.00543212487174117,-0.107829924670788,-0.0865359951735625,9.68195487992108e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,40527,0.106767126340235,0.00596890819317063,0.095068066281621,0.11846618639885,1.3802913940412e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.109586560278575,0.00613829227719852,0.0975555074152658,0.121617613141884,1.74988547373096e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0603048820726991,0.00338208708467719,-0.0669337727586664,-0.0536759913867318,3.69683664368635e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0690307221219395,0.00391306087468824,-0.0767003214363285,-0.0613611228075506,6.95726432880339e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0445814029033186,0.0025276929285056,0.0396271247634476,0.0495356810431896,7.48305301602766e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.132851549148366,0.00754927692673285,-0.147648131924762,-0.11805496637197,1.55611655276841e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0862950291251519,0.00490205502118214,0.0766870012836349,0.0959030569666689,1.87619093436389e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.114200097593124,0.00654555869354904,-0.12702939263248,-0.101370802553768,1.99653470503205e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.124994988103041,0.00717882211798552,-0.139065479454293,-0.110924496751789,5.07046119368056e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0417785063875012,0.0024049642256581,-0.0464922362697911,-0.0370647765052113,7.19205916602132e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42754,-0.0456841031956521,0.00263508155800105,-0.0508488630493341,-0.04051934334197,1.29333681184964e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.2570142037861,0.0148533890991433,-0.286126846420421,-0.22790156115178,2.36341681896969e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0608829488560664,0.00354543361023499,0.0539338989800058,0.067831998732127,2.12983434172443e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0680466245757552,0.00397065007436125,-0.0758290987215032,-0.0602641504300071,3.78356475051433e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0277098069050645,0.00162673345240864,0.0245214093383435,0.0308982044717854,2.15292117229445e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.132945414316129,0.00786228104399308,-0.148355485162355,-0.117535343469902,1.74938628261865e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0776704719579712,0.00459612059844893,-0.0866788683309311,-0.0686620755850113,2.02349829132008e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0738694167639649,0.00444231909817935,-0.0825763621963965,-0.0651624713315334,1.74937994939788e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0582583575579441,0.00350506607171027,-0.0651282870584962,-0.051388428057392,2.01630019143447e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.114500376237012,0.00690646888779101,-0.128037055257083,-0.100963697216942,4.03325994684596e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0764364703205082,0.00461716905290578,-0.0854861216642035,-0.0673868189768128,7.91980305368243e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42754,-0.050320800481663,0.00304580236507583,-0.0562905731172116,-0.0443510278461144,1.00878061321134e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42764,0.0905392379477174,0.00548170976580613,0.0797950868067374,0.101283389088697,1.08875684435193e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42676,0.069322271336817,0.00420079138091818,0.0610887202302174,0.0775558224434166,1.38803150567463e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,40283,-0.0636181962520341,0.00385201895768954,-0.0711681534091056,-0.0560682390949626,1.49511429817813e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.0783331582557841,0.00475889038186327,-0.0876605834042361,-0.0690057331073321,2.80923084569807e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.134630266472767,0.00819523407849385,-0.150692925266614,-0.118567607678919,4.74879203073082e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.120156067134609,0.00736095192470606,-0.134583532907033,-0.105728601362185,3.18629224826341e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42611,-0.0503972830116229,0.00309315037675328,-0.0564598577500593,-0.0443347082731864,4.0718340953745e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.0777320175295462,0.00478587416362502,-0.0871123308902512,-0.0683517041688411,9.39719179901657e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.151909183602982,0.00937771842910056,-0.170289511724019,-0.133528855481945,1.83672552944511e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0529601275178064,0.00327015770178892,-0.0593696366133127,-0.0465506184223001,1.93230460361481e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0544326778348995,0.00336511282873818,0.0478370566905727,0.0610282989792264,2.6712546064649e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0358563938828659,0.00221985559319127,-0.0402073108455207,-0.031505476920211,3.82235230304e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0884345121156739,0.00549840682416961,-0.0992113894910464,-0.0776576347403015,1.14850243422671e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,40527,0.0615633717230526,0.0038302340201172,0.0540561130436228,0.0690706304024823,1.70121137858532e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0585759270291917,0.0036700539793512,0.0513826212296633,0.06576923282872,1.00298571104556e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,40223,-0.0987431430532922,0.00622744522723182,-0.110948935698667,-0.0865373504079178,5.28993936616365e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,40424,-0.0397507685270002,0.0025087548882488,-0.0446679281079679,-0.0348336089460326,6.15131449275778e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.15982753959638,0.0101014579287638,-0.179626397136757,-0.140028682056003,7.2411417445376e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0426002169859388,0.0027023489067482,0.0373036131287124,0.0478968208431653,1.72703276440846e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0810987484852704,0.00515583948529172,-0.0912041938764421,-0.0709933030940986,3.66597600853113e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.19479823488692,0.0123993088012871,-0.219100880137442,-0.170495589636397,3.93902663853498e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0440397235677923,0.00280667961165201,-0.0495408156066302,-0.0385386315289544,6.59056107225347e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.0863205279284344,0.0055137921660724,-0.0971275605739363,-0.0755134952829325,9.50811337224051e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0772917983968017,0.00494119793898124,-0.0869765463572049,-0.0676070504363984,1.43304065195628e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0616278971185305,0.00395189584324754,-0.0693736129712957,-0.0538821812657653,2.38242269328184e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.0884089221339226,0.00567848202196724,-0.0995387468969784,-0.0772790973708668,4.43407777790858e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,40283,0.0359425106846461,0.00230893466394518,0.0314169987433136,0.0404680226259787,4.56784212143972e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,42636,-0.101978114223519,0.00658930953970413,-0.114893160921339,-0.0890630675256986,1.45229044033451e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42668,0.059831350751838,0.00386781782715489,0.0522504278106144,0.0674122736930616,1.61889205302738e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0431954398213039,0.00279261381678813,-0.0486689629022086,-0.0377219167403992,2.0129285257581e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0857902779614955,0.00556188019530131,-0.0966915631442861,-0.0748889927787049,4.04909682460209e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.0908997522266171,0.00593919086487336,-0.102540566321769,-0.0792589381314654,2.00321605042739e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,42488,0.0421189139661146,0.00276733265666788,0.0366949419590455,0.0475428859731836,7.12149520322969e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0587023978201665,0.00386030814954065,-0.0662686017932661,-0.0511361938470668,8.70161851224042e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42794,-0.0764210231214229,0.00504026939917575,-0.0862999511438073,-0.0665420950990384,1.66110983199043e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.0820688582716748,0.00541366140090239,-0.0926796346174435,-0.0714580819259061,1.73480244265832e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.112808746706328,0.0074722648043618,-0.127454385722877,-0.0981631076897788,5.32648845235946e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.121556752475135,0.00805977032324316,-0.137353902308692,-0.105759602641579,5.68037474936129e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.156291642926236,0.0103669645018889,-0.176610893349938,-0.135972392502533,6.10214535152288e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42587,-0.063727273609436,0.0042405246130164,-0.0720387018509482,-0.0554158453679239,1.24143901549031e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0243328442742075,0.00162207882568567,0.0211535697758635,0.0275121187725514,1.83031257753829e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0682431458520627,0.00455638909531193,0.0593126232252513,0.0771736684788741,2.63027090632881e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0542842856110851,0.00363161171497682,-0.0614022445724397,-0.0471663266497305,4.11111623371671e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.127982309850633,0.00858351469446087,-0.144805998651777,-0.11115862104949,7.09905716025455e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.0866252560560915,0.00582052915799598,-0.0980334932057636,-0.0752170189064193,1.07133342304688e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0524516252818901,0.0035321670491369,-0.0593746726981984,-0.0455285778655818,1.71491728140865e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.0895325133180012,0.00603198131183225,-0.101355196689192,-0.07770982994681,1.88275618601722e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42636,-0.0932392596607781,0.00631620668061676,-0.105619024754787,-0.0808594945667692,6.2282659775805e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.163692844390891,0.0110868786506473,-0.185423126546159,-0.141962562235622,7.0974115533385e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42754,-0.0649465387036143,0.00441128612764742,-0.0735926595138032,-0.0563004178934254,1.09282811382397e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.044678436274359,0.00303896260376355,0.0387220695709824,0.0506348029777355,1.49010605580793e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.135149303960128,0.00919500659807286,-0.153171516892351,-0.117127091027905,1.60574366417855e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0353029221814835,0.00240333258974434,-0.0400134540573824,-0.0305923903055846,1.7840806854471e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0728065144040098,0.00497389239810942,-0.0825553435043043,-0.0630576853037154,3.79560771831182e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0550350739603304,0.00376896724418113,-0.0624222497589254,-0.0476478981617354,7.55671416575113e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0878666532556241,0.00603885720849876,0.0760304931269666,0.0997028133842817,1.60277405402036e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.0822157644806089,0.00565766532282965,-0.093304788513355,-0.0711267404478628,2.04675378089761e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.079672994621138,0.0054979511159134,-0.0904489788083283,-0.0688970104339478,3.19185919294343e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.0960423831031278,0.00663210760082251,-0.10904131400074,-0.0830434522055157,3.5901501102845e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0734096650771855,0.00509702994668297,-0.0833998437726841,-0.0634194863816869,1.10116972264961e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42594,0.0629784795284877,0.00439480498514393,0.0543646617576056,0.0715922972993698,3.11081101568043e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.100291015028321,0.0070086626149638,-0.11402799375365,-0.0865540363029922,4.17501940254081e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0732549139024779,0.00515114268738965,-0.0833511535697616,-0.0631586742351942,1.45360043020363e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0387881917829032,0.00272762126476762,-0.0441343294618477,-0.0334420541039586,1.46551981214242e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0529375059228212,0.00373649627226421,-0.060261038616459,-0.0456139732291833,3.12267700706647e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0709536845839841,0.00501902948750621,-0.0807909823794963,-0.0611163867884719,4.69529872037219e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0405526445320129,0.00287462378753269,-0.046186907155577,-0.0349183819084489,7.14003454399638e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0491868401025107,0.00349298561642076,0.042340588294326,0.0560330919106954,1.02640281081998e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,40346,-0.0389998524442243,0.00277896810567188,-0.0444466299313412,-0.0335530749571074,2.30255421367785e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,40283,-0.0884830961054663,0.00630900679915922,-0.100848749431818,-0.0761174427791142,2.62280430844092e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.101464517348359,0.00730135551870036,-0.115775174165011,-0.0871538605317059,1.33956847402564e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0729205501562474,0.0052500039532633,-0.0832105579046435,-0.0626305424078513,1.46378216228836e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.0382255271394501,0.00275475389951152,0.0328262094964075,0.0436248447824927,1.99731536691188e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.0862163120959077,0.00622227151689647,0.0740206599227906,0.0984119642690248,2.32877594714499e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42676,-0.0501655391286177,0.00362136355071901,-0.0572634116880269,-0.0430676665692084,2.42795083775581e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.112241906631328,0.00810358610922664,-0.128124935405412,-0.0963588778572434,2.53034818460364e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0615370923875575,0.00445948222887799,-0.0702776775561583,-0.0527965072189566,5.87130580307476e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0632196635073719,0.00458902685651083,-0.0722141561461332,-0.0542251708686107,7.01809588989874e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,40482,-0.0604892097405081,0.00439243723456487,-0.0690983867202553,-0.051880032760761,8.41831310300999e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0625113624256181,0.00454973083228673,-0.0714288348569001,-0.0535938899943361,1.14356303545008e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0631836211196918,0.00460668807834866,-0.0722127297532552,-0.0541545124861284,1.57568920897028e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.114646096065845,0.00835561031610461,-0.13102309228541,-0.0982690998462801,1.66583638930728e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0423890528763027,0.00310028512736878,-0.0484656117259455,-0.0363124940266599,2.83965080400434e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,40482,-0.0613094134979015,0.00448789761094144,-0.0701056928153467,-0.0525131341804563,3.75048751463948e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42689,-0.075932950857655,0.00556363154886958,-0.0868376686934394,-0.0650282330218706,3.94495994888386e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,40527,0.0553872255242171,0.00406452941169684,0.0474207478772913,0.063353703171143,5.92276901330747e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,40511,-0.0359336329282386,0.0026420421223616,-0.0411120354880674,-0.0307552303684099,8.44506233645907e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0299666583139308,0.00221426141535864,-0.0343066106880338,-0.0256267059398279,2.0790803688215e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42613,0.229284356736487,0.0170823105649754,0.195803028029135,0.262765685443838,8.20178792473523e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42594,-0.0985868881424914,0.00735133826139662,-0.112995511134829,-0.0841782651501541,9.5777093538214e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0453210647221766,0.00338097414363338,-0.051947774043698,-0.0386943554006552,1.04299238807596e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42659,-0.0401910234582774,0.00301102685165508,-0.0460926360875213,-0.0342894108290334,2.19825886232674e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42754,-0.0470753106510271,0.00353505663771126,-0.0540040216609412,-0.040146599641113,3.31003305342755e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,40342,-0.0319659946438324,0.00240229891277611,-0.0366745005128735,-0.0272574887747912,4.29290058767334e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.0896637280644102,0.00675223664663117,-0.102898111891807,-0.0764293442370132,6.23714747852475e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0363952747792845,0.00275350232168097,-0.0417921393297792,-0.0309984102287898,1.21786952292053e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0746322952815674,0.00564857995650408,-0.0857035119963154,-0.0635610785668194,1.30419325718539e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42588,0.0507599173914068,0.00384753113087415,0.0432187563748934,0.0583010784079201,1.70064815855197e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0658385892236922,0.00500319961621816,-0.0756448604714798,-0.0560323179759045,2.637702615569e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,40488,0.0254450551268858,0.00194369579025025,0.0216354113779954,0.0292546988757763,7.10237828495799e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0300726951679586,0.00230078636652915,-0.0345822364463558,-0.0255631538895615,8.36420740522055e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0731278648552208,0.00559262617799296,-0.084089412164087,-0.0621663175463546,8.79532271225587e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0970518669040156,0.00745391801392158,0.0824421875967293,0.111661546211302,1.77324181684036e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.10609501505221,0.00816873411141174,-0.122105733910577,-0.0900842961938434,2.44070333699813e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0807413246226647,0.00622103449515182,-0.0929345522331623,-0.0685480970121672,2.72539785643465e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,40511,0.0453070119395014,0.00349195164703216,0.0384627867113184,0.0521512371676845,3.18824486144538e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0411132033576084,0.00317374892594229,-0.0473337512524552,-0.0348926554627615,3.76498142433203e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.0759891101901024,0.00586730025472765,-0.0874890186893686,-0.0644892016908362,3.90614639315573e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0346264036572161,0.00267383334479576,-0.0398671170130158,-0.0293856903014164,3.95359014218957e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0322668987964825,0.00249402663573394,0.027378606590444,0.0371551910025211,4.66267346331295e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.051641593752905,0.00400102501413849,-0.0594836027806165,-0.0437995847251936,6.89655826978835e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,42188,-0.0513076252162984,0.00397716230539068,-0.0591028633348641,-0.0435123870977327,7.62729345025015e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.0771285760522846,0.00598616009075451,-0.0888614498301635,-0.0653957022744058,9.20239985698357e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0442914638297486,0.00343934063734376,0.0375503561805548,0.0510325714789423,9.98584427161543e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0569552830495268,0.00442855079527035,0.0482753234907969,0.0656352426082567,1.24201523837994e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0460933567532121,0.00360574059078345,-0.0531606083111476,-0.0390261051952765,3.35172093155375e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0469450434846799,0.00368902689303403,-0.0541755361950266,-0.0397145507743332,6.99623685575371e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,40539,-0.0248340804999936,0.0019515743750273,-0.0286591662750471,-0.0210089947249401,7.65137701389988e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.0966052125416128,0.00760695642909666,-0.111514847142642,-0.0816955779405833,9.62239910023208e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0555318098661487,0.00438021095486843,-0.0641170233376908,-0.0469465963946066,1.27284116955654e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0520596326123148,0.00411299827722133,0.043998155988961,0.0601211092356686,1.6472492769679e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0345464357767175,0.00273095194521188,-0.0398991015893328,-0.0291937699641022,1.80713600246005e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.0841191739799622,0.00667718411168205,-0.097206454838859,-0.0710318931210654,3.78460429351965e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0338819060948379,0.00269446291540686,-0.0391630534090353,-0.0286007587806404,5.12426307122938e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42613,-0.0539427771164956,0.00430262029482945,-0.0623759128943613,-0.0455096413386299,7.42042601593451e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.030956151519502,0.00247744615615501,0.0261003570534382,0.0358119459855659,1.24431233252288e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42613,-0.0389557384397744,0.0031466068693658,-0.0451230879037314,-0.0327883889758174,5.19162568786164e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0853399697058261,0.0069088899873998,-0.0988813940811297,-0.0717985453305225,7.33542187148043e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.044360202111095,0.00359475100869778,-0.0514059140881427,-0.0373144901340474,8.46264000809771e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.043983301233905,0.00357247135399247,-0.0509853450877302,-0.0369812573800797,1.21041789577872e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0420216051251836,0.00341376103955145,0.0353306334876627,0.0487125767627044,1.23738780773621e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0547114562999748,0.00444317686504786,-0.0634200829554686,-0.046002829644481,1.29304371832325e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0291638262604948,0.0023716323413213,0.0245154268715051,0.0338122256494845,1.44496333429169e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0741520080454822,0.0060313229055592,-0.0859734009403783,-0.0623306151505862,1.48327635885237e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0419274031856815,0.00341563014938193,-0.0486220382784701,-0.0352327680928929,2.05115384043729e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0444029822229131,0.00362478151163867,-0.0515075539857249,-0.0372984104601013,2.55841155877867e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0534377539606747,0.00436733086536609,0.0448777854645571,0.0619977224567922,3.03998888618798e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42495,0.0422268812207564,0.00345302491771124,0.0354589523820423,0.0489948100594704,3.3229885718853e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,40223,-0.071886027442129,0.0058827588239962,-0.0834162347371615,-0.0603558201470964,4.049283658275e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0481869326281754,0.00394917004367587,-0.0559273059137801,-0.0404465593425707,4.609530858472e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42721,-0.0682624591370256,0.00559554051933347,-0.0792297185549192,-0.057295199719132,4.72452018504959e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.028220010941158,0.0023133112474697,-0.0327541009861986,-0.0236859208961174,4.77746081157758e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0527977110641442,0.00432828731597958,-0.0612811542034642,-0.0443142679248243,4.80325819396223e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42618,-0.0406820785360628,0.00334760845043814,-0.0472433910989215,-0.034120765973204,8.36448010270634e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42620,-0.0390778955955951,0.0032167769610823,-0.0453827784393164,-0.0327730127518738,8.82423694892748e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.0772005436319681,0.00638763456457803,-0.0897203073785411,-0.0646807798853952,1.8708933568334e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42671,-0.0373234159657389,0.00309114664531629,-0.0433820633905588,-0.031264768540919,2.14728972015884e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,40483,-0.17525774682775,0.0145237788879475,-0.203724353448127,-0.146791140207372,2.53084844666226e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0467014211377272,0.00387859218375292,-0.054303461817883,-0.0390993804575715,3.2171658852594e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0630438739145947,0.00525224203018647,0.0527494795354292,0.0733382682937601,5.04354016487716e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0386949526077875,0.00322455641919239,-0.0450150831894046,-0.0323748220261704,5.2368162146802e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0453353666896259,0.00378646482934362,-0.0527568377551394,-0.0379138956241124,7.2084461811611e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,40527,-0.0885218276441769,0.00740606915182143,-0.103037723181747,-0.0740059321066069,9.89495713031349e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42636,0.0369930642286714,0.00310971669863304,0.0308980194993506,0.0430881089579921,1.80749144496971e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0496767318413417,0.00418421984841658,-0.0578778027442382,-0.0414756609384452,2.3865603857394e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0691036727758818,0.00582683496255768,-0.0805242693024949,-0.0576830762492688,2.77502960339055e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0346892959460348,0.0029342635258762,-0.0404404524567522,-0.0289381394353175,4.69202684681806e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0354851275886426,0.00300567841958066,-0.0413762572910207,-0.0295939978862645,5.22270623729118e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.102554317829321,0.00870959835131266,-0.119625130597894,-0.0854835050607486,7.5698737536081e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0423642062805618,0.00360005394805481,-0.0494203120187492,-0.0353081005423743,8.24955831979348e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0317620757763519,0.00270556254330343,-0.0370649783612267,-0.0264591731914772,1.1407899462489e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0385891635166345,0.00328744802791747,0.0321457653819162,0.0450325616513527,1.15234201450409e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0438955851049875,0.00374140171784419,0.0365624377380129,0.0512287324719621,1.2386942379305e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,40511,0.0329740144470067,0.00281241832241665,0.0274616745350701,0.0384863543589434,1.45416413772892e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0726635879446608,0.00620902877649674,-0.0848332843465944,-0.0604938915427272,1.87126398028988e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42638,0.0249173856677431,0.00213695492236672,0.0207289540199043,0.0291058173155819,2.87749135597706e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42640,0.0443364069309148,0.00380287774280369,0.0368827665550196,0.0517900473068101,2.93080746592534e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0405727372372168,0.00348546369697843,-0.0474042460832946,-0.0337412283911391,3.64822112396617e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,42311,-0.0593244872757087,0.00510626194470521,-0.0693327606873309,-0.0493162138640865,4.73828789885743e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0356895504512898,0.00307708717561243,-0.0417206413154902,-0.0296584595870895,5.88186268995619e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42663,-0.0371439060859281,0.00320621858994656,-0.0434280945222234,-0.0308597176496329,6.88106166612864e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0294067520423323,0.00254254814653436,-0.0343901464095397,-0.0244233576751249,8.59879595526675e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42594,-0.101861884321459,0.00882508903351424,-0.119159058827147,-0.0845647098157714,1.12731180400748e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,40223,-0.0689436522457658,0.00597620843570539,-0.0806570207797484,-0.0572302837117833,1.29618371222925e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,40199,-0.0941894203927498,0.00819855291365002,-0.110258584103504,-0.0781202566819957,2.24390251184538e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0677524749892715,0.00590212817404621,-0.0793206462104021,-0.056184303768141,2.32370519264631e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0760016778435302,0.00662141758298393,-0.0889796563061787,-0.0630236993808817,2.34808744383983e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0373755624770607,0.00326661878491713,-0.0437781352954983,-0.0309729896586232,3.57721475714423e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.030296905905769,0.0026559600092848,0.0250912242875708,0.0355025875239672,5.2984245952388e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0321261110480467,0.00281856519581454,0.0266017232642502,0.0376504988318432,5.89708603962583e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42711,0.0432181885702275,0.0037953720385625,0.035779259374645,0.05065711776581,6.63734506328106e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0587041903656248,0.00516107685458726,-0.0688199010006158,-0.0485884797306338,7.6645421253198e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.085331517943415,0.00751806891182344,-0.100066933010589,-0.0705961028762411,1.01042041141385e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.060367796798077,0.00533925764926794,-0.0708327417906422,-0.0499028518055119,1.65874544748864e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,40283,-0.0512871269146815,0.00454314847273117,-0.0601916979212345,-0.0423825559081284,2.15359200834946e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0750463193131183,0.00665189111600313,-0.0880840259004845,-0.0620086127257522,2.18640799053231e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.138484103243807,0.0122762131787056,-0.16254548107407,-0.114422725413544,2.21782054532019e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0308973253373253,0.00274307631900117,0.025520895752083,0.0362737549225676,2.83393508159893e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.12688610653449,0.0112778802957025,-0.148990751914067,-0.104781461154913,3.10095531550337e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0888841101025254,0.00791592681648146,-0.104399326662829,-0.0733688935422217,4.21722758974396e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.141027289105028,0.0125592467829621,-0.165643412799633,-0.116411165410422,4.23010870050588e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0617326243343101,0.00551026944750917,-0.0725327524514281,-0.0509324962171922,5.29146340414671e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.0832991537278534,0.0074384323584102,-0.0978784811503374,-0.0687198263053694,5.93032894705108e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0569418200374512,0.00508863508859275,-0.066915544811093,-0.0469680952638094,6.16670835781789e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0463578652943343,0.00414324466563989,0.0382371057496801,0.0544786248389885,6.21749988920287e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.02709590085882,0.00242241057102134,0.0223479761396182,0.0318438255780219,6.43673931018947e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0354158936407753,0.00316553597881684,0.0292114431222943,0.0416203441592563,6.53079479747744e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.0954602904387971,0.00853745895810932,-0.112193709996691,-0.0787268708809028,7.13437165664086e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,40379,0.121845769240556,0.0109020698574147,0.100477712320023,0.143213826161089,7.56395430953322e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0583346627225797,0.00523637194187237,-0.0685979517286495,-0.0480713737165098,1.06560516618888e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0485969780735546,0.00437431851893985,-0.0571706423706767,-0.0400233137764325,1.50111394057332e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0766305432812557,0.00690019640531659,-0.0901549282356762,-0.0631061583268351,1.57764582353484e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0482031360311685,0.00434509702834247,-0.0567195262067198,-0.0396867458556173,1.79120961291154e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42636,-0.0770095724011282,0.00695093430346535,-0.0906334036359203,-0.0633857411663361,2.10475529581334e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42754,-0.0404745698037129,0.00365721514464765,-0.0476427114872223,-0.0333064281202035,2.3970828319825e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.0878924376704092,0.00794014507619444,-0.10345512201975,-0.0723297533210681,2.49168157427362e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.074595416849923,0.00675948048729947,-0.08784399860503,-0.0613468350948161,3.41836663116987e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0377009695061781,0.00341588379786085,-0.0443961017499853,-0.0310058372623708,3.53287539297416e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42611,0.0284246163423668,0.00257938933575921,0.0233690132442787,0.0334802194404549,4.04438638622164e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0417407705960683,0.00379259717366141,-0.0491742610564447,-0.0343072801356919,4.70298005700307e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.038359519331592,0.0034888480190756,-0.0451976614489801,-0.0315213772142038,5.32186599867207e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.106115314436608,0.00965184875774205,-0.125032938001782,-0.0871976908714333,5.36218428953929e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.114974559071003,0.010462191992198,-0.135480455375712,-0.0944686627662953,5.65257918370625e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0680892689416903,0.00620132436894391,-0.0802438647048204,-0.0559346731785603,6.28681841561052e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0792102233545489,0.00724512898047945,-0.0934106761562887,-0.0650097705528092,1.0526826813776e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.0806229506540771,0.00737333261024667,-0.0950746825701606,-0.0661712187379937,1.0856520832264e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0724373999265884,0.00662582740979961,-0.0854240216497956,-0.0594507782033811,1.10923991657254e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.037461159913464,0.00343328778689237,0.030731915851155,0.0441904039757731,1.33118417104513e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0261762779898479,0.00239911403596678,0.021474014479353,0.0308785415003428,1.33470067641201e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0608725541053833,0.00558049601609019,-0.0718103262969201,-0.0499347819138465,1.37717930799912e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0374421090187096,0.00343357831812471,-0.044171922522234,-0.0307122955151851,1.42561663181771e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0746941924115107,0.00684673330078343,-0.0881137896810462,-0.0612745951419752,1.43731456605427e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0516457398272822,0.00474154708188544,-0.0609391721077776,-0.0423523075467867,1.72074416862162e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0334853618836002,0.00307768478475016,-0.0395176240617106,-0.0274530997054899,1.86827100243411e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0730540265953633,0.0067355622671188,-0.0862557286389162,-0.0598523245518105,2.69997835439783e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0932376686723654,0.00862617225084712,-0.110144966284026,-0.0763303710607051,4.04716420401326e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39956,-0.024832024161184,0.00229708366323398,-0.0293343081411227,-0.0203297401812454,4.24114969636355e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00942190285439372,0.000872436202256072,0.00771192789797182,0.0111318778108156,4.45834708776446e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0780963890797194,0.00725171503523489,-0.0923097505487798,-0.063883027610659,6.19051989202933e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42587,-0.0756186442641118,0.00702594599297847,-0.0893894984103496,-0.0618477901178739,6.64702851220011e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0322756899196127,0.00300353083902722,-0.0381626103641061,-0.0263887694751193,7.96421025584892e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.121415482561374,0.0113310450510572,-0.143624330861446,-0.0992066342613021,1.10617747686081e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0738764617091517,0.00691178054011022,-0.0874235515677678,-0.0603293718505357,1.54460422738148e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0611578499452144,0.00574628885692274,-0.0724205761047829,-0.0498951237856458,2.50484723796337e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.111593099901982,0.0105007768935503,-0.132174622613341,-0.0910115771906237,2.83552603164931e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.050189975539411,0.00472507660212001,-0.0594511256795662,-0.0409288253992558,2.99291808114196e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0413425445499862,0.00389078984764055,-0.0489684926513617,-0.0337165964486107,3.00574991743139e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0795763570048094,0.0074923751987773,-0.0942614123944129,-0.0648913016152059,3.01849203216209e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.115012724664783,0.0108316430148724,-0.136242744973933,-0.0937827043556327,3.26150174983936e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,40515,-0.0593015001303918,0.00558608239773296,-0.0702502216299484,-0.0483527786308352,3.33634014913123e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0334368049664497,0.00314962251669059,-0.0396100650991632,-0.0272635448337361,3.34023870034991e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.101359381928911,0.00958035055455446,-0.120136869015837,-0.082581894841984,4.67827173229672e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0427576086541106,0.00404620540377284,-0.0506881712455054,-0.0348270460627159,5.3299136322338e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.0657368102980004,0.00624801880946219,-0.0779829271645462,-0.0534906934314545,8.6760615942804e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,40527,-0.12009061839514,0.0114143077281695,-0.142462661542352,-0.0977185752479278,9.0814523968086e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42711,-0.0385645039056461,0.00366815979909323,-0.0457540971118689,-0.0313749106994234,9.42965213604638e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0624197947859223,0.00594459348760539,-0.0740711980216288,-0.0507683915502157,1.0879812028367e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0307693012332784,0.0029307022249696,-0.0365134775942188,-0.025025124872338,1.14760761858806e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.059956762831672,0.00572269541720882,-0.0711732458494013,-0.0487402798139427,1.3832840289551e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0484436034768668,0.00462753249903079,-0.0575135671749671,-0.0393736397787664,1.51445241586615e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0662737684512454,0.00633860362760997,-0.0786974315613609,-0.0538501053411298,1.82190675799745e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0353159922544688,0.00338582287312791,-0.0419522050857995,-0.0286797794231381,2.25000423930813e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.113833339358586,0.0109374272143234,-0.135270696698659,-0.0923959820185117,2.86671548606069e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.11121333998923,0.0106845652517709,-0.132155087882701,-0.0902715920957593,2.94350174196571e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.0920556297387511,0.00884747946054723,-0.109396689481424,-0.0747145699960785,2.95001192818125e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0662432360850956,0.00636966778648914,-0.0787277849466144,-0.0537586872235769,3.11231395300682e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42711,-0.0247225924415174,0.00238001699664776,-0.0293874257549471,-0.0200577591280878,3.513161396198e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.0949235089485532,0.00914265728425666,-0.112843117225696,-0.0770039006714101,3.711101103405e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0437562394329809,0.00422245689919278,-0.0520322549553987,-0.035480223910563,4.54915933612483e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0211677259444756,0.00204646486599324,-0.0251787970818224,-0.0171566548071289,5.55867896274562e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0605584978369932,0.00585685380307636,-0.0720379312910229,-0.0490790643829636,5.76166187120262e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0441236044820978,0.00427056087817411,-0.052493903803319,-0.0357533051608765,6.25157473613573e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0221402500885203,0.00214528310602487,0.0179354952007116,0.0263450049763291,7.08647216583332e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0373089737554172,0.00361633389564817,-0.0443969881908876,-0.0302209593199468,7.69228460973492e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,42346,-0.0488142364870486,0.00473392163202439,-0.0580927228858164,-0.0395357500882808,7.76590649706193e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.093545411184085,0.00908384442700312,-0.111349746261011,-0.0757410761071589,8.88708115481778e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42721,0.0485399658450421,0.00471400209790666,0.039300521733145,0.0577794099569391,8.97538247217162e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.0697252464736452,0.00678163151248434,-0.0830172442381146,-0.0564332487091759,1.09651676118322e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.057414708753202,0.00558916267341553,-0.0683694675930965,-0.0464599499133076,1.20251479998733e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0315548421401952,0.00307735814519205,-0.0375864641047716,-0.0255232201756187,1.40180216197514e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0330032875447813,0.00321962817357551,-0.0393137587649893,-0.0266928163245733,1.44722614404977e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,40199,-0.0479138426390836,0.00467750281537341,-0.0570817481572155,-0.0387459371209517,1.63110090515654e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0522173640017036,0.00511500111405925,-0.0622427661852598,-0.0421919618181475,2.23671938989159e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,42437,-0.0433836473279105,0.00425121200639265,-0.0517160228604401,-0.0350512717953809,2.31748537388038e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0501026397687887,0.00491772992043501,-0.0597413904128413,-0.040463889124736,2.74476101469393e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.100414532188131,0.009867047508734,-0.119753945305249,-0.0810751190710122,3.20557121422673e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0917560103814828,0.00903492723580851,-0.109464467763668,-0.0740475529992982,3.82243668343644e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0527108925892764,0.00519626728915706,-0.0628955764760242,-0.0425262087025285,4.31210000879644e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.0853989495796103,0.0084195917880587,-0.101901349484205,-0.0688965496750153,4.35486972810998e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.065129544753002,0.0064370367145734,-0.0777461367135659,-0.0525129527924382,5.59865535587472e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42794,0.0281645483114885,0.00278370875248216,0.0227084791566234,0.0336206174663535,5.61006314264282e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0297602846783457,0.0029468649211395,0.0239844294329123,0.0355361399237792,6.79582494021728e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0692084779350561,0.00686465123944978,-0.0826631943643777,-0.0557537615057346,8.09227371374584e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0520013314875101,0.00515884760401221,0.0418899901836461,0.062112672791374,8.22675121638378e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0371105197841342,0.00368205010170877,-0.0443273379834834,-0.029893701584785,8.3267520677051e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,42317,-0.04982591799908,0.00494497474002281,-0.0595180684895247,-0.0401337675086353,8.60256441121612e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0707493115995172,0.00704419496229646,-0.0845559337256182,-0.0569426894734161,1.18826286862321e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,42370,-0.0471706553562563,0.00469658705448778,-0.0563759659830524,-0.0379653447294603,1.19238710138862e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,42370,-0.0454207173803512,0.00452306748516389,-0.0542859296512725,-0.03655550510943,1.2115784358284e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0583192627279397,0.00580981773340011,-0.0697065054854039,-0.0469320199704755,1.2557448094021e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0269456421966927,0.00268864189038186,-0.0322153803018412,-0.0216759040915443,1.53290189066776e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.0843639921983385,0.00842948540090857,-0.100885783584119,-0.0678422008125577,1.76740639653134e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0287423044310918,0.00287986310063348,-0.0343868361083334,-0.0230977727538502,2.24915506654516e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0359312181961367,0.00360049287177114,-0.0429881842248082,-0.0288742521674653,2.25928610713381e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,40511,-0.0366155039291043,0.00366785844389706,-0.0438045064791425,-0.029426501379066,2.26441425395588e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0573172323323582,0.00574434072696391,-0.0685761401572074,-0.0460583245075089,2.29467699034382e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0655903334099187,0.00658126923109814,-0.0784896211028711,-0.0526910457169663,2.57546300913666e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0302131475106671,0.00303229434745537,-0.0361564444316796,-0.0242698505896546,2.74100806643861e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0622362929888322,0.00624912212614752,0.0499880136215831,0.0744845723560814,2.77022885635693e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,40199,-0.0931870595804455,0.00937260501141686,-0.111557365402823,-0.0748167537580685,3.40590641218094e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,40482,-0.0546528875721681,0.00549819979256915,-0.0654293591656036,-0.0438764159787326,3.4670255672167e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.026363111781841,0.00265609610996267,-0.0315690601573678,-0.0211571634063141,4.00618764639529e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0399291029850931,0.00402724403863275,0.0320357046693729,0.0478225013008133,4.30818765388359e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39872,-0.0241374547288443,0.0024405346828096,-0.0289209027071511,-0.0193540067505375,5.76030764025453e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0629011965291379,0.00636352389113677,-0.075373703355766,-0.0504286897025098,5.83750818646573e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0284764429275744,0.00288712461133472,0.0228176786893583,0.0341352071657905,7.45890245018195e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0443499459937804,0.00450804689691171,-0.0531857179117274,-0.0355141740758335,9.58896802968933e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0677786025772916,0.00689354011889425,-0.0812899412103243,-0.0542672639442588,1.0094130000459e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0386328367943299,0.00393186774981438,-0.0463392975839661,-0.0309263760046937,1.0838066784374e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0301233515983018,0.00306709722151909,-0.0361348621524792,-0.0241118410441244,1.12078332466913e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0287479404217214,0.00292947175154473,0.0230061757886937,0.034489705054749,1.17459129203404e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0325247611872202,0.00331708679364728,0.0260232710716715,0.0390262513027688,1.31498725904858e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0441934423830242,0.00450946582455139,-0.053031995399145,-0.0353548893669035,1.33693654209718e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0282792368646745,0.0028862502350383,0.0226221864039994,0.0339362873253495,1.368379907913e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.039484221468897,0.00403478531546881,-0.0473924006872159,-0.0315760422505781,1.53769778926849e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0802345750251386,0.00820346932159086,-0.0963133748954566,-0.0641557751548205,1.67608364977992e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0505629989354459,0.00517587292805996,-0.0607077098744435,-0.0404182879964484,1.878604815196e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0565764248956961,0.00579448780055775,-0.0679336209847893,-0.0452192288066029,1.91170363519104e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42679,-0.0432465142146541,0.00443086453574205,-0.0519310087047085,-0.0345620197245997,1.97757381280405e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0603811767202552,0.00618844260960378,-0.0725105242350786,-0.0482518292054318,2.05026722708937e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0400920104716925,0.00410948533659547,-0.0481466017314196,-0.0320374192119654,2.06272621416171e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.0819747401874671,0.00840202738962409,-0.0984427138711303,-0.0655067665038039,2.1304463723455e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0285401682969162,0.00292679005918338,-0.0342766768129157,-0.0228036597809168,2.1631597318367e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0561653377291887,0.00576047626909203,-0.0674558712166091,-0.0448748042417683,2.19488625712956e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0576922439853988,0.00592256404308525,-0.0693004695098459,-0.0460840184609517,2.38883522752442e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0713899797014424,0.00735739128771945,-0.0858104666253725,-0.0569694927775123,3.5915689453079e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0561157012100507,0.00579120368657854,-0.0674664604357446,-0.0447649419843567,3.9374609135286e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42594,-0.0909232928843556,0.00940479021935392,-0.109356681714289,-0.072489904054422,4.87788577415835e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0560995528035292,0.00580283317452438,-0.0674731058255969,-0.0447259997814614,4.8995045776666e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0661038379145757,0.0068546562927524,-0.0795389642483704,-0.052668711580781,6.38237545698365e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0191698833830674,0.00198983965600881,-0.0230699691088447,-0.0152697976572901,6.77183717281958e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0473500397585943,0.00492302263130342,-0.056999164115949,-0.0377009154012396,8.17570024697092e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0224634049591276,0.002338495816904,-0.0270468567602594,-0.0178799531579957,9.13518219479088e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0359223663293898,0.00374492861261067,-0.0432624264101068,-0.0285823062486729,1.01132817586904e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0189332524793193,0.00197705891140222,-0.0228082879456676,-0.0150582170129709,1.18301947218562e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0432297784327337,0.00452410684022728,-0.0520970278395792,-0.0343625290258883,1.48555030426071e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,42654,0.0467746980868713,0.00491501389200708,0.0371412708585374,0.0564081253152052,2.08744252050751e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,40283,-0.0489065233571964,0.00514070359690949,-0.058982302407139,-0.0388307443072538,2.22240041368906e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.043251703376959,0.00455462169579591,-0.052178761900719,-0.0343246448531991,2.61253664563987e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0310430398676804,0.00327310576110822,-0.0374583271594525,-0.0246277525759083,2.94098641739206e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0446585758164317,0.00471144557681016,0.0354241424858838,0.0538930091469796,2.99598634559554e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42679,-0.0538030780804606,0.00567810242888368,-0.0649321588410726,-0.0426739973198485,3.08983561274721e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0562328847554081,0.00593904509310501,-0.0678734131378939,-0.0445923563729223,3.40927048886251e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0262047999124342,0.00277166958243862,0.0207723275308545,0.0316372722940139,3.77467490545484e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.0763317080124737,0.00807623769759314,-0.0921611338997563,-0.0605022821251912,3.88495673952249e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,42476,-0.059513713219602,0.00630364011434576,-0.0718688478437196,-0.0471585785954843,4.29261482451227e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42587,-0.0504592451602825,0.00534637489206843,-0.0609381399487366,-0.0399803503718284,4.41661395121457e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42618,-0.0264232271223321,0.00280140465060469,-0.0319139802375173,-0.0209324740071469,4.66871553577888e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.059011496817383,0.00626130622273196,-0.0712836570139376,-0.0467393366208283,5.02043962782602e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0261363323688408,0.00277336838702678,-0.0315721344074132,-0.0207005303302683,5.04244016747055e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,42357,-0.0514513992657036,0.00546081553366134,-0.0621545977116798,-0.0407482008197274,5.15772399969837e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0798480434439062,0.00847817685413554,-0.0964652700780119,-0.0632308168098006,5.33514478398917e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.036045386497981,0.00383207582537558,-0.0435562551157171,-0.0285345178802448,5.96576620760122e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0564316005317691,0.00600124714156241,-0.0681940449292314,-0.0446691561343067,6.15075823739502e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42534,-0.0655377776940583,0.00698410312310491,-0.0792266198153439,-0.0518489355727726,7.3749026265422e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0395452550739922,0.00421824067300603,-0.047813006793084,-0.0312775033549004,8.01614412391244e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.046281482567848,0.00494040027333011,-0.055964667103575,-0.036598298032121,8.58324003895186e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0794447675962802,0.00848255087913403,-0.0960705673193828,-0.0628189678731775,8.74068992393994e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.0922603910097246,0.00984995389610271,-0.111566300646086,-0.0729544813733633,8.91517490392586e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0745624852352795,0.00797376516727616,-0.0901910649631408,-0.0589339055074182,1.03611926750459e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0756079285921295,0.0080994402035536,-0.0914828313910946,-0.0597330257931645,1.16689699417807e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0844877703431327,0.00905426251926829,-0.102234124880899,-0.0667414158053668,1.20819211712905e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42692,-0.0580757403245618,0.00623067811104279,-0.0702878694222056,-0.0458636112269179,1.32968095520297e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0141953880153963,0.00152380196871225,0.0112087361567203,0.0171820398740723,1.43429458853158e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0748091966720049,0.00803262044139804,-0.0905531327371451,-0.0590652606068648,1.47032458178233e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0775981052949734,0.00833423385234735,-0.0939332036455742,-0.0612630069443726,1.50795938513925e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0382153206998352,0.00411850913248828,-0.0462875985995123,-0.0301430428001582,1.96781550270413e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0472066477654175,0.00509736162740234,-0.0571974765551261,-0.037215818975709,2.3292801535781e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0255515894793253,0.00276291650450823,-0.0309669058281615,-0.0201362731304892,2.62620391182344e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,42136,-0.0845300933424603,0.0091429685290208,-0.102450311659341,-0.0666098750255795,2.70690025184109e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0370926774891956,0.00401320218903891,-0.0449585537797118,-0.0292268011986793,2.84537210586786e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42689,0.0446651310933363,0.00483690291893692,0.03518480137222,0.0541454608144527,2.98395176511085e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,42475,-0.0469425919239308,0.00508568416721982,-0.0569105328916816,-0.0369746509561799,3.10079376166407e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0870220911096751,0.00943150346956247,-0.105507837910018,-0.0685363443093327,3.20985436556695e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0413820158340731,0.00448670295103212,0.0325880780500501,0.050175953618096,3.30664149647372e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0382916481822824,0.00415353817900735,-0.0464325830131368,-0.030150713351428,3.52573806592181e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0583424604864886,0.00634428574714346,-0.0707772605508898,-0.0459076604220874,4.36292320868988e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0526785739765539,0.00573141457574747,-0.0639121465450189,-0.0414450014080889,4.46252100698801e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0735699624233522,0.00801596928038138,-0.0892812622128997,-0.0578586626338047,5.02970534003005e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0369281140917414,0.00403728178297957,-0.0448411863863813,-0.0290150417971014,6.69117853246235e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42636,-0.0324454584811261,0.00354899356088644,-0.0394014858604635,-0.0254894311017887,6.98894508456243e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0275876463736975,0.00302801213487036,0.0216527425893516,0.0335225501580434,9.31360562282557e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0578785469836585,0.00635889087248986,-0.0703419730937386,-0.0454151208735784,1.01314297070803e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.0936269768453929,0.0102974023874928,-0.113809885524879,-0.073444068165907,1.10441257359049e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0362527007929803,0.00399449785901268,-0.0440819165966452,-0.0284234849893155,1.28686062868262e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0403355840106226,0.00444758717252595,-0.0490528548687735,-0.0316183131524718,1.40193210948916e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0743642675789514,0.00820590708161737,-0.0904478454589214,-0.0582806896989813,1.45124987470671e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42495,0.0232970635743794,0.00257348169090667,0.0182530394602024,0.0283410876885565,1.58584596934476e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0550295015879696,0.00607977044530012,-0.0669458516607579,-0.0431131515151814,1.60579004005507e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0293005673056822,0.00324281758596991,-0.0356564897741833,-0.0229446448371812,1.8528912361103e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0432287936850018,0.00478892587300652,-0.0526150883960946,-0.0338424989739091,2.00236428840115e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.0823558081497219,0.00913072908776543,-0.100252037161742,-0.0644595791377017,2.19061841082601e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.046445772548041,0.0051494638359637,-0.0565387216665299,-0.0363528234295522,2.20102416441015e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0646921439105797,0.00717818268997963,-0.0787613819829397,-0.0506229058382196,2.29260253572597e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0340588150164377,0.00378042914588162,-0.0414684561423656,-0.0266491738905097,2.34926842393156e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,42636,-0.097323177066753,0.0108171139109965,-0.118524720332306,-0.0761216338011999,2.62335512350144e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.0357268318477021,0.00397142290089426,-0.0435108207334549,-0.0279428429619493,2.65879753707776e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0403332873204986,0.00448613579385359,0.0315404611645456,0.0491261134764517,2.78170382546078e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0376698875231839,0.00418971788674611,-0.0458817345812063,-0.0294580404651616,2.8386791332155e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0270111520647875,0.00300581761624335,-0.0329025545926245,-0.0211197495369506,2.97072228277072e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.0344549314049559,0.00383888329077522,-0.0419791426548754,-0.0269307201550365,3.27337469056802e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0302876184362654,0.00337621163525897,0.0236702436311578,0.036904993241373,3.32992392648169e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42587,-0.0287309875892231,0.00320839956552949,-0.0350194507376609,-0.0224425244407853,3.84270060279518e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.069583868422864,0.00777518165630964,-0.0848232244692309,-0.0543445123764971,4.12689596457311e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0848979166253187,0.00949287357448675,-0.103503948831313,-0.0662918844193247,4.26090198187899e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0355592283813535,0.00397609990838887,-0.0433523842017957,-0.0277660725609113,4.2777930841826e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,42594,-0.0274794590245582,0.00307577235509597,-0.0335079728405463,-0.0214509452085701,4.63193827925062e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0320399996948983,0.00359104102584583,-0.0390784401055561,-0.0250015592842405,5.15353148372997e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0213963495059896,0.00239994211691522,0.0166924629568357,0.0261002360551434,5.48196867380868e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0338770925499782,0.00380124285042125,0.0264266565631526,0.0413275285368039,5.64519935715865e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0472630075180036,0.00530765987286001,-0.0576660208688092,-0.036859994167198,6.17148362948703e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.064260126396864,0.0072353696975454,-0.078441451004053,-0.050078801789675,7.62513628392732e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0241220018058613,0.00272009216214659,0.018790621168054,0.0294533824436686,8.55340235707244e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42556,-0.0734294021778267,0.00830095865175127,-0.0896992811352592,-0.0571595232203942,1.02069892094578e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0747761144347434,0.00845358098004577,-0.0913451331556331,-0.0582070957138536,1.02655901357747e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,40449,-0.0760619168372444,0.00859957925158944,-0.0929170921703598,-0.0592067415041291,1.05301239830208e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.0746902554013598,0.00845408899097416,-0.0912602698236691,-0.0581202409790504,1.12837124788119e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0459491471383104,0.00520260124050376,-0.0561462455696978,-0.035752048706923,1.1539241241851e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0608767878660623,0.00690757591808961,-0.0744156366655179,-0.0473379390666066,1.37038133522916e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0484226702095179,0.00549811548509925,-0.0591989765603124,-0.0376463638587233,1.43738829927008e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0509840258166756,0.00578977630506866,-0.0623319873746102,-0.0396360642587411,1.4879504602832e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0729211874743362,0.00828803992646608,-0.0891657457302097,-0.0566766292184627,1.55625851828964e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0694714911112302,0.00790124229119364,-0.0849579260019697,-0.0539850562204907,1.6753158574126e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0233705606489207,0.00265894225321416,-0.0285820874652205,-0.018159033832621,1.68329207903127e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0468264541345966,0.00534066543092661,-0.0572941583792128,-0.0363587498899805,2.03900344759768e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.0954412160959078,0.010883632011871,-0.116773134839175,-0.0741092973526407,2.05793262195258e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.081677146518592,0.00932436788297531,-0.0999529075692236,-0.0634013854679604,2.190564993795e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.033081161324454,0.00378763045163743,-0.0405049170096634,-0.0256574056392446,2.74674521307343e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0529949588515814,0.00607144912390573,-0.0648949991344367,-0.0410949185687262,2.8883736732145e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0369473179109469,0.00424001813244589,-0.0452577534505408,-0.0286368823713529,3.27608040737952e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0438694500490591,0.00503835928879369,-0.0537446342550947,-0.0339942658430234,3.47851318793845e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0592366596231002,0.006802292925308,-0.0725691537567039,-0.0459041654894965,3.52748296863288e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.084346416719762,0.00972158511545456,-0.103400723546053,-0.065292109893471,4.65206519119865e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0367727214680018,0.00424816754093655,0.0284463130877662,0.0450991298482375,5.54780088388887e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0645307645143987,0.00745705489425658,-0.0791465921071416,-0.0499149369216558,5.56215745228579e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0502460432234312,0.00580738203316975,-0.0616285120084439,-0.0388635744384185,5.63749816958529e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0340676277288503,0.00393997633651281,-0.0417899813484154,-0.0263452741092852,5.89606106214979e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,40283,0.045154650338124,0.00522140466909734,0.0349206971866932,0.0553886034895548,5.96243817013138e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0626530011916783,0.00724719735227623,-0.0768575080021397,-0.0484484943812169,5.97487733933729e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.0903106883744943,0.0104495167183043,-0.110791741142371,-0.0698296356066179,6.23841906699511e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42611,0.0248252015268361,0.00287322523560722,0.019193680065046,0.0304567229886263,6.24105272857371e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0459843102663144,0.0053225201229828,-0.0564164497073606,-0.0355521708252681,6.27555864567868e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0166480383102606,0.00192848768779144,-0.0204278741783318,-0.0128682024421894,6.65392641517774e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0585648786713951,0.00678618183459114,-0.0718657950671937,-0.0452639622755965,6.81477283673658e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,42357,0.0202825930606155,0.0023526606737649,0.0156713781400363,0.0248938079811947,7.38075528121028e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0615739746903469,0.00714150166973666,-0.0755713179630307,-0.047576631417663,7.4594469951594e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0394527339150459,0.00457711019430148,-0.0484238698958768,-0.030481597934215,7.46408733442798e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42711,0.026346876468458,0.00305942989713581,0.0203503938700718,0.0323433590668442,7.98838708871121e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0388122422465034,0.00450819121969193,-0.0476482970370996,-0.0299761874559072,8.16862906481049e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0388461410478081,0.00451560943113853,-0.0476967355328396,-0.0299955465627766,8.64801774112828e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0455738669229121,0.005329770287763,-0.0560202166869276,-0.0351275171588966,1.3838826952652e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0308051541626734,0.00360769771644625,0.0237340666384387,0.037876241686908,1.50048483329212e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0713501652861114,0.00836849152746164,-0.0877524086799362,-0.0549479218922866,1.67521036004835e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.083171712312835,0.00976368264435507,-0.102308530295771,-0.0640348943298991,1.78557063805672e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0664423836448948,0.00780219403972543,-0.0817346839627566,-0.0511500833270329,1.83228114000123e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0633975365879064,0.00744412879273639,-0.0779880290216697,-0.0488070441541431,1.85865126230743e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.065059289556778,0.00764543219526824,-0.0800443366595038,-0.0500742424540523,1.92991343112547e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0315739660076536,0.00371449012649154,-0.038854366655577,-0.0242935653597301,2.13594712271964e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42676,-0.038896178640974,0.00457927028949994,-0.0478715484083938,-0.0299208088735541,2.2044271520885e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.10239178731785,0.0120515622282462,-0.126012849285212,-0.0787707253504873,2.21269544146884e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0451821005445888,0.00532035125736749,-0.0556099890090291,-0.0347542120801485,2.23885179507743e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.0949620300313173,0.0111812319954541,-0.116877244742407,-0.0730468153202272,2.2703119135855e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.0879464120252256,0.0103719953333412,-0.108275522878574,-0.0676173011718768,2.54891001849646e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42538,-0.0607763545933645,0.00717829130106,-0.0748458055434421,-0.0467069036432869,2.78628537979149e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42495,0.0291370831804166,0.00344201109770241,0.0223907414289198,0.0358834249319133,2.8244036506383e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42566,-0.039258458610698,0.00464155192673463,-0.0483559003870979,-0.0301610168342981,2.99888036701358e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,42449,0.023337416720177,0.00275961908204002,0.0179285633193785,0.0287462701209754,3.03473580298764e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0326494096908794,0.00387189016933301,-0.0402383144227721,-0.0250605049589867,3.72821743367665e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,40539,0.0201869327171324,0.00239520889304313,0.0154923232867678,0.0248815421474969,3.9385505994766e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0302185335195378,0.00358834652788364,0.0231853743248858,0.0372516927141897,4.09782414650688e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0448565818612209,0.00532964035449185,-0.0553026769560249,-0.0344104867664169,4.36802467591763e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0234570143062517,0.00278903283182078,-0.0289235186566205,-0.017990509955883,4.57317078719431e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42587,-0.0852071974580542,0.0101634096380872,-0.105127480348705,-0.0652869145674032,5.63620487322456e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.0952171101589023,0.0113556716912994,-0.117474226673849,-0.0729599936439555,5.67695556177076e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0611455233345101,0.00730433930863601,-0.0754620283794367,-0.0468290182895836,6.38086195561124e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0263208467236239,0.00315056534114418,-0.0324959547922665,-0.0201457386549813,7.34565383622802e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0336805529822325,0.00403315448439744,-0.0415855357716515,-0.0257755701928135,7.44642826699291e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0526125277862757,0.00630675226431312,-0.0649737622243294,-0.0402512933482219,7.99381683207389e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,40511,-0.0269357250248872,0.00322805298861153,-0.0332627088825658,-0.0206087411672086,7.99675874294943e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0678178113632187,0.00814089589317265,-0.0837739673138371,-0.0518616554126003,9.0098967889621e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42721,-0.0333015650138973,0.00400387024072838,-0.0411491506857249,-0.0254539793420697,9.84950765311681e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0408611620545602,0.00491925337543145,-0.0505028986704058,-0.0312194254387146,1.08253860692731e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0546519834975268,0.0065797215030594,-0.0675482376435232,-0.0417557293515304,1.08489831093441e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0246476830493749,0.00296875780901487,-0.030466448355044,-0.0188289177437057,1.11707229140861e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0232773261286804,0.00282115966353482,-0.0288067990692086,-0.0177478531881521,1.71578636956165e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,40499,-0.0363045018830598,0.00440039890357035,-0.0449292837340577,-0.0276797200320619,1.75531020849068e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0473442498164265,0.00574225293592572,-0.0585990655708409,-0.0360894340620121,1.80458458815344e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0394908913928859,0.00479390602508025,-0.0488869472020432,-0.0300948355837287,1.91484612877175e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0450438659917761,0.00547044710192905,-0.0557659423115571,-0.0343217896719952,2.01458717258212e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0509444624533316,0.00619545600608028,-0.0630875562252489,-0.0388013686814142,2.21182016334791e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,40532,-0.023424265580077,0.00284896568085532,-0.0290082383145534,-0.0178402928456006,2.21876255928403e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,40483,-0.03102788231478,0.00377736982288387,-0.0384315271676324,-0.0236242374619276,2.36943309855112e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0691902948072226,0.00843838806788683,-0.0857295354202808,-0.0526510541941644,2.63277239594741e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0667347802172632,0.00815342791362733,-0.0827154989279728,-0.0507540615065536,2.97047838083384e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0477617820922707,0.0058361503618525,-0.0592006368015016,-0.0363229273830398,2.99625641989808e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.0749185485739348,0.00916393373445246,-0.0928798586934616,-0.056957238454408,3.20976806021767e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,40539,-0.0174764428792714,0.00213820380518548,-0.0216673223374349,-0.0132855634211078,3.31578903176258e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.112708682767426,0.0138196184126135,-0.139795134856148,-0.0856222306787035,3.83982782635168e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0467968419466629,0.00574470889350396,-0.0580564713779307,-0.0355372125153952,4.09255636003644e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42705,0.0226140888128065,0.00277648012423791,0.0171721877693002,0.0280559898563128,4.12771924880139e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0360080161564496,0.00442371933555067,-0.0446785060541289,-0.0273375262587703,4.38358354718491e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0368448203666614,0.00453100143046081,-0.0457255831703646,-0.0279640575629582,4.60514586171189e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0533106379407959,0.00656159641979026,-0.0661713669235848,-0.040449908958007,4.95164134967572e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42611,-0.0315533946627035,0.00388642059987055,-0.0391707790384498,-0.0239360102869572,5.11276837251521e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0138216407546659,0.00170383954184054,-0.0171611662566733,-0.0104821152526584,5.48912265813417e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0321407615704991,0.00396907718483566,0.0243613702882212,0.039920152852777,6.08566388994483e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0423849901233603,0.00523443757626725,-0.0526444877728442,-0.0321254924738765,6.10068263350985e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0536656258448256,0.0066271185035353,-0.0666547781117548,-0.0406764735778964,6.17744633078449e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.0263150902741969,0.00325196400357161,0.0199412408271965,0.0326889397211972,6.36562690702966e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,40283,-0.0576870682221143,0.00712778654828005,-0.0716575298567432,-0.0437166065874854,6.41483233816281e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0271257370039234,0.00335522531687473,-0.0337019786249979,-0.020549495382849,6.89935945537867e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0524458829123925,0.00649464773444015,-0.0651753924718952,-0.0397163733528898,7.30062037520335e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0387226020721052,0.004799033923078,-0.0481287085613381,-0.0293164955828723,7.81745835369912e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0296605571738565,0.00367835639785288,-0.0368701357136482,-0.0224509786340649,8.03662267049091e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0415122167862225,0.00514990563605981,-0.0516060318328997,-0.0314184017395453,8.234657324465e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42754,-0.0394568867135133,0.00490823273710717,-0.0490770228782434,-0.0298367505487833,9.80959373993741e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0521940841621299,0.00649354653728528,-0.064921435375209,-0.0394667329490507,1.00708736777249e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0264793568549478,0.00329589107775108,0.0200194103425557,0.0329393033673399,1.03930576166432e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0306817109517267,0.00382184083223564,-0.0381725189829086,-0.0231909029205448,1.07292417323146e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0157980454746893,0.00197050165310137,0.0119358622346106,0.019660228714768,1.17037956061556e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0347871502303247,0.00434796585766112,-0.0433091633113405,-0.0262651371493089,1.33809422233338e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0625471898926718,0.00782465310579384,-0.0778835099800277,-0.0472108698053159,1.44043937252941e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0419722633005931,0.00526950487405066,0.0316440337474538,0.0523004928537324,1.7830499475128e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0169354398637265,0.00212870998609512,0.0127631682909801,0.021107711436473,1.95008075579629e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0502755285665586,0.0063204852465645,-0.062663679649825,-0.0378873774832922,1.97161057503358e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0246416541845552,0.00310439012171938,-0.0307262588231252,-0.0185570495459852,2.25477653284699e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0500384227085811,0.00631264444968246,-0.0624112058299587,-0.0376656395872035,2.46210467824409e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0667402549317116,0.00843514149503905,-0.0832731322619881,-0.050207377601435,2.76623226720407e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42636,-0.0331919355068689,0.00421180913183824,-0.0414470814052719,-0.024936789608466,3.50533497518287e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0235218048077039,0.00299235564947596,0.017656787734731,0.0293868218806768,4.10826208168693e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.107342156804911,0.0136556317392072,-0.134107195013757,-0.080577118596065,4.11219257545006e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,40449,-0.0818426731937099,0.0104124027299722,-0.102250982544455,-0.0614343638429645,4.18748733792141e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0182834021573071,0.00232862520618995,-0.0228475075614394,-0.0137192967531748,4.41861495898614e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,40054,-0.0571353609393278,0.00727657785090383,-0.0713974535270993,-0.0428732683515562,4.48168247420931e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0272278514796789,0.00347126430579701,-0.034031529519041,-0.0204241734403167,4.70014666803134e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0453875738621729,0.00578722890778428,-0.0567305425214301,-0.0340446052029157,4.8134230354867e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42679,-0.0310738356253957,0.00396483720849105,-0.0388449165540381,-0.0233027546967532,4.9448400555909e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0398828897614653,0.00508816264749491,-0.0498556885505554,-0.0299100909723753,4.98195547409727e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0613842954608753,0.00783653335812668,-0.0767439008428036,-0.046024690078947,5.18640467206545e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0181726524863227,0.00233025274244779,-0.0227399478615204,-0.013605357111125,6.82188982814378e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0642023453528196,0.00823509034207521,-0.080343122423287,-0.0480615682823522,6.93926915847779e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0574756805712022,0.00737578102135366,-0.0719322113730554,-0.0430191497693491,7.1447332587467e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0225944296781183,0.00290023853172758,0.0169099621559323,0.0282788972003044,7.15404851061217e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.0847593128816158,0.0108902174399318,-0.106104139063882,-0.0634144866993494,7.704153178961e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0464908348229043,0.00597694122594037,-0.0582056396257474,-0.0347760300200611,7.88612506671135e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.036579274124071,0.00470488800313858,-0.0458008546102226,-0.0273576936379194,8.10343043815442e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.051756257803436,0.00666080788789438,-0.064811441263709,-0.038701074343163,8.41294518993621e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0179009059426141,0.00230538806476336,-0.0224194665495503,-0.0133823453356779,8.76284682819156e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0298624138029051,0.00384561818200011,-0.0373998254396253,-0.0223250021661849,8.8616277432845e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,40302,-0.100063629744139,0.0129028716703835,-0.125353258218091,-0.0747740012701875,9.59561344964183e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0236431605450129,0.00304964280500066,0.0176658606472116,0.0296204604428142,9.75926306421497e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0194290753405217,0.00251187215254548,0.0145058059215326,0.0243523447595109,1.10743925391127e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0294690167343409,0.0038099902048212,0.0220014359328913,0.0369365975357904,1.11143600640311e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0268664785392343,0.00348773173254478,-0.0337024327350221,-0.0200305243434466,1.41973014405356e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0299371288048969,0.00389238654335112,-0.0375662064298651,-0.0223080511799287,1.56081703243843e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0725512131017493,0.00943959649652466,-0.0910528222349377,-0.054049603968561,1.62627494364179e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42754,-0.0265967841678299,0.00346454949055584,-0.0333873011693194,-0.0198062671663405,1.74189298468006e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0436072811265134,0.00569098417980981,-0.0547616101189406,-0.0324529521340862,1.95059715164853e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.056849564296427,0.00742147868809753,-0.0713956625250981,-0.0423034660677558,2.00870928851606e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,40511,-0.0359425419499495,0.00469637918070162,-0.0451474451441246,-0.0267376387557743,2.11885690398652e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.074281658475447,0.00970776330566618,-0.0933088745545528,-0.0552544423963413,2.11990318940543e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0580037838316601,0.00759074969356508,-0.0728816532310477,-0.0431259144322726,2.3235311695161e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.0818003452328911,0.0107087882900961,-0.10278957028148,-0.0608111201843027,2.37304555580814e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0583324361468912,0.0076416527195389,-0.0733100754771875,-0.043354796816595,2.43944901988341e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0685435113693608,0.00897793897939747,-0.0861402717689799,-0.0509467509697418,2.44671347427353e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0373521521575156,0.00490055745085998,0.0277470595538301,0.0469572447612012,2.66840556504583e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0394519307634679,0.00518087127761726,-0.0496064384675978,-0.0292974230593381,2.81403984445457e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0357888898069884,0.0046995187776498,-0.044999946611182,-0.0265778330027948,2.83836704387339e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0220759639281352,0.0028990184548151,-0.0277580400995728,-0.0163938877566976,2.84836752266221e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0305534678848529,0.00401339176478739,-0.0384197157438362,-0.0226872200258696,2.85888398903552e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0445828985321879,0.00585741967491789,-0.056063441095027,-0.0331023559693488,2.89170060939514e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,40269,0.0160203433367045,0.00210917658158096,0.0118863572368058,0.0201543294366032,3.31184792516385e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0580120638237624,0.00764175360803437,-0.0729899008955098,-0.043034226752015,3.41318485685113e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0215960381593133,0.00285128694133328,-0.0271845605643265,-0.0160075157543,3.85623013761212e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42711,-0.0452192821369436,0.00597065114292115,-0.0569217583770691,-0.0335168058968182,3.86562869992273e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42754,-0.0436525001862866,0.00576711398261496,-0.0549560435922119,-0.0323489567803613,3.99692563853582e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,42311,-0.0509066599216687,0.00672935597234388,-0.0640961976274627,-0.0377171222158747,4.14098049193781e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0404198315302812,0.00534859276273209,-0.0509030733452361,-0.0299365897153263,4.38616705485288e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.025977598800936,0.00345316005349658,-0.0327457925057893,-0.0192094050960827,5.77730223866612e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0617960818496472,0.0082185137871642,-0.077904368872489,-0.0456877948268053,5.9319202042149e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,40283,-0.0247455425277897,0.00329183887080729,-0.031197546714572,-0.0182935383410074,6.0257883341066e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0620131243154338,0.00825872086952682,-0.0782002172197063,-0.0458260314111612,6.41791068691622e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0359222843318845,0.00478961387911692,-0.0453099275349537,-0.0265346411288154,6.78569971371848e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.035704292847177,0.00476403690238693,-0.0450418051758553,-0.0263667805184986,7.0777499692701e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42594,-0.0287142744354445,0.00383668326063363,-0.0362341736262864,-0.0211943752446026,7.6504134908759e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0661591271786751,0.00885840801293199,-0.0835216068840218,-0.0487966474733284,8.70849848477292e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0424047722822484,0.00568075065450354,-0.0535390435650754,-0.0312705009994215,8.86382665147099e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0277975095390679,0.00373245980438236,-0.0351131307556574,-0.0204818883224785,1.00914012678326e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0157725150513045,0.00211772455476092,-0.0199232551786359,-0.0116217749239731,1.01801294781068e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0648664562619391,0.00871157962117675,0.0477917602044327,0.0819411523194455,1.02054707041908e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.0132327209232464,0.00177948263810432,0.00974493495256194,0.0167205068939309,1.0984902064113e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.035330935861064,0.00475442919770513,-0.044649617088566,-0.0260122546335619,1.15611198856356e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,40527,0.0370956912109758,0.00499714885222183,0.027301279460621,0.0468901029613305,1.2235424703034e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0300277694904516,0.00404614133269033,-0.0379582065025247,-0.0220973324783786,1.2312230563538e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0288165623753999,0.00389261756183837,-0.0364460927966031,-0.0211870319541967,1.41201067347671e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42689,-0.0413871785459653,0.00559105628358458,-0.052345648861791,-0.0304287082301395,1.41668993767944e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0310028753799916,0.00420093352189911,-0.0392367050829138,-0.0227690456770693,1.6761268999482e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0500997339310415,0.0067913688285944,-0.0634108168350865,-0.0367886510269965,1.7161437031416e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.0758616282667503,0.0102822480060394,-0.0960148343585876,-0.055708422174913,1.72091381970628e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0503855835375,0.00683773840482678,-0.0637875508109605,-0.0369836162640395,1.8232256993114e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,42476,-0.0278779604719136,0.00378374897562882,-0.0352941084641461,-0.0204618124796811,1.83683896164475e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.02505574598022,0.00340436097199226,-0.0317282934853248,-0.0183831984751152,1.94775011346928e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0515223521140427,0.00700189587895115,-0.065246068036787,-0.0377986361912985,1.99168461493159e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0813435189523344,0.0110605060816265,-0.103022110872322,-0.0596649270323465,2.03003659225532e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,40483,-0.0411895564075563,0.00560029984955054,-0.0521661441126754,-0.0302129687024372,2.04327856860969e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,42311,-0.0235834519434906,0.00321636504333661,-0.0298875274284304,-0.0172793764585509,2.3944373196904e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0502007580996232,0.00684792876195282,-0.0636226984730508,-0.0367788177261957,2.41855240790859e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42636,-0.0879721283076958,0.0120014003859735,-0.111494873064204,-0.0644493835511877,2.43012944748391e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.055921613230057,0.00763480077176995,-0.0708858227427261,-0.0409574037173879,2.56390964367608e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0292326104758797,0.00399240052232023,-0.0370577154996274,-0.0214075054521321,2.60794736904393e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42587,-0.0401409055574511,0.00548634265986181,-0.0508941371707803,-0.029387673944122,2.6897176579369e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.020514542557958,0.00281050075328475,-0.0260231240343962,-0.0150059610815199,3.05575378936611e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0301265945855172,0.00412910074868198,-0.0382196320529339,-0.0220335571181005,3.12862160451541e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0215759566401724,0.00295692031441976,-0.0273715204564351,-0.0157803928239097,3.14484978316213e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.032040312786847,0.00439447895627114,-0.0406534915411384,-0.0234271340325556,3.28685792747035e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,42638,-0.037184794594344,0.00510377102313023,-0.0471881857996792,-0.0271814033890087,3.37709153921742e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.025853087139447,0.00354820568108892,0.0188986040045127,0.0328075702743813,3.4048626366547e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,42311,-0.0254753115785434,0.00349788630464786,-0.0323311687356532,-0.0186194544214336,3.44952121169419e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.020283209076633,0.00279040031756066,-0.0257523936990519,-0.0148140244542141,3.82303306187906e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0483665219799985,0.00666096901346126,-0.0614220212463825,-0.0353110227136144,4.04619666951993e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.049225546497463,0.00677957237571731,-0.062513508353869,-0.0359375846410571,4.10528061662899e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42613,-0.0267879755905464,0.00369178291359675,-0.034023870101196,-0.0195520810798968,4.20261340523714e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.0114227194919602,0.00157718776646436,0.00833143146969006,0.0145140075142303,4.69143356585224e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0204987931528068,0.00283357063907332,-0.0260525916053905,-0.0149449947002231,4.93335036283023e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0598006466784931,0.00827065913016862,-0.0760111385736236,-0.0435901547833626,5.0749700232642e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0354512611017838,0.00490439244472669,-0.0450638702934481,-0.0258386519101195,5.20834169500946e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0360401397105509,0.00499368031058481,0.0262525263018047,0.0458277531192971,5.59709763890106e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0466261691591302,0.00647195982522776,-0.0593112104165766,-0.0339411279016838,6.14161458614023e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0596879149352788,0.00828693676091023,-0.0759303109866629,-0.0434455188838948,6.28217244938046e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0285106859178548,0.00396089415682052,-0.036274038465223,-0.0207473333704866,6.49712506879317e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0311208020970589,0.00432645223165518,-0.039600648471103,-0.0226409557230147,6.73228436419892e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0348640237820321,0.00485359128006023,-0.0443770626909502,-0.0253509848731141,7.24169424046703e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0243102252553683,0.00338545319087601,-0.0309457135094853,-0.0176747370012513,7.31003508021236e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.066475549268572,0.00926359529472757,-0.084632196046238,-0.048318902490906,7.56252427714276e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0233171652478843,0.00325067876671525,-0.0296884956306462,-0.0169458348651225,7.72175644949578e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0307181911197292,0.00428312201811322,0.0223232719642273,0.0391131102752311,7.86929799831299e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0484701510689079,0.00676702040585391,-0.0617335110643815,-0.0352067910734342,8.32050286806975e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0682904355966985,0.00953703090349699,-0.0869830161675526,-0.0495978550258444,8.45127006508848e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0696006842431139,0.00971888057962784,-0.0886496901791845,-0.0505516783070434,8.49495192081112e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0201762586184705,0.00281841874519431,-0.0257003593590513,-0.0146521578778896,8.56925233304039e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0318482959513123,0.00445148688976645,-0.0405732102552545,-0.02312338164737,8.83165621650174e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0191916832778666,0.00268222551849749,0.0139345212616115,0.0244488452941217,8.87438494049129e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0235694694803387,0.00330112229992009,-0.030039669188182,-0.0170992697724953,9.83504722045274e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0391404397067982,0.00548782265523846,-0.0498965721110655,-0.0283843073025308,1.03757693007113e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0192024064576794,0.00269298123327482,0.0139241632404607,0.024480649674898,1.06086143207248e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0357596560994715,0.00501497654076771,-0.0455890101193762,-0.0259303020795668,1.0618736347917e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,40483,-0.0442941827931849,0.00622225672487441,-0.0564898059739388,-0.0320985596124311,1.15588416637758e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0526264858268259,0.0073976320831396,-0.0671258447097795,-0.0381271269438722,1.18475216616572e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0742463771324192,0.0104415526225886,-0.094711820272693,-0.0537809339921455,1.21302633130548e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0403382271760941,0.00567600655057669,-0.0514632000152244,-0.0292132543369638,1.24889227683579e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0406837781755908,0.00573132465734422,-0.0519171745039855,-0.0294503818471961,1.32520008769033e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0454284255481425,0.00640159642594028,-0.0579755545429855,-0.0328812965532995,1.35725170704229e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0285512370824311,0.00402343194387871,-0.0364371636924334,-0.0206653104724288,1.36129318253105e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0429123364132444,0.00604725465708023,-0.0547649555411217,-0.0310597172853672,1.361349797824e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0273831597706747,0.00386032924658506,-0.0349494050939815,-0.019816914447368,1.37477830968651e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0350744532091822,0.00494919255916718,-0.0447748706251499,-0.0253740357932146,1.45709154870871e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.037609654889983,0.00531068578512245,-0.048018599028823,-0.027200710751143,1.49346500088244e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0254897350492215,0.00360411999173833,-0.0325538102330286,-0.0184256598654144,1.61318680750401e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0230143281203014,0.00325637926701316,-0.0293968314836472,-0.0166318247569556,1.67322904374054e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,42476,-0.0566252204514704,0.00801814551670844,-0.0723407856642189,-0.0409096552387219,1.7212294951448e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0550562289778532,0.0077998388070718,-0.0703439130397139,-0.0397685449159925,1.78346252260585e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0560578544702185,0.00795867089287475,-0.071656849420253,-0.040458859520184,1.98201587958329e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0504038130863499,0.00716993128303654,-0.0644568784011015,-0.0363507477715983,2.16782580070532e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0297095437164952,0.00423504507691569,-0.03801023206725,-0.0214088553657405,2.40905304182758e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0193078739598844,0.00275421378443093,-0.024706132977369,-0.0139096149423998,2.51761898420042e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42636,-0.0383716941573681,0.00547493451351432,-0.0491025658038562,-0.0276408225108801,2.52168280814553e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0279119377369774,0.00398293782238537,-0.0357184958688527,-0.0201053796051021,2.53752104249375e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0247527383557422,0.00353387462062762,-0.0316791326121723,-0.0178263440993121,2.59852776270983e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.050698211729107,0.00724791099121047,-0.0649041172718795,-0.0364923061863345,2.78331162085224e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0623130113808288,0.00890679738257377,-0.0797703342506733,-0.0448556885109842,2.78435896555882e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0451527863827481,0.00646246053012439,-0.0578192090217919,-0.0324863637437043,2.97155167755625e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0463047957289788,0.00663418559582469,-0.0593077994967952,-0.0333017919611624,3.09552377334022e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.066345341261633,0.00951512359995003,-0.0849949835175351,-0.0476956990057309,3.2579916947254e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,40527,-0.0195499818987958,0.00280665304468224,-0.025051021866373,-0.0140489419312186,3.45151897669196e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,40483,-0.0161672702751021,0.00232111975283197,-0.0207166649906527,-0.0116178755595514,3.45948689119253e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0469674843809466,0.00674434074174196,-0.0601863922347609,-0.0337485765271324,3.46239285249231e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0456871911400406,0.00656114683744885,-0.0585470389414403,-0.0328273433386408,3.50867538663049e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0746654817878469,0.0107309483833551,-0.0956981406192229,-0.0536328229564709,3.61402369260071e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0317922854273341,0.00457247962781954,-0.0407543454978604,-0.0228302253568078,3.77763245263486e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.037010374365012,0.0053240701724728,-0.0474455519030587,-0.0265751968269653,3.8178530920281e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0192616553215328,0.00277233488967012,-0.0246954317052863,-0.0138278789377794,3.88029777430496e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0529010460689979,0.00762455913124517,-0.0678451819662384,-0.0379569101717573,4.15285539227664e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0406213575802622,0.00585953967539676,0.0291366598164846,0.0521060553440399,4.32163544797534e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.040776621285705,0.00588497664163355,-0.0523111755033067,-0.0292420670681032,4.43539075396221e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0223837319903148,0.00324126977893165,-0.0287366207570208,-0.0160308432236088,5.21361679422981e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42794,0.0208331054169817,0.00301816969259633,0.0149174928194929,0.0267487180144705,5.33361785133293e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.0210299069247697,0.00304882810605112,0.0150542038369095,0.0270056100126298,5.56843551377995e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,40440,-0.0199921113740198,0.00290359449159103,-0.0256831565775382,-0.0143010661705014,6.07392427443771e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.04035371112165,0.00586246708903581,-0.0518441466161602,-0.0288632756271398,6.1612945192749e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0442808827969811,0.00643340680823948,-0.0568903601411304,-0.0316714054528317,6.17281402085843e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0480434375066467,0.00698054734543336,-0.0617253103036961,-0.0343615647095973,6.1947876419833e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,40449,-0.046259799920586,0.00673161986677825,-0.0594537748594714,-0.0330658249817006,6.66444579981035e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0296228548882827,0.00431278212494966,-0.038075907853184,-0.0211698019233813,6.76827522709315e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0395049195620129,0.00575832844727234,-0.0507912433186667,-0.0282185958053591,7.17109852134466e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,42475,0.0224595415783101,0.00327749836519248,0.0160356447825329,0.0288834383740874,7.56929017096988e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0221345956338402,0.00323016783536707,0.0158034666765207,0.0284657245911596,7.63602056683733e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0283891002548148,0.00415625743469928,-0.0365353648268254,-0.0202428356828042,8.90804152520202e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,40482,-0.037542359543367,0.00549941536688971,-0.0483212136624709,-0.0267635054242632,9.14037063015408e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0700358969396809,0.010264078917154,-0.0901534916173028,-0.049918302262059,9.27136596648314e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.0841491079319666,0.0123413569436661,-0.108338167541552,-0.059960048322381,9.59362326998463e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0148090853757136,0.00217164424162193,-0.0190655080892926,-0.0105526626621346,9.62447172991846e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0375708583341834,0.00551112832929052,-0.0483726698595928,-0.0267690468087739,9.75178296949929e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0275005126580715,0.00404701196094918,-0.0354326561015319,-0.0195683692146111,1.13657372421484e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0327942060246643,0.00483298698652047,-0.0422668605182444,-0.0233215515310842,1.21480269340501e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0278564127394206,0.0041155701927781,-0.0359229303172657,-0.0197898951615756,1.35416694557163e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.0840472525598603,0.0124155863147215,-0.108381801736714,-0.0597127033830062,1.36015737873591e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0451723385541185,0.00667327072639962,-0.0582519491778617,-0.0320927279303752,1.36187228897164e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0269899134331139,0.00398960350184711,-0.0348095362967343,-0.0191702905694936,1.39842639269979e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.018539624914143,0.00274445538430178,0.0131604923609115,0.0239187574673745,1.48421635812202e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0356660295023504,0.00528435640064803,-0.0460233680476206,-0.0253086909570803,1.5589344636702e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0745430557429875,0.0110587933916342,-0.0962182907905906,-0.0528678206953844,1.64172758262729e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0732540381774891,0.0108748221136091,-0.094568689520163,-0.0519393868348152,1.70610395984006e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0403565215225348,0.00599719069974844,-0.0521110152940417,-0.0286020277510278,1.77606483175535e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0668700585518111,0.00995148152007514,-0.0863749623311584,-0.0473651547724638,1.89524782666896e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42611,0.0161827765209637,0.00240989261016994,0.0114593870050306,0.0209061660368968,1.95443304314896e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42594,-0.0236975564893804,0.00352919790698335,-0.0306147843870677,-0.016780328591693,1.96027972883642e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.039451668505902,0.00587973553145112,-0.0509759501475461,-0.0279273868642578,2.02914786961259e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0389013892756068,0.00580460901850875,-0.0502784229518839,-0.0275243555993296,2.14242668886839e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0361632929132523,0.00539998138450797,-0.0467472564268879,-0.0255793293996167,2.23137267120955e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42585,-0.0585165070597465,0.00874246524302721,-0.0756517389360798,-0.0413812751834132,2.26780375819797e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0402607885806874,0.00601807335490235,-0.052056212356296,-0.0284653648050788,2.32064318760216e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0190539989161181,0.00284859079865171,-0.0246372368814754,-0.0134707609507607,2.33664918249384e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0429272467073192,0.00643100371445108,-0.0555320139876433,-0.0303224794269951,2.58707970850992e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,40451,-0.0409504523547193,0.00613699565584142,-0.0529789638401685,-0.0289219408692701,2.6289130311418e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,42598,-0.0289318542510043,0.00433655378770781,-0.0374314996749116,-0.020432208827097,2.62921956603986e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0413391606199148,0.00619759003486677,-0.0534864370882537,-0.0291918841515759,2.67394580496477e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0178988716306951,0.00268462397119375,-0.0231607346142349,-0.0126370086471554,2.72897469237703e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0373649708857797,0.00561391761165354,-0.0483682494046207,-0.0263616923669388,2.92776955488738e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0206659414952248,0.00310470735932923,-0.0267511679195101,-0.0145807150709395,2.93809746856699e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0497398486891708,0.00747962940566826,-0.0643999223242806,-0.035079775054061,3.06536953698935e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0352316977740625,0.00530236954856107,-0.0456243420892422,-0.0248390534588828,3.15904679405794e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42666,0.018491766964533,0.00278321495832308,0.0130366656462198,0.0239468682828462,3.16944863125663e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,40494,-0.0312342280701992,0.00470466854740777,-0.0404553784231185,-0.02201307771728,3.30319266569751e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0447002739758781,0.00673474733733151,-0.0579003787570479,-0.0315001691947083,3.34708474406328e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0364533275900773,0.00550509575141727,-0.0472433152628552,-0.0256633399172995,3.68774028295293e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0447048514457216,0.00675110821883469,-0.0579370235546376,-0.0314726793368056,3.71118699820832e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0643503868977389,0.00972688483835728,-0.0834150811809192,-0.0452856926145587,3.83761718720874e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0679203403045025,0.0102700697137634,-0.0880496769434788,-0.0477910036655263,3.92537837475407e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0373669421262022,0.00565342775359488,-0.0484476605232482,-0.0262862237291562,4.03157069974875e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0239372015477187,0.00362588576569967,-0.03104393764849,-0.0168304654469473,4.24453073484065e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0515907430023229,0.0078163744372091,-0.0669108368992527,-0.0362706491053931,4.25990329524134e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0511308834712228,0.00774907898635064,-0.06631907828447,-0.0359426886579755,4.34460180223064e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0415228681197858,0.00629400895187187,-0.0538591256654547,-0.029186610574117,4.34859138936782e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,42488,-0.0234085305783577,0.00354987119849982,-0.0303662781274174,-0.0164507830292981,4.43739243154479e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0318350149980975,0.00483186118960011,-0.0413054629297137,-0.0223645670664813,4.60693520091171e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0347036682162405,0.00527194182630272,-0.0450366741957939,-0.0243706622366872,4.78949869574309e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0376161606116905,0.00571601609656113,0.0264127690624306,0.0488195521609503,4.85199183924858e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0254192306693562,0.00386958368073921,-0.033003614683605,-0.0178348466551073,5.25344327288474e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,40483,-0.0188777182845565,0.00287595468908902,-0.024514589475171,-0.0132408470939421,5.46850849798552e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0682649343607084,0.0104063921313256,-0.0886614629381065,-0.0478684057833102,5.58072665768607e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0423363505883672,0.00645473448322803,-0.0549876301754942,-0.0296850710012403,5.61737356335198e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0221047034321856,0.00337025539354455,-0.028710404003533,-0.0154990028608383,5.62482310128376e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0280015753657899,0.00426970051014892,-0.0363701883656818,-0.019632962365898,5.64351995401357e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0265008607540997,0.00404343061302126,-0.0344259847556214,-0.018575736752578,5.80410270545538e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0371320113257565,0.00566557337298663,-0.0482365351368103,-0.0260274875147027,5.80735896491729e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0284526050781436,0.00434192334283289,-0.0369627748300961,-0.0199424353261912,5.89332704587751e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0197617306797444,0.00301853277069922,-0.0256780549103149,-0.0138454064491739,6.09055289270688e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.02309034872903,0.00352755439463626,-0.0300043553425171,-0.016176342115543,6.1368961219618e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0215918756601804,0.00330102575676412,-0.0280618861434381,-0.0151218651769227,6.33300334128432e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,42370,-0.034906826950826,0.00535317512703732,-0.0453990501998191,-0.0244146037018328,7.24984473650139e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0609435979319168,0.00936971794350983,-0.0793082451011961,-0.0425789507626376,8.082015083166e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0291890108988133,0.0044893783731108,-0.0379881925101105,-0.0203898292875161,8.28047799151178e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0162717737578999,0.00250319962942817,-0.0211780450315792,-0.0113655024842207,8.29453998150634e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0227444605455423,0.00350172293300056,0.0158810835968612,0.0296078374942234,8.64760873135813e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0279954428855264,0.00431162855082512,-0.0364462348451436,-0.0195446509259092,8.76699009436771e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.039154197187558,0.0060314737206939,-0.0509758856801181,-0.027332508694998,8.79509874255359e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.042139599104724,0.00649427965072318,-0.0548683872201414,-0.0294108109893065,8.96674110618519e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.055534622599835,0.00856981718148772,-0.0723314642755509,-0.038737780924119,9.48696526230675e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.028350809222217,0.00437799781871237,-0.0369316849468933,-0.0197699334975408,9.83550114248552e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0249918225329341,0.00385994249389386,-0.032557309820966,-0.0174263352449021,9.83941120582334e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0351670381329634,0.00543245054342746,-0.0458146411980812,-0.0245194350678456,9.98159321677676e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0247606395709134,0.00382587315677523,-0.0322593509581928,-0.0172619281836339,1.0080374536508e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0450112041835643,0.00695615427943261,-0.0586452665712522,-0.0313771417958764,1.01698921988505e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0195996725544341,0.00303312063555409,-0.0255445890001201,-0.0136547561087481,1.07688764031729e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0270224103393875,0.00418364855358908,-0.0352223615044221,-0.0188224591743529,1.0894316443293e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0283164542426484,0.00438757568089262,-0.0369161025771979,-0.0197168059080989,1.13040673982274e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0380474959504532,0.00590132362188196,-0.0496140902493418,-0.0264809016515645,1.17777244235921e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.062503005710482,0.00969411022271566,-0.0815034617470047,-0.0435025496739593,1.18453596836335e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42624,-0.035534619607237,0.00551342545654506,-0.0463409335020654,-0.0247283057124087,1.19463880708533e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0457613258245965,0.00711601742263954,-0.05970871997297,-0.031813931676223,1.32198267635408e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42494,-0.0447933288638045,0.00697504741519802,-0.0584644217975926,-0.0311222359300164,1.39124368638621e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42754,-0.0316388512072623,0.00492970457000805,-0.0413010721644781,-0.0219766302500465,1.42667286382811e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0736026129823956,0.0114803964889747,-0.0961041901007861,-0.0511010358640051,1.49317348536224e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,42311,-0.0458652447089587,0.00716175579933999,-0.0599022860756651,-0.0318282033422524,1.56325734231133e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.0129718647564237,0.00202662196824039,0.00899968569867248,0.0169440438141748,1.59740574263737e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0208709991744981,0.00326306130796366,-0.0272665993381068,-0.0144753990108893,1.65651860276263e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,40408,-0.0598785807624683,0.00937119716865332,-0.0782461272130288,-0.0415110343119078,1.72866516100925e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0682147142478221,0.010678383693896,-0.0891443462878583,-0.0472850822077859,1.74551195585003e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0207605134170521,0.00325081802752851,-0.027132116751008,-0.0143889100830962,1.75538730465813e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0382508669282537,0.00599123830459746,0.0265080398512426,0.0499936940052647,1.77732801299659e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0204451715140983,0.00320395428646339,0.01416542111263,0.0267249219155665,1.8267605793253e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.02549591741276,0.00399829015417134,-0.0333325661149358,-0.0176592687105842,1.88025797125903e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0300026712341172,0.00471436064306086,-0.0392428180945165,-0.0207625243737179,2.04013155861223e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.044220511526599,0.00695248644567499,-0.057847384960122,-0.0305936380930761,2.07739306634745e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0529781788945337,0.00832956814866788,-0.0693041324659227,-0.0366522253231446,2.07962318879828e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0439622694340858,0.0069112608835927,-0.0575083407659275,-0.0304161981022441,2.08388760695311e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0424423785070061,0.00667636780928206,-0.055528059413199,-0.0293566976008133,2.12195361328346e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42587,0.0295402112674327,0.00464702472655859,0.0204320428033779,0.0386483797314875,2.12677977092322e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,42456,-0.0261503296232447,0.00411703009302888,-0.0342197086055813,-0.0180809506409081,2.19834376019024e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0489973621153626,0.00771705032654429,-0.0641227807553894,-0.0338719434753358,2.23501953132916e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0377801820624677,0.00596678835994039,-0.0494750872479509,-0.0260852768769846,2.51690957030077e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0437177806125982,0.00691772695891201,-0.0572765254520657,-0.0301590357731306,2.70414711132674e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.045538229442212,0.00720825438005843,-0.0596664080271266,-0.0314100508572975,2.75811821344525e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0172442995879047,0.00273013988457975,-0.022595373761681,-0.0118932254141284,2.7798309789213e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,42333,-0.031984343939451,0.0050685749568856,-0.0419187508549467,-0.0220499370239552,2.87395797389292e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0216997096000539,0.00344226457655154,-0.0284465481700949,-0.0149528710300129,2.99342163950725e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0249685697060689,0.0039617630138066,-0.0327336252131298,-0.017203514199008,3.04390821700032e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0180129573291233,0.00285867486666306,-0.0236159600677829,-0.0124099545904637,3.06811969136982e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0306263356622371,0.00486782793842862,-0.0401672784215572,-0.021085392902917,3.25851928244921e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0535534864801299,0.00851364765761834,-0.0702402358890618,-0.0368667370711979,3.28783542199607e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0617615663561756,0.00982539685419195,-0.0810193441903918,-0.0425037885219594,3.37930022965097e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0425582674987156,0.00677044033498324,-0.0558283305552827,-0.0292882044421484,3.38031874873293e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.043966313224767,0.0069965665881111,-0.0576795837374648,-0.0302530427120693,3.40172354270935e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0595735860455625,0.009484405160042,-0.0781630201592449,-0.0409841519318802,3.46518706199162e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.0132520741718389,0.00211218075478876,0.00911219989245288,0.0173919484512248,3.64800805400476e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0409155393180091,0.00652990166322284,-0.0537141465779258,-0.0281169320580923,3.84245018117955e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0179552647498014,0.0028672960439172,-0.0235751649958791,-0.0123353645037237,3.91292373047605e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0252165564078151,0.00402949091373248,0.0173187542168994,0.0331143585987307,4.02025390607986e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0229634809553788,0.00367443926456085,-0.0301653819139181,-0.0157615799968395,4.26946407661675e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0491044793221373,0.00785878289695881,-0.0645076938001766,-0.033701264844098,4.27309891072484e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0147574244534749,0.00236309344572387,-0.0193890876070937,-0.0101257612998561,4.36522006490525e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0489378668904794,0.00784693503789407,-0.0643178595647518,-0.033557874216207,4.60742466799125e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0238147514698962,0.00381935283892911,-0.0313006830341973,-0.0163288199055951,4.64743114795441e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0639206610514762,0.0102539039211886,-0.0840183127370059,-0.0438230093659466,4.71926896634584e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0349521555597954,0.00560827155399692,-0.0459443678056294,-0.0239599433139614,4.73607021720581e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,42141,0.0201403519851245,0.00323443906710283,0.013800851413603,0.0264798525566461,4.90635564062589e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0593454209276318,0.00954354978577648,-0.0780507785077537,-0.0406400633475099,5.17344673803971e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,42370,-0.0465476875392059,0.00748831640033602,-0.0612247876838645,-0.0318705873945473,5.2523307934544e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0301876120691874,0.00487397501952984,-0.0397406031074659,-0.0206346210309089,6.09079149453145e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0618396768086225,0.00999958828329044,-0.0814388698438718,-0.0422404837733733,6.4223005500551e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0213227146099275,0.00344853892355533,-0.028081850900096,-0.0145635783197591,6.5026401256426e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0294279940654124,0.00476183177008165,-0.0387611843347724,-0.0200948037960524,6.63294067955013e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0182862055305233,0.00296054669540614,0.0124835340075273,0.0240888770535193,6.73784898297485e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0638190373765054,0.0103384709057452,-0.0840824403517659,-0.0435556344012449,6.89539495227064e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0402015109320904,0.00651347951205655,-0.0529679307757213,-0.0274350910884596,6.93917351201284e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.0800392335594293,0.0129739779270597,-0.105468230296466,-0.0546102368223923,7.10462318895643e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0405339511330671,0.0065789435989469,-0.0534286805870031,-0.0276392216791312,7.47560630342119e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42587,-0.0365733856810968,0.00594126738099911,-0.0482182697478551,-0.0249285016143386,7.68214426431034e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.028003797455089,0.00455268553220034,-0.0369270610982017,-0.0190805338119764,7.96491225733907e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0584899416212985,0.00951111470810475,-0.0771317264491838,-0.0398481567934132,7.98657812992882e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0405383714762923,0.00659436413588405,-0.053463325182625,-0.0276134177699596,8.14998057605374e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0806274542365799,0.013124304013521,-0.106351090103081,-0.0549038183700786,8.30558388776308e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.0154945582749807,0.00252471124335406,0.0105461242380068,0.0204429923119547,8.63630694980851e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0324241382987957,0.00529689303547455,-0.0428060486483258,-0.0220422279492655,9.59821099123092e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0261881557293456,0.00429064755665322,-0.0345978249403859,-0.0177784865183053,1.07163398311287e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0295433537966526,0.0048412484477369,-0.0390322007542169,-0.0200545068390883,1.07993094784217e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0235861221565354,0.00386855399046335,-0.0311684879778435,-0.0160037563352272,1.11129251620389e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,40223,-0.0444222120214622,0.00728536874149438,-0.0587015347547912,-0.0301428892881332,1.11377640778624e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0380448388710922,0.00625550638749007,-0.0503056313905728,-0.0257840463516117,1.22123270990791e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0426601214251302,0.00703252585497286,-0.056443872100877,-0.0288763707493834,1.35237661186015e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0319606209469073,0.00527640688313309,-0.0423023784378481,-0.0216188634559664,1.42238902125982e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0488348878520653,0.00807107849343798,-0.0646542016992037,-0.0330155740049268,1.49008120977408e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0196643709948052,0.00325255636286813,-0.0260393814660267,-0.0132893605235837,1.53364378143648e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42771,0.0286031812187465,0.00473728690090464,0.0193180988929734,0.0378882635445196,1.60223547588505e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0482105170699799,0.00798466634140534,-0.0638604630991344,-0.0325605710408255,1.60236789807912e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0459557581214378,0.0076132778836105,-0.0608777827733144,-0.0310337334695612,1.6280708688643e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0142210638262041,0.00236170833221326,-0.0188500121573421,-0.00959211549506615,1.77344739513095e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0358294566723591,0.00595250174560219,0.0241625532509788,0.0474963600937394,1.79785955058494e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.039945241899865,0.00664105972650215,-0.0529617189638092,-0.0269287648359208,1.84697771024826e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0190424641839069,0.00317024615941733,0.0128287817114489,0.0252561466563649,1.94330956046465e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0486990659616372,0.0081064026147614,-0.0645876150865695,-0.0328105168367049,1.94490646704373e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.031910504803069,0.00531370303768242,-0.0423253627569265,-0.0214956468492114,1.9597764396596e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0512175649152044,0.00854240869331892,-0.0679606859541094,-0.0344744438762993,2.07812242274804e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0402913520078379,0.00671930736611525,-0.0534611944454238,-0.027121509570252,2.07971382404743e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42636,-0.0626464232798703,0.010455020120472,-0.0831382627159955,-0.0421545838437451,2.1258367962101e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0622642917596178,0.0103898806365952,-0.0826284578073445,-0.0419001257118912,2.12693676116311e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,40539,-0.0248355173438827,0.00416485277808656,-0.0329986287889324,-0.0166724058988331,2.5483761098845e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0100130414261363,0.00168110344619735,-0.0133080041806831,-0.00671807867158947,2.65774082710736e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0391608668117101,0.00657819481072193,-0.0520541286407251,-0.0262676049826951,2.71047839069518e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0281063049842593,0.00472262270266146,-0.0373626454814758,-0.0188499644870429,2.72622098535658e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0198910997678705,0.00334281606814173,-0.0264430192614283,-0.0133391802743127,2.74078110777912e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0337529147091062,0.00567227103336441,-0.0448705659345004,-0.0226352634837119,2.75426175644652e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0113015857250691,0.0018996586601798,-0.0150249166990215,-0.00757825475111666,2.76059465739302e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,42328,0.0716110579748687,0.012037719590242,0.0480171275779943,0.0952049883717432,2.76837785393572e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,40199,-0.0298432442925138,0.00502055612241064,-0.0396835342924387,-0.020002954292589,2.86218928650045e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0311523987507803,0.0052421309250009,-0.0414269753637821,-0.0208778221377786,2.87464204751653e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0240025522062501,0.00403957761576351,-0.0319201243331466,-0.0160849800793537,2.90147842040444e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0304800253266056,0.00512995916957084,-0.0405347452989645,-0.0204253053542468,2.90657117597056e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0178110192739343,0.00300246936934695,-0.0236958592378544,-0.0119261793100143,3.06555828991239e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0531872658430304,0.0089811490503595,-0.070790317981735,-0.0355842137043258,3.25645440471142e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.020743444128859,0.00350293401615915,-0.027609194800531,-0.0138776934571871,3.27819047952888e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0393943809408305,0.00666988076393965,-0.0524673472381522,-0.0263214146435087,3.59941254748028e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0494804512613489,0.00838587256257867,-0.0659167614840031,-0.0330441410386947,3.71282497651063e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0446851143152871,0.00757564137106471,-0.0595333714025739,-0.0298368572280003,3.7556808094813e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0254583378595631,0.00431616953284281,-0.033918030143935,-0.0169986455751911,3.76127493221652e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,40302,-0.0323060912165552,0.00547938252330437,-0.0430456809622318,-0.0215665014708787,3.83403664010106e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.023290014082366,0.00395146579358844,-0.0310348870377993,-0.0155451411269327,3.85889294535413e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42611,-0.0261694191674885,0.0044428019080365,-0.03487731090724,-0.017461527427737,3.94736896930514e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0323692895958046,0.00549587148611713,-0.0431411977085942,-0.021597381483015,3.96065566574032e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0342069314602408,0.00582874794937298,-0.0456312774410119,-0.0227825854794698,4.51685294138192e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.0855174935061066,0.0145727440103221,-0.114080071766338,-0.0569549152458753,4.52648147414453e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0178772403231277,0.00305343993322386,-0.0238619825922465,-0.011892498054009,4.9123971638449e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42669,-0.0175443951812707,0.00299728919720121,-0.023419082007785,-0.0116697083547563,4.9276646026294e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0357499420864686,0.00610908811444547,-0.0477237547907817,-0.0237761293821555,4.99414270680215e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0366088198253763,0.00626166443459106,-0.0488816821171748,-0.0243359575335778,5.16258109194864e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0330688163384733,0.00566195274419685,-0.0441662437170991,-0.0219713889598474,5.32388791294049e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0454624560845713,0.00778446618812059,-0.0607200098132877,-0.030204902355855,5.33720103248263e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0385353753564066,0.00660046525882645,-0.0514722872637065,-0.0255984634491068,5.4194544479168e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0269058589172116,0.00461031325111817,-0.0359420728894032,-0.0178696449450199,5.46894158952844e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0516807483679012,0.00886668097368543,-0.0690594430763247,-0.0343020536594778,5.74441033074727e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0351127066645656,0.00603776359547674,-0.0469467233117,-0.0232786900174312,6.20825276999576e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0428379509057873,0.00736983348739868,-0.0572828245410887,-0.0283930772704859,6.32021658210997e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0123686719802975,0.00212878240722409,-0.0165410854984568,-0.00819625846213834,6.38132562436144e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0180232448815823,0.00310204662068266,-0.0241032562581203,-0.0119432335050443,6.41177152923742e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42636,-0.0144350102376285,0.00248606031091,-0.0193076884470121,-0.00956233202824489,6.52803973655922e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0445875941187278,0.00768148117806716,-0.0596432972277395,-0.0295318910097162,6.6315083473097e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0424377269156719,0.0073150618412396,-0.0567752481245015,-0.0281002057068423,6.72323835402623e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,40470,-0.0188768499303231,0.003256108295863,-0.0252588221902145,-0.0124948776704316,6.91713593609145e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0384761092470632,0.00663998993713749,0.0254617289702737,0.0514904895238527,7.00233847827211e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0324034903992127,0.0055975342628715,-0.0433746575544408,-0.0214323232439845,7.2434394813341e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.041081275335766,0.00709987033980309,-0.05499702120178,-0.0271655294697519,7.36057563944598e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0448005979738103,0.00775415108341054,-0.059998734097295,-0.0296024618503257,7.78316202058929e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42711,-0.02165654986238,0.00375857245736559,-0.0290233518788165,-0.0142897478459434,8.49810992945545e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42642,-0.0541413447104815,0.00940503315224438,-0.0725752096888805,-0.0357074797320825,8.76804523851179e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42594,-0.0274140181561066,0.00476896638621062,-0.0367611922730794,-0.0180668440391337,9.20444244332041e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0257015444446693,0.00447321003970547,-0.034469036122492,-0.0169340527668466,9.39380160460826e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0399113069989829,0.00695115252849342,-0.0535355659548301,-0.0262870480431358,9.57770999730928e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0157131468694024,0.00273821028746666,-0.021080039032837,-0.0103462547059677,9.75985889021954e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0193121861079772,0.00336633224164639,-0.0259101973016042,-0.0127141749143503,9.89900222655755e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0325034814542264,0.00567436596685264,-0.0436252387492576,-0.0213817241591953,1.04183544734231e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0383371492125304,0.00669504330321011,-0.0514594340868222,-0.0252148643382386,1.049099005757e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.0189904083410435,0.00331729697059188,0.0124885062786835,0.0254923104034036,1.05853804327602e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0419122710856328,0.00732197408067014,-0.0562633402837463,-0.0275612018875194,1.06157094360378e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0334306698213186,0.00584100356780713,-0.0448790368142206,-0.0219823028284166,1.06613438777125e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.023035899410076,0.00402845370484943,-0.0309316686715809,-0.0151401301485711,1.10319954065729e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0256687336699044,0.00449135004719144,-0.0344717797623996,-0.0168656875774091,1.12464759045838e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0232015511483155,0.00406148620731787,-0.0311620641146586,-0.0152410381819725,1.14099275513772e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.036430522142172,0.00638391297130946,-0.0489429915659385,-0.0239180527184055,1.17739532265753e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.050035936232629,0.00877735006098189,-0.0672395423521535,-0.0328323301131045,1.22406537381195e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0218894420871946,0.00384079818240648,-0.0294174065247113,-0.0143614776496779,1.22968374104032e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0198799576613523,0.00349501950138601,-0.0267301958840689,-0.0130297194386357,1.31158214566397e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.0152078963298724,0.00267520454553116,-0.0204512972391135,-0.0099644954206313,1.33725031707581e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,40539,-0.0117337584528094,0.00206605533385452,-0.0157832269071642,-0.00768428999845453,1.38567541108515e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0276639774792474,0.00487105867871414,0.0181167024689677,0.0372112524895271,1.3869538273776e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0172352108585206,0.00303769849849824,-0.0231890999155772,-0.0112813218014641,1.42578719966894e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0204216128202897,0.00360159998505238,-0.0274807487909924,-0.013362476849587,1.45592509277658e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0406322499181477,0.00716646393117319,-0.0546785192232472,-0.0265859806130483,1.45891510212741e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0341240877564135,0.00601878726810217,0.0223272647109332,0.0459209108018938,1.46089503201901e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0475806571014575,0.00839513116601221,-0.0640351141868414,-0.0311262000160735,1.48415685187807e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0217271480506709,0.00383570553429484,-0.0292451308978887,-0.014209165203453,1.50599573870958e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0322849721395863,0.00570218650832353,-0.0434612576959004,-0.0211086865832722,1.53492584517975e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0452053351616479,0.00799522412693488,-0.0608759744504403,-0.0295346958728555,1.59941596724104e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0310698872270236,0.0054957493011762,-0.041841555857329,-0.0202982185967183,1.60479834564421e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0358414228695476,0.00634081757715394,-0.0482694253207693,-0.0234134204183258,1.6198427192014e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.046740751434318,0.00827500007995726,-0.0629597515910342,-0.0305217512776018,1.65213900320404e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42580,-0.016380877940371,0.00290043128205731,-0.0220657232532033,-0.0106960326275387,1.65880508581126e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,40199,-0.0240174560174921,0.00425214155222733,-0.0323516534598577,-0.0156832585751266,1.6604313678411e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,42261,-0.0410111312994606,0.00726755189669012,-0.0552555330169733,-0.026766729581948,1.70539810714859e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0243860643626031,0.00433269790656987,-0.0328781522594801,-0.0158939764657262,1.85537463906368e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.030611047983424,0.00543882423710644,-0.0412711434881526,-0.0199509524786954,1.86529695564649e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0226064253589037,0.00401767408950837,0.0147317841434673,0.0304810665743401,1.87317006389372e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0334360908811346,0.00594592034811285,-0.0450900947634358,-0.0217820869988334,1.90991916300388e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0272032114864556,0.0048430497678169,0.0177108339415345,0.0366955890313767,1.98242407732904e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0276100040076795,0.00491802534231527,-0.0372493336786174,-0.0179706743367416,2.02430799501281e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0246007748135152,0.00438282460465918,-0.0331911110386472,-0.0160104385883832,2.0366717007417e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,40482,0.0272425326730566,0.00485359308747989,0.017729490221596,0.0367555751245171,2.03705788787387e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.0178077164843544,0.00317817463184729,0.0115784942059337,0.0240369387627751,2.14605938153144e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,42446,-0.0319391256994054,0.0057034295449343,-0.0431178476074766,-0.0207604037913341,2.18631911500799e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0236855079196267,0.00423108097238332,0.0153925892137554,0.031978426625498,2.21925874718673e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,40471,-0.0471779906176297,0.00843418170484219,-0.0637089867591204,-0.030646994476139,2.27505054301391e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42677,0.0234572835881625,0.00419462138367977,0.0152358256761502,0.0316787415001749,2.28529853872623e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0152688549430775,0.00273423941549369,-0.0206279641974451,-0.00990974568870984,2.39156316317888e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0294137832993623,0.00526945587074746,-0.0397419168060273,-0.0190856497926973,2.4334153623842e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0247528492446819,0.00443858751768179,-0.0334524807793382,-0.0160532177100256,2.49811127619997e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.0141052366040669,0.00253862935202561,0.00912952307409673,0.0190809501340371,2.80853943198511e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0266768041315125,0.0048045922136726,-0.0360938048703108,-0.0172598033927142,2.87299457162267e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0394344432911804,0.00710465222303261,-0.0533595616483243,-0.0255093249340365,2.91268243551676e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0286941813886511,0.00517563181353882,-0.0388384197431872,-0.018549943034115,3.01062077495976e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0388387924015816,0.00700990369120811,-0.0525782036363495,-0.0250993811668137,3.07192045293175e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0139135530227514,0.00251163565069625,-0.0188363588981161,-0.00899074714738675,3.09016109692106e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42676,0.0356868625777929,0.00644724282304573,0.0230502666446233,0.0483234585109625,3.16654831512549e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0201048667270343,0.00363478823149659,-0.0272290516607676,-0.012980681793301,3.23942163621596e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0258974283112361,0.00468273438321631,-0.0350755877023401,-0.0167192689201321,3.25469067850006e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.0155393110104523,0.00280961454911758,0.0100324664941818,0.0210461555267228,3.26069562852833e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0397614523952724,0.00719349415618671,-0.0538607009413983,-0.0256622038491465,3.32394957037677e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0337605417845836,0.00610896884675016,-0.0457341207242139,-0.0217869628449533,3.32918714127632e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0234742676268693,0.00424984751633711,-0.03180396875889,-0.0151445664948486,3.38398075977662e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42594,-0.0183167048343804,0.00331940223362061,-0.0248227332122768,-0.011810676456484,3.49098258889147e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0420882424430725,0.00762841691857365,-0.0570399396034768,-0.0271365452826681,3.50631462658827e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,40199,-0.0315606200578758,0.00572097655527412,-0.042773734106213,-0.0203475060095385,3.53338904529693e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42721,-0.0600184974604055,0.0108888608895649,-0.0813606648039527,-0.0386763301168584,3.61443951087233e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0165734012117144,0.00300812762434139,-0.0224693313554235,-0.0106774710680053,3.66400646869786e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.0698586143604705,0.012687441173223,-0.0947259990599875,-0.0449912296609535,3.73551924053562e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,40532,-0.0401900561723522,0.00732254634972684,-0.0545422470178168,-0.0258378653268876,4.13997708635629e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0459546455860265,0.00837584213467738,-0.0623712961699942,-0.0295379950020588,4.18655244908624e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0193691073230076,0.00353222612708993,-0.0262922705321038,-0.0124459441139113,4.26104130363465e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0310165648358797,0.00566065882570695,-0.0421114561342653,-0.0199216735374941,4.36292952117086e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,40283,-0.0297441976162635,0.00544565390778966,-0.0404176792755312,-0.0190707159569957,4.80944489602197e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0197847541956403,0.00362283335383296,-0.0268855075691529,-0.0126840008221277,4.83518593956905e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0371187659437397,0.00681184365849878,-0.0504699795143973,-0.0237675523730821,5.15023350830721e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0276834148747987,0.00508159146624643,-0.0376433341486417,-0.0177234956009557,5.19186079748899e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42794,0.0223111891655808,0.00409914778494738,0.014276859507084,0.0303455188240777,5.33331605189911e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0285457826718261,0.00524996729175333,-0.0388357185636626,-0.0182558467799896,5.52394243502715e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0409572422607053,0.00753421289232964,-0.0557242995296714,-0.0261901849917392,5.55717762581371e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0171795340543555,0.0031610006271345,-0.0233750952835391,-0.0109839728251719,5.57964217031377e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0318360539955133,0.00586240576133467,-0.0433263692877293,-0.0203457387032974,5.73504004399509e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42613,-0.0211631209843831,0.0038990897843557,-0.0288053369617203,-0.0135209050070459,5.80742087961681e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0272303585015386,0.00501718688716879,-0.0370640448003894,-0.0173966722026878,5.83889927935634e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0236549127735853,0.00435947922508808,-0.032199492054758,-0.0151103334924127,5.86231686972151e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42611,0.0243018934020339,0.00448127420065112,0.0155185959687577,0.0330851908353101,5.96262935391932e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0296098232748103,0.00546250454916373,-0.0403163321911713,-0.0189033143584494,6.06788740475617e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0200135441471792,0.00369283560138288,-0.0272515019258896,-0.0127755863684687,6.1016032731023e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0311769459269708,0.00575606845657068,-0.0424588401018494,-0.0198950517520923,6.207205812313e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0222974359823243,0.00412233775823832,-0.0303772179884714,-0.0142176539761772,6.44806041620759e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0248339370273517,0.00459236072980712,-0.0338349640577736,-0.0158329099969297,6.49685764939659e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,42216,-0.0412372301623812,0.00764297442577786,-0.0562174600369058,-0.0262570002878566,6.9550896214742e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0282769897353996,0.00524167518587421,-0.0385506730997131,-0.0180033063710861,7.00777306337094e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,40283,-0.0623384346583403,0.0115600008347321,-0.0849960362944152,-0.0396808330222655,7.08721405954786e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0214329330465858,0.00397626089444932,-0.0292264043997065,-0.0136394616934652,7.15508741464494e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0163762001747088,0.00304116300306829,-0.0223368796607226,-0.0104155206886949,7.37286326867068e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0285936761285375,0.00531841880324052,-0.0390177769828889,-0.018169575274186,7.72973501377514e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0433824708893788,0.00808499471056238,-0.0592290605220811,-0.0275358812566766,8.22286513494884e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0541982054748886,0.0101096468057322,-0.0740131132141238,-0.0343832977356534,8.4117663398258e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0196303446914034,0.00366296678353249,-0.026809759587127,-0.0124509297956797,8.53084231971364e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.00994017520412308,0.00185688597592229,-0.0135796717169308,-0.0063006786913154,8.81250362526667e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0346264935907325,0.00646859644188539,-0.0473049426168279,-0.0219480445646371,8.82422698816401e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0499282115644163,0.00933079277294677,-0.068216565399392,-0.0316398577294406,8.9226260956667e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0156014837670784,0.00292040643077505,-0.0213254803713976,-0.00987748716275934,9.36369928963648e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0151760649621811,0.00284334670959914,-0.0207490245129954,-0.00960310541136675,9.58338519185885e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0205050670598334,0.00384256550299374,0.0129736386739657,0.0280364954457012,9.64386838194681e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0142162311220079,0.00266455244386852,0.00899370833202556,0.0194387539119902,9.72145879962838e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42563,-0.0194802332187344,0.00365208659733736,-0.0266383229495156,-0.0123221434879532,9.76376125690425e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0150265391177415,0.00281933123100646,0.00950064990496886,0.0205524283305142,9.98824918187599e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0463683735144742,0.00869914976165979,-0.0634187070473274,-0.029318039981621,1.00029461252544e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0324637554396855,0.00609413417344622,-0.0444082584196401,-0.0205192524597309,1.0141633542452e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,40199,0.0163976790577514,0.00309227652492685,0.0103368170688948,0.022458541046608,1.16258677002512e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42587,0.00811675119453725,0.00153218799276641,0.00511366272871509,0.0111198396603594,1.19264363379153e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0332575055547824,0.00627983170322816,-0.0455659756931096,-0.0209490354164552,1.20272548455062e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0349162289301127,0.00659423037090471,-0.047840920457086,-0.0219915374031395,1.21309984250121e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0357887847916254,0.00676375035690922,-0.0490457354911674,-0.0225318340920833,1.23389338629081e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0440726379968919,0.00833064288522102,-0.0604006980519251,-0.0277445779418588,1.24010723053943e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0328214242642767,0.0062091411303544,-0.0449913408797714,-0.0206515076487821,1.27362694041168e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0478746876122726,0.00905871605846529,-0.0656297710868645,-0.0301196041376806,1.28090131865686e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0352843123047523,0.00668092374804399,-0.0483789228509186,-0.0221897017585861,1.30233222940394e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,40532,-0.042925775683671,0.00813547872626739,-0.0588713139871551,-0.0269802373801869,1.34199428222581e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42495,0.0223850175133716,0.00424516885096736,0.0140644865654756,0.0307055484612677,1.36271216950137e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0352398143397692,0.00668615657489628,-0.0483446812265659,-0.0221349474529725,1.38161617113039e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,42311,-0.0457276346357695,0.00867613339319147,-0.0627328560864248,-0.0287224131851142,1.3820312576721e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0631294820564301,0.0119795628988313,0.0396495387747206,0.0866094253381395,1.38732699295246e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0562924459319766,0.0106815444043969,-0.0772282729645946,-0.0353566188993586,1.38882205377428e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,40182,-0.0221408846454683,0.00420286261477074,-0.030378495370419,-0.0139032739205176,1.40489522650624e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0481238680965488,0.00915715792092531,-0.0660718976215624,-0.0301758385715352,1.50014143139618e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0252662126865776,0.00481797872841741,-0.0347094509942757,-0.0158229743788795,1.59842041354124e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.040307096777217,0.00768648435363502,-0.0553726061103416,-0.0252415874440923,1.60075063687953e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0152026263775715,0.00290058931436255,-0.0208877814337221,-0.00951747132142088,1.61919050943212e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42611,-0.0244044786087688,0.00465810552921836,-0.0335343654460368,-0.0152745917715008,1.63766974008509e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0276304284338367,0.00527354259442278,-0.0379665719189054,-0.0172942849487681,1.63956570731806e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0251124987545166,0.00479632781216665,-0.0345133012663632,-0.0157116962426699,1.67254373902727e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0190839436428586,0.00364758954556119,0.0119346681335587,0.0262332191521585,1.70295026254318e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0169277341684742,0.00323526657675575,-0.0232688566589154,-0.0105866116780329,1.70457444780893e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0283988591783393,0.00542924392109195,-0.0390401772636795,-0.017757541092999,1.71440196429868e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0366258306920176,0.00700564515753649,-0.0503568952007891,-0.0228947661832461,1.74372335733674e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0473020026977906,0.0090583714635044,-0.0650564107662592,-0.029547594629322,1.79787483218944e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0450500619135882,0.00862730150835079,-0.0619595728699558,-0.0281405509572207,1.80341646825254e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42679,-0.0364937287639394,0.00699863116399288,-0.0502110458453655,-0.0227764116825134,1.87130806616459e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.0095854368927539,0.00183954241398476,0.00597993376134377,0.013190940024164,1.91363247452325e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0322383359998865,0.00618817718530948,-0.0443671632830931,-0.0201095087166799,1.91953268658754e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.032080138399444,0.00615861608230835,-0.0441510259207684,-0.0200092508781197,1.92752151780175e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0298439037530949,0.00573364619118094,-0.0410818502878095,-0.0186059572183802,1.97352695641358e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0179588086517747,0.00345736681933193,-0.0247352476176653,-0.0111823696858842,2.09062863018952e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0180222233602004,0.00346998136347711,-0.0248233868326156,-0.0112210598877853,2.09081920792718e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0223520034567543,0.00430378238934066,-0.030787416939862,-0.0139165899736466,2.09377388639409e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0348221849623049,0.00670894217804544,-0.047971711631274,-0.0216726582933358,2.13472716756759e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0173708791648207,0.00335027136913117,-0.0239374110483178,-0.0108043472813236,2.19917589255034e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0475817096986199,0.00917834947614458,-0.0655712746718633,-0.0295921447253766,2.2087294548929e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0218388619926303,0.0042144676583436,-0.0300992186029838,-0.0135785053822769,2.23521835985747e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0160117691024884,0.00309101799477861,-0.0220701643722545,-0.00995337383272233,2.24960999541144e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0406759707409296,0.00785354670886772,-0.0560689222903103,-0.0252830191915489,2.25989214985142e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.0161257840252693,0.00311425667781367,0.0100218409367545,0.0222297271137841,2.28142967758686e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42611,-0.0340988890307233,0.00658752388772318,-0.0470104358506607,-0.0211873422107858,2.29619616952798e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0721166617677027,0.0139377441076318,-0.0994346402186611,-0.0447986833167443,2.32198025945997e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,40463,-0.0506468026378964,0.00983825012462917,-0.0699297728821696,-0.0313638323936232,2.67789731361878e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0388225109448569,0.00755167562845441,-0.0536237951766276,-0.0240212267130863,2.77326233886201e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0235420881970458,0.00458235154481715,-0.0325234972248874,-0.0145606791692042,2.83007574009719e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0275351087141531,0.00536068968190316,-0.0380420604906833,-0.0170281569376229,2.84580071657094e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0160566356200012,0.00312631689719127,-0.0221842167384961,-0.00992905450150627,2.8460553869693e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0196230861759418,0.00382554244058117,-0.0271211493594809,-0.0121250229924027,2.94592295173375e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0268363670624722,0.00523273480466096,-0.0370925272796077,-0.0165802068453367,2.96137124632097e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42779,-0.0181831163868823,0.00355794504853172,-0.0251566886820045,-0.0112095440917601,3.25553601388181e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0361087095113788,0.00706741952316181,0.0222565672459816,0.0499608517767759,3.27996767881344e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0505871620929439,0.00991783135421991,-0.070026111547215,-0.0311482126386729,3.43146018778239e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,42663,-0.0117083367066976,0.00229622415388822,-0.0162089360483186,-0.00720773736507673,3.46174500863862e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,40449,-0.028609330053739,0.0056249292727333,-0.0396341914282963,-0.0175844686791817,3.71255168397081e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0332079324914801,0.00653225254123749,0.0204047175106546,0.0460111474723056,3.75143921160167e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42552,-0.0124786189349548,0.00246046237911578,-0.0173011251980217,-0.00765611267188788,3.99654383974767e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,40483,0.0189907032168845,0.00374791699363247,0.0116447859093649,0.0263366205244042,4.1052262880558e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42594,-0.0339511006873693,0.00670987772887818,-0.0471024610359705,-0.0207997403387681,4.25100185085426e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0763197440568392,0.0150936322792399,-0.105903263324149,-0.046736224789529,4.32841402452587e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0245882984112239,0.0048630355889946,0.0150567486567945,0.0341198481656533,4.33424703382591e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,40483,-0.0686456537696116,0.0135822255932318,-0.095266815932346,-0.0420244916068772,4.39244008233401e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0216423835831391,0.00428355924697196,-0.0300381597072041,-0.0132466074590741,4.43266179903244e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0380368707492316,0.00753641401789449,-0.0528082422243048,-0.0232654992741584,4.54486509810949e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0516618528538861,0.0102707339428574,-0.0717924913818867,-0.0315312143258856,4.96809764759825e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.0655141560674187,0.013025816347719,-0.091044756108948,-0.0399835560258894,4.97920736396498e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,40527,-0.0417183696848228,0.00829676143519074,-0.0579800220977967,-0.025456717271849,5.02489949187927e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.017136620167926,0.00340952028613683,0.0104539604070979,0.0238192799287542,5.06968915010548e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0587418023643488,0.0116922774922531,-0.0816586662491647,-0.0358249384795328,5.13853177512871e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0143162305297881,0.00285423848600907,-0.0199105379623659,-0.00872192309721031,5.34866033467758e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0346141461144828,0.00692323691501282,-0.0481836904679079,-0.0210446017610577,5.8309392664213e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0263169357458407,0.00526526675807767,-0.0366368585916729,-0.0159970129000084,5.87520052903274e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,40361,-0.0272851597330036,0.00546176762733974,-0.0379902242825895,-0.0165800951834177,5.95209116154828e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0454581641876865,0.00911777852650961,-0.0633290100996453,-0.0275873182757276,6.26889904255146e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0170956781805652,0.00343117989352534,-0.0238207907718749,-0.0103705655892555,6.35602597723312e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42587,-0.0148924994910437,0.00299390816339602,-0.0207605594912999,-0.00902443949078751,6.63069708377537e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0244560807149801,0.00492615364983408,-0.0341113418686549,-0.0148008195613053,6.98873027248077e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0390788065535661,0.00787278029158045,-0.0545094559250638,-0.0236481571820684,6.99877775594522e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.0116179515927055,0.00234064390330233,-0.016205613643178,-0.0070302895422329,7.00669725334743e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.050787530907158,0.0102337897429327,-0.0708457588033062,-0.0307293030110098,7.05434991424047e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0121473711929897,0.00245048384199636,-0.0169503195233025,-0.00734442286267679,7.24172788166226e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,40511,-0.0268172365334173,0.00542096477672851,-0.0374423274958052,-0.0161921455710294,7.64695009156883e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0490798392715,0.00992811395519733,-0.0685389426236868,-0.0296207359193133,7.76592985494521e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0172816805311302,0.00349689866876555,-0.0241356019219107,-0.0104277591403498,7.8255716167328e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0560800983687161,0.0113523590845974,-0.078330722174527,-0.0338294745629053,7.92623470513206e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.043938068443811,0.0088946144299035,-0.0613715127264219,-0.0265046241612001,7.93063203656133e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0222004520113656,0.00449887530644226,0.0133826564107388,0.0310182476119924,8.12461134789385e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0400389321622533,0.00812303926896905,-0.0559600891294327,-0.024117775195074,8.38291236324394e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0252928720237736,0.00513523963988425,-0.0353579417179468,-0.0152278023296005,8.5207431335698e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0458682290935841,0.00931300354996703,-0.0641217160515194,-0.0276147421356487,8.52948984132579e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,39989,-0.0233498889691657,0.00474132454980011,-0.0326428850867739,-0.0140568928515575,8.57150183405743e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0242102208487225,0.0049358678796262,-0.0338845218927898,-0.0145359198046552,9.47547095947656e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.025397000378473,0.00518119940101258,-0.0355521512044577,-0.0152418495524884,9.63062969046823e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.0167951772279623,0.00342763368968333,-0.0235133392597416,-0.0100770151961829,9.70032187082163e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0149019879648427,0.00304181152690616,-0.0208639385575787,-0.00894003737210658,9.74344031412818e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0442424012569634,0.00904071049279732,-0.0619621938228462,-0.0265226086910807,1.00336424085391e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0416075046925086,0.00850377597769544,-0.0582749056087917,-0.0249401037762256,1.0079546291954e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0160639840121749,0.00328353104574168,-0.0224997048618286,-0.0096282631625212,1.01042298870391e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.036927227009647,0.00755210907453797,-0.0517293607957414,-0.0221250932235526,1.02403264604085e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0258663111046056,0.00529593414481605,-0.036246342028445,-0.0154862801807661,1.0530657614722e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0189789968066951,0.00388747133391667,-0.0265984406211717,-0.0113595529922184,1.06403108557559e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0265663283467146,0.00544299844947998,-0.0372346053076953,-0.0158980513857338,1.07125150348835e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.0189652488124262,0.00388818372678019,-0.0265860889169154,-0.011344408707937,1.08606718348878e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.022225542978215,0.00455697097703355,-0.0311572060932008,-0.0132938798632292,1.0883028958134e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0170756388577768,0.00350338493514385,-0.0239422733306588,-0.0102090043848949,1.10600427386217e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0128778285144325,0.00264723351873071,-0.0180664062111446,-0.00768925081772028,1.15951728687038e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0271651050846085,0.00558440582397861,-0.0381105404996065,-0.0162196696696104,1.16359715910855e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0428179884986289,0.00881015029826525,-0.0600858830832288,-0.025550093914029,1.18927117769091e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.024942436665388,0.00513518750523588,0.0148774691551256,0.0350074041756503,1.20683824278244e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,40267,0.0147734194572904,0.00304566568998173,0.00880391470492623,0.0207429242096546,1.24741292814576e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0208693550947172,0.00430979692585419,-0.0293165570693914,-0.012422153120043,1.30090587438119e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0124257928113725,0.00256659442362263,0.00739526774107218,0.0174563178816729,1.30391807845213e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0285000934027073,0.00589098549293892,0.016953761836547,0.0400464249688676,1.32934628862227e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0192855329429878,0.00399526463886754,-0.0271162516351682,-0.0114548142508074,1.40358075685246e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0304420243807808,0.00630787398875703,-0.0428054573987446,-0.0180785913628171,1.40846223588165e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0168639742936265,0.00350075427100364,-0.0237254526647937,-0.0100024959224594,1.47499249826749e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0287722614943822,0.00597415293935945,-0.0404816012555267,-0.0170629217332377,1.47975183100586e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,40283,-0.0369335327064741,0.00768597278348862,-0.0519980393621118,-0.0218690260508364,1.56532828356276e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,42357,-0.023822918371304,0.00497146185747724,-0.0335669836119594,-0.0140788531306486,1.669847315341e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0251900976313829,0.0052571811792093,-0.0354941727426332,-0.0148860225201327,1.6724418678115e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.0190363029440035,0.00397454230400616,0.0112462000281514,0.0268264058598556,1.68916782624665e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,42311,-0.0347336949832749,0.00725888256768879,-0.0489611048159449,-0.0205062851506049,1.72857431837292e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0419724351521605,0.00877487459155359,-0.0591711893516055,-0.0247736809527155,1.74319806393591e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0404450448394967,0.00846428307860143,-0.0570350396735555,-0.0238550500054379,1.79034739208156e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42562,-0.017178527602343,0.00359639580335174,-0.0242274633769124,-0.0101295918277735,1.80181250903181e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,40449,-0.0361482883043739,0.00758318870971023,-0.051011338175406,-0.0212852384333419,1.89426814524952e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.029296889241839,0.00615065430198994,0.0172416068099387,0.0413521716737393,1.92549210973389e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.0144134123193074,0.00302675891575378,0.00848096484443001,0.0203458597941848,1.93665138259509e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0326045674262292,0.00686305331933124,-0.0460561519321185,-0.01915298292034,2.05218581542979e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.051166167081204,0.0107774177650428,-0.0722899059006878,-0.0300424282617201,2.08441956665198e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0293491431953037,0.00619738706776195,-0.0414960218481171,-0.0172022645424903,2.2049219454648e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0155284823320251,0.00327888880760349,-0.0219551043949279,-0.00910186026912226,2.20790835931301e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0135507549408349,0.00286847031012984,-0.0191729567486894,-0.00792855313298047,2.33991250890004e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0228742765356765,0.00484758592957261,-0.0323755449576388,-0.0133730081137142,2.39802961523306e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0198787409196947,0.00422021610667387,-0.0281503644887755,-0.0116071173506139,2.50235420485297e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0286738815177865,0.00611568409873213,-0.0406606223513015,-0.0166871406842716,2.77818332262708e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0401732526711499,0.00857988750309304,-0.0569898321772123,-0.0233566731650876,2.86501791966061e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0423125212858171,0.00903770947127069,-0.0600264318495076,-0.0245986107221265,2.8779997489547e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42611,0.0236742824132703,0.00506048510394042,0.0137557316095471,0.0335928332169935,2.92139675138081e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0195801591894966,0.00418541230899625,-0.0277835673151293,-0.011376751063864,2.92857030646382e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0259662532806094,0.00555211765481229,-0.0368484038840415,-0.0150841026771773,2.94185362371961e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0394745236182489,0.00844105315834217,-0.0560189878085996,-0.0229300594278983,2.94725821074686e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0414298933470571,0.00886041972878591,-0.0587963160154775,-0.0240634706786368,2.95616521618324e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42594,0.0202559633686299,0.0043327122649871,0.0117638473292552,0.0287480794080047,2.96642067273017e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.0129089996483372,0.00276126512023365,0.00749692001267924,0.0183210792839951,2.96732966545843e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,40532,-0.0426442495407166,0.00912569900841397,-0.0605306195972079,-0.0247578794842252,3.00271822388083e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0277476191906704,0.00593922190626204,-0.039388494126944,-0.0161067442543968,3.01342046145968e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0140636976680123,0.00301231537863719,-0.0199678358101412,-0.00815955952588344,3.05982976415067e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0187617363081713,0.0040228052819187,-0.0266464346607319,-0.0108770379556106,3.14010615909841e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0537091281137035,0.0115330207077608,-0.0763138487009147,-0.0311044075264924,3.2395470526061e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0335052949490647,0.00719652119172883,-0.0476104764848532,-0.0194001134132761,3.25948336254753e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0415153579180919,0.0089180259120093,-0.0589946887056301,-0.0240360271305537,3.26813893577128e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0317451781548475,0.00683230585857154,-0.0451364976376477,-0.0183538586720473,3.41102451838716e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0316532474848706,0.00682721246729614,-0.0450345839207711,-0.0182719110489702,3.58727698862778e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.0172372511540076,0.00371980411310689,0.00994643509231811,0.0245280672156971,3.62823485928033e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0425664240088326,0.00918796508915615,-0.0605748355835786,-0.0245580124340865,3.64127596538103e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0125112065383408,0.00270739156270435,-0.0178176940012413,-0.00720471907544029,3.8586566816591e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0212777339472329,0.00460608896682525,-0.0303056683222104,-0.0122497995722554,3.88363692234644e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.0128832667905843,0.00279190595449436,0.00741113111977538,0.0183554024613933,3.97687369178395e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0206689486928612,0.00448307800214904,-0.0294557815770733,-0.0118821158086491,4.06348818265737e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.0102109529239328,0.00222100677541658,0.00585777964411627,0.0145641262037493,4.32435381009817e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,40449,-0.0468702077616831,0.0102180915374154,-0.0668976671750174,-0.0268427483483488,4.54553541838463e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0290017863632452,0.00632304494994947,0.0166086182613442,0.0413949544651461,4.55362464802383e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0277867373569959,0.0060587232177569,-0.0396618348637994,-0.0159116398501924,4.55369006797952e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42636,-0.016098678902352,0.00351379631445536,-0.0229857196786845,-0.00921163812601951,4.65664153747857e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0125524806268043,0.00274121790891358,-0.0179252677282749,-0.00717969352533369,4.70996070105609e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0403321384494448,0.00882121882777966,-0.057621727351893,-0.0230425495469967,4.87956688804139e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0324034246782036,0.00708754463031683,0.0185118372027826,0.0462950121536246,4.88513833489287e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0242010434321641,0.00529450065605309,-0.0345782647180282,-0.0138238221463,4.90732139853936e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0313429320035941,0.00687090345216907,-0.0448099027698455,-0.0178759612373427,5.11939396205011e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0197297927325803,0.0043272439938195,-0.0282111909604665,-0.0112483945046941,5.17410524099425e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0255325623635057,0.00559983810744576,-0.0365082450540994,-0.014556879672912,5.18232260599702e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,40483,-0.0381135275933233,0.00836161200348384,-0.0545022871201516,-0.021724768066495,5.21470008718191e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0334795895608502,0.00734706105655221,-0.0478798292316925,-0.0190793498900079,5.24797687850332e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0316929558736752,0.00696131078974138,-0.0453371250215683,-0.0180487867257821,5.34179928881487e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.016013881042468,0.0035300823369185,-0.0229328424228283,-0.00909491966210776,5.78274778283272e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0394835932492717,0.00870497418580597,-0.0565453426534514,-0.022421843845092,5.79924542367436e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0444622640661767,0.0098058482367229,-0.0636817266101536,-0.0252428015221998,5.83164018098675e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0324644011867242,0.00716021912092908,-0.0464984306637452,-0.0184303717097032,5.83884327360997e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0220322152000712,0.00486625297981591,-0.0315700710405104,-0.012494359359632,6.0298499840058e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0265195838758993,0.00586127282074956,-0.0380076786045684,-0.0150314891472301,6.11459319104134e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0530879544310778,0.0117351702798876,-0.0760888881796574,-0.0300870206824982,6.135119386052e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0275064442136476,0.00609904985037423,-0.0394605819203811,-0.0155523065069141,6.54935140061443e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0510407607774465,0.0113226154950162,-0.0732330871476783,-0.0288484344072146,6.60395027167191e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0214896274480206,0.00477623343340312,-0.0308510449774907,-0.0121282099185504,6.88633299860048e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0271365816345465,0.0060387101836319,0.015300709674628,0.038972453594465,7.06688496543718e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0141569173462314,0.00315133479098789,0.00798030115589514,0.0203335335365677,7.11394107207473e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,42357,-0.0349410239928953,0.00780689158126869,-0.0502425314921819,-0.0196395164936086,7.68136819923362e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,42370,-0.0506000534105107,0.011325446174901,-0.0727979279133168,-0.0284021789077047,7.9679096499007e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42587,-0.020413726903955,0.00457842488962481,-0.0293874396876196,-0.0114400141202904,8.31368564985732e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0298475580884045,0.00670141781011101,-0.0429823369962221,-0.0167127791805869,8.49980392090188e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42597,-0.0183145917221177,0.00411311894040549,-0.0263763048453125,-0.0102528785989229,8.54722900165562e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42611,-0.0329608866607606,0.00740359754805856,-0.0474719378549554,-0.0184498354665658,8.57569219723509e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0306252562999216,0.00689829747038255,-0.0441459193418714,-0.0171045932579718,9.10314834118629e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0194204551258548,0.00437876415720084,-0.0280028328739684,-0.0108380773777411,9.28831006108869e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.012921945361103,0.00291661226638728,-0.0186385054032221,-0.00720538531898398,9.47740448236596e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.040044433042839,0.00904119613300405,-0.057765177463527,-0.0223236886221511,9.55117668939405e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0218908396266277,0.0049445080318372,-0.0315820753690286,-0.0121996038842268,9.61866230555041e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,42311,-0.0464636793134924,0.0104965064573493,-0.0670368319698971,-0.0258905266570876,9.65097713884751e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0123598800977151,0.00279247574204304,-0.0178331325521194,-0.00688662764331071,9.6860439998384e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,40182,-0.0206381397444594,0.00467381907344441,-0.0297988251284104,-0.0114774543605083,1.01650069927314e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.020147345192955,0.00457291827314732,-0.0291102650083237,-0.0111844253775863,1.06367883564434e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.016555557191224,0.00376121207282131,-0.0239275328539537,-0.00918358152849419,1.0844861483145e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.00945852159970383,0.00215135803919124,0.00524185984288901,0.0136751833565187,1.1083606784053e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0215722640087995,0.00491178044686663,-0.0311993536846581,-0.011945174332941,1.13393233205367e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0320160690294073,0.00729926264787636,-0.0463226238192449,-0.0177095142395696,1.16387836214383e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0350390217361422,0.00800495258575821,-0.0507287288042283,-0.0193493146680561,1.21340550487921e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0172132222087716,0.00393309879073285,-0.024922095838608,-0.0095043485789352,1.21718459431652e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0253745519227527,0.0058097557981066,-0.0367616732870416,-0.0139874305584637,1.26594075073329e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0263390869222829,0.00603997119555038,-0.0381774304655616,-0.0145007433790041,1.30574057674563e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0202911260559466,0.00465398120419846,-0.0294129292161755,-0.0111693228957176,1.31244433380539e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42679,-0.0251857163273683,0.00578291016510802,-0.03652022025098,-0.0138512124037566,1.3392818303019e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0525331241444827,0.0121115775526694,-0.0762718161477148,-0.0287944321412507,1.45245180884508e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0395960287699106,0.00913235248304719,-0.0574954396366831,-0.0216966179031381,1.46524776215502e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0286018244445733,0.00659970723161697,-0.0415372506185425,-0.015666398270604,1.47642441666963e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0475754068766485,0.0109784705093098,-0.0690932090748957,-0.0260576046784013,1.47833485326576e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42636,0.0118467788710986,0.00273645316794507,0.00648333066192625,0.0172102270802709,1.5070353679061e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0401200214475584,0.00927155325902281,-0.0582922658352431,-0.0219477770598736,1.52304848939624e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.011544955077841,0.00267013022769157,0.00631149983156556,0.0167784103241165,1.54502290644251e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0271659494584366,0.0062880851220246,-0.0394905962976048,-0.0148413026192683,1.5723920991002e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0122964415765763,0.00285361138842954,-0.0178895198978982,-0.00670336325525443,1.6531949718439e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0259445349570888,0.00602402041960184,-0.0377516149795084,-0.0141374549346692,1.67022963766376e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0291694837130821,0.00678724612170287,-0.0424724861116197,-0.0158664813145444,1.74033757953328e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42721,-0.0128126482569784,0.00298161664437517,-0.0186566168799537,-0.00696867963400306,1.74166268319486e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0461075304264783,0.0107542901712319,-0.0671859391620929,-0.0250291216908637,1.82336975537385e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0508305544025383,0.0118714837553696,-0.0740986625630628,-0.0275624462420138,1.86725170001645e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0197952244676457,0.00462509355342411,-0.028860407832357,-0.0107300411029345,1.88472473131428e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0294676563318397,0.00688792415707326,-0.0429679876797033,-0.0159673249839761,1.90020683592624e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0381989523203035,0.00894097212340189,-0.0557232576821712,-0.0206746469584358,1.94760285089444e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0370806970576565,0.00868370534137719,-0.0541007595267558,-0.0200606345885573,1.96689854975204e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.011403275866562,0.00267318583836922,-0.0166427201097656,-0.0061638316233583,2.00566229798302e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0499187001390445,0.011715750676357,-0.0728815714647043,-0.0269558288133847,2.05386521606728e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0221898452929818,0.00521198738659763,-0.0324053405707131,-0.0119743500152504,2.08194257520161e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0395838819126141,0.00930894830080922,-0.0578294205822002,-0.0213383432430281,2.13066235211304e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42594,-0.0395897468691146,0.00931088271859028,-0.0578390769975516,-0.0213404167406777,2.13318625871626e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0152341948319261,0.00358487867455826,-0.0222605570340603,-0.00820783262979196,2.1589569669803e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42676,-0.0151891011275567,0.00357674568522801,-0.0221995226706036,-0.00817867958450983,2.18468483073007e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0129430876357018,0.00304782466381463,-0.0189168239767784,-0.0069693512946251,2.18710431855993e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0200780529531109,0.00473121460136363,-0.0293512335717836,-0.0108048723344382,2.21314762286629e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0278775365857336,0.00657645359477665,-0.0407673856314959,-0.0149876875399714,2.26313961457154e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0503020042116691,0.0118759741043311,-0.073578913456158,-0.0270250949671802,2.2977151405127e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.016797169445935,0.00397217696338017,-0.0245826362941602,-0.0090117025977099,2.36599644073877e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.00879624604109753,0.00208069611202961,0.0047180816615195,0.0128744104206756,2.37806758382435e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0208821641552154,0.00494060765669356,0.0111985731480961,0.0305657551623348,2.38772312013133e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42594,-0.0132367958572739,0.00313321089413949,-0.0193778892097873,-0.00709570250476055,2.40868715359384e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0359480244925505,0.00851707954374845,-0.0526415003982975,-0.0192545485868035,2.45452253478766e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0156533189665919,0.00371432402421797,-0.0229333940540591,-0.00837324387912472,2.52562485008731e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0346351458553283,0.00822682783969639,-0.0507597284211332,-0.0185105632895233,2.57327391687821e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.00992561693823252,0.00236062775502998,-0.0145524473380913,-0.00529878653837377,2.63172022141609e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0408629344831565,0.00971975814374679,-0.0599136604449002,-0.0218122085214128,2.6413141447048e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0348667611037461,0.00829605248270255,-0.0511270239698431,-0.0186064982376491,2.65321424212309e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0294898352048975,0.00701625775509035,-0.0432417004048746,-0.0157379700049204,2.65377728330623e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0172564132791152,0.00410805542587236,-0.025308201913825,-0.00920462464440538,2.68226704604096e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0215240274484358,0.00512698067866015,-0.0315729095786097,-0.0114751453182619,2.70781389067945e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.02729781346626,0.00650785080542823,-0.0400532010448993,-0.0145424258876207,2.75110199570698e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0198533994032597,0.0047358515108499,-0.0291356683645255,-0.0105711304419939,2.78091822962018e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0290257858583229,0.00693284425779031,-0.0426141606035919,-0.0154374111130539,2.85250677550129e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0160668261555224,0.00383961149942699,-0.0235924646943993,-0.00854118761664553,2.87967541273044e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0238664332279678,0.00572987180141562,-0.0350969819587424,-0.0126358844971932,3.13336448362347e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0125791800058808,0.00302680247734248,-0.018511712861472,-0.0066466471502895,3.26395277179516e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,42134,-0.0252563796519771,0.00608429580354687,-0.0371815994269289,-0.0133311598770252,3.33033807829322e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.00914225104647053,0.00220268095001401,-0.013459505708498,-0.00482499638444308,3.33765161447969e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0203460964189836,0.00490494401808548,-0.0299597866944311,-0.010732406143536,3.37731630372771e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,40539,0.0131452888132955,0.00317286012993292,0.00692648295862692,0.019364094667964,3.4521690723744e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,40116,-0.0242311046619438,0.00585399091056557,-0.0357049268466523,-0.0127572824772353,3.51066511071264e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0341587939923257,0.00826461712728835,-0.0503574435618108,-0.0179601444228405,3.60476935297686e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0183269616983519,0.00445889365301149,-0.0270663932582544,-0.00958753013844936,3.97668092312396e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,40532,-0.0284791854589113,0.00693142686581565,-0.04206478211591,-0.0148935888019126,4.00682257643414e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0400106077835637,0.00974585598892658,-0.0591124855218598,-0.0209087300452676,4.0645568255258e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0105342704604849,0.00257268919121574,0.00549179964570209,0.0155767412752678,4.2573298140363e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0180281611244341,0.00440656337619832,-0.0266650253417828,-0.00939129690708534,4.32125347423567e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,42746,-0.00889695984474925,0.00217786811938376,-0.0131655813587414,-0.00462833833075708,4.42980946362928e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0281665455393372,0.00690469781534672,-0.0416997532574168,-0.0146333378212577,4.54242165089479e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0220942779684644,0.00541674502234157,-0.0327110982122539,-0.011477457724675,4.55137174249166e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0287170515036719,0.00704070312255934,-0.0425168296238882,-0.0149172733834556,4.55947130100568e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0339414933901321,0.0083423783505488,-0.0502925549572078,-0.0175904318230565,4.75732313746163e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0286011046352738,0.00702980510143247,-0.0423795226340815,-0.0148226866364662,4.76296095104321e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0176401052984291,0.00433734920089461,-0.0261413097321825,-0.00913890086467563,4.78879972945117e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.0102149737322778,0.00251534224472139,-0.0151450445319317,-0.0052849029326239,4.91253986030211e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0179764255309554,0.00442920489186443,-0.0266576671190096,-0.00929518394290108,4.97057719251393e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0443729208647106,0.0109616811239031,-0.0658578158675606,-0.0228880258618606,5.19449611833392e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0120457730463889,0.00297635253566379,-0.0178794240162899,-0.00621212207648789,5.21975762265844e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.00871444660473021,0.00216456459925046,-0.0129569932192611,-0.00447189999019931,5.71157830914198e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0139628076321486,0.00347704663288779,-0.0207778190326087,-0.00714779623168855,5.95937537774402e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0213071358811839,0.00530677237337017,0.0109058620293784,0.0317084097329894,5.98076226291139e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0143584282102965,0.00357962071530139,-0.0213744848122872,-0.00734237160830577,6.08119987180296e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0272419793194321,0.00679749603896153,-0.0405650715557967,-0.0139188870830675,6.1726529191437e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.023528396036137,0.00587217441501947,-0.0350378578895752,-0.0120189341826988,6.18933414839631e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0223885776439805,0.00559101599136085,-0.0333469689870478,-0.0114301863009133,6.25921561618872e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42543,-0.013144081222057,0.00328378074371664,-0.0195802914797416,-0.00670787096437236,6.2954746247384e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0198751986336277,0.00496566791484509,-0.0296079077467241,-0.0101424895205313,6.30153561607957e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0193867740280689,0.0048515016955375,-0.0288957173513224,-0.00987783070481537,6.48241701638007e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0249841560462413,0.00626322235288998,-0.0372600718579056,-0.0127082402345769,6.67041963007638e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0225860055829142,0.00566648392448915,-0.033692314074913,-0.0114796970909155,6.75894586206215e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0142500053150694,0.00357800103763216,-0.0212628873488284,-0.00723712328131035,6.85074296496943e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0101460230903058,0.00254857814698099,-0.0151412362583885,-0.00515080992222305,6.90392253658295e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,40223,-0.0206189714277003,0.00517977392181878,-0.0307713283144651,-0.0104666145409355,6.9161723416599e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0322244694781241,0.00810603488701063,-0.048112297856665,-0.0163366410995833,7.06455616099994e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0151313506045962,0.00380742064123962,-0.0225938950614258,-0.00766880614776652,7.10645412039079e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42611,0.00982329905189149,0.00247244804800369,0.00497730087780426,0.0146692972259787,7.13122893070661e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42505,0.0515977470109188,0.012997655662406,0.026122341912603,0.0770731521092346,7.23189922577631e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0293896075198397,0.00740961307611582,-0.0439124491490267,-0.0148667658906527,7.34195267445918e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0190730439840162,0.00481295231722143,-0.0285064305257702,-0.00963965744226223,7.45139423135059e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0272823623014899,0.00688764925831061,-0.0407821548477787,-0.0137825697552011,7.50931297662896e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0283815714773671,0.00717873998582801,-0.04245190184959,-0.0143112411051442,7.73904431542299e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0331386573560475,0.0084039728045218,-0.0496104440529102,-0.0166668706591847,8.0880887355387e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,40344,-0.0127819625133213,0.00325297093462351,-0.0191577855451833,-0.0064061394814592,8.57006807030542e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0125792308667167,0.00320459420172774,-0.0188602355021031,-0.00629822623133033,8.71214475911446e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,40451,0.0455234131041033,0.0115979090395637,0.0227915113865585,0.0682553148216481,8.71954957365991e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0311167269267312,0.007935381664974,0.0155633788633821,0.0466700749900802,8.85230799290362e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0230875965847318,0.0058953293327973,-0.0346424420770145,-0.0115327510924491,9.04757878044499e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,40223,-0.0119771450963678,0.00306293256912109,-0.0179804929318452,-0.0059737972608905,9.27137748758064e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.0139212762149041,0.00357177944875807,-0.0209219639344699,-0.00692058849533827,9.76425196979339e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0321699340588449,0.00825491041341959,-0.0483495584691473,-0.0159903096485426,9.79290820152157e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0127388137834174,0.00327394604609175,-0.0191557480337572,-0.00632187953307754,0.000100419321750748
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0236439674307743,0.0060782861744531,-0.0355574083327024,-0.0117305265288462,0.000100775527922554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0488154188379419,0.0125542072782531,-0.0734216651033181,-0.0242091725725658,0.000101516822182721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,42357,-0.0222031544682372,0.00571077378432752,-0.0333962710855191,-0.0110100378509552,0.000101594374311417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.026468260704446,0.00682984431186572,-0.0398547555557028,-0.0130817658531892,0.000106973594474663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,42346,-0.0224314154329141,0.00579322253982929,-0.0337861316109795,-0.0110766992548487,0.000108463806850541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0280296854952258,0.00723950706363525,-0.0422191193399509,-0.0138402516505007,0.000108556071273071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.0109014162286109,0.00281751715861951,0.00537908259771665,0.0164237498595051,0.000109726220325181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.0101724109710845,0.00263430489784767,0.00500917337130306,0.0153356485708659,0.000113330704573784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0276150635326443,0.00716223159459217,-0.041653037458045,-0.0135770896072437,0.000116061068989261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0253026070482516,0.00656316442206033,-0.0381664093154898,-0.0124388047810134,0.000116145908750794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0256457929021218,0.00665305965878233,-0.0386857898333352,-0.0126057959709084,0.000116496624608626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,40482,0.0138561475793172,0.00359838022286188,0.00680332234250791,0.0209089728161265,0.000118449297000805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.0135254516850039,0.0035188621532956,0.0066284818645445,0.0204224215054633,0.000121880004667846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,40384,-0.0172222017133325,0.00448136262649609,-0.0260056724612649,-0.0084387309654002,0.000122175379594211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0111495701228278,0.00290278154958714,-0.0168390219600186,-0.00546011828563699,0.000123208636611201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0264808202613049,0.00690287206546078,-0.040010449509608,-0.0129511910130018,0.000125649910303209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0346007982147729,0.00902539456785845,-0.0522905715677754,-0.0169110248617703,0.000126798518501564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0174885316729872,0.00456351002387224,0.00854405202619762,0.0264330113197768,0.000127662923614801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0423340472240306,0.0110833007148202,-0.0640573166250781,-0.0206107778229831,0.000134254570789011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0225953961428531,0.00592167664649053,-0.0342018823699745,-0.0109889099157316,0.000136518855665943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0210626497959297,0.00552101800305433,-0.0318838450819162,-0.0102414545099432,0.000136936796492334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0211699686114727,0.00555152606107159,-0.032050959691173,-0.0102889775317724,0.0001377162302498
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0291627057986737,0.00765449346030392,-0.0441655129808694,-0.0141598986164781,0.000139783459481679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0120292455018032,0.00315837947357288,-0.0182196692700061,-0.00583882173360039,0.000140332103603369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0237440126467282,0.00623843962499452,-0.0359713543117175,-0.011516670981739,0.000141956790857753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42794,-0.0202693568635437,0.00532640597631754,-0.0307091125771261,-0.00982960114996137,0.000142168498007682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0206699075768296,0.00543803941568567,-0.0313284648315735,-0.0100113503220857,0.000144764837769681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0196077191905682,0.00516023761879714,0.00949365345772584,0.0297217849234106,0.000145587688621173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0213029206873432,0.00561333430612693,0.0103007854473344,0.032305055927352,0.000148383582052571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0133286203691059,0.00351508122802847,-0.0202181795760417,-0.00643906116217011,0.00015020415750019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0219814897598982,0.0058033031248592,-0.0333559638846223,-0.0106070156351742,0.00015268270424732
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0138370213557911,0.00365371861965414,-0.0209983098503132,-0.00667573286126897,0.000153082435370078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00665015578296328,0.00175627464563282,0.00320785747752294,0.0100924540884036,0.000153441224579656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0159290439035239,0.00421268480266057,-0.0241859061167387,-0.00767218169030921,0.000156902661827716
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0206696099080312,0.00547121456103872,-0.0313931904476671,-0.00994602936839528,0.000158851816057089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0407319491687916,0.0107945352811529,-0.0618892383198513,-0.0195746600177319,0.000161872900148425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.00885772404774865,0.00234800843814458,0.00425562750898527,0.013459820586512,0.00016234775428966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0110856644225016,0.00294842078724062,-0.0168645691654932,-0.00530675967950999,0.000170862997314388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0230317264566932,0.00613584485856515,-0.0350579823794809,-0.0110054705339055,0.000175017333912908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0167014021865421,0.00445583860258673,-0.0254348458476121,-0.0079679585254721,0.000178865435936772
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,42261,-0.0115766575119596,0.00309008951814,-0.017633232967514,-0.00552008205640519,0.000180174390904742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0182000731793086,0.00486230751281828,-0.0277301959044324,-0.00866995045418478,0.000182520851855981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,40539,0.0273515648273958,0.00731074573852566,0.0130225031798855,0.0416806264749061,0.000183985959783569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0182481169085597,0.00488838882545962,-0.0278293590064606,-0.00866687481065888,0.000190200762476086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.010642924568541,0.00285612588240183,0.0050449178390334,0.0162409312980486,0.000195064049402983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0141830006437866,0.00381867189482571,-0.021667597557645,-0.00669840372992821,0.000204895758314402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0170643910400794,0.00459667391466908,-0.0260738719128308,-0.00805491016732803,0.000206377452998918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0205773715584681,0.00554562332808275,-0.0314467932815103,-0.00970794983542587,0.000207796596107276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.0112710167958361,0.00303852058543064,0.00531551644839209,0.0172265171432802,0.000208602285550582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,40116,-0.0149618817082916,0.00403381567738711,-0.0228681604359704,-0.00705560298061289,0.000209016670483875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,40375,-0.0366627168158453,0.00988882778321589,-0.0560448192709485,-0.0172806143607422,0.000210336483540467
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,42347,-0.0159926530603369,0.00433229341329388,-0.0244839481503929,-0.00750135797028088,0.000223837985404812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00934880023656868,0.00253309938606099,0.00438392543988914,0.0143136750332482,0.000224723812449135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.016008271340244,0.0043381971371,-0.02451113772896,-0.00750540495152804,0.000225091359719339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00877433760290587,0.00238116921819588,0.00410724593524194,0.0134414292705698,0.000229705206871362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0152353621448062,0.00413724112854299,-0.0233443547567505,-0.00712636953286197,0.000232041978602185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0300471004034083,0.00816040500555507,-0.0460414942142962,-0.0140527065925204,0.000232266405658813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0117616738456734,0.00319946819417581,-0.018032631506258,-0.0054907161850888,0.000237720339620723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0193798853190625,0.00527599710762211,-0.0297208396500018,-0.00903893098812314,0.000240441878820518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,40136,-0.0235032286400451,0.00640837603229442,-0.0360636456633421,-0.010942811616748,0.000246018520026206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0246796858282347,0.00673029231992523,-0.0378710587752881,-0.0114883128811812,0.000246582489056848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,42346,-0.0242696173824223,0.00662456247512666,-0.0372537598336705,-0.011285474931174,0.000249691017291511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0215730288833389,0.00588857101646063,-0.0331146280756017,-0.010031429691076,0.00024971722172064
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42654,-0.0114095439434915,0.00311479971953772,-0.0175145513937854,-0.00530453649319753,0.000250224483144134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.10886622209362,0.0297840463831213,-0.167242953004537,-0.0504894911827017,0.000257976336740769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.016857759847227,0.00461842601797454,-0.0259098748424571,-0.00780564485199691,0.00026311675741096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0315624833791288,0.00864815224339606,-0.0485128617761851,-0.0146121049820725,0.00026383325864767
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0361860093134986,0.00991763584883062,-0.0556245755772066,-0.0167474430497906,0.000264807412149866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0272408281735632,0.00748085944177456,-0.0419033126794414,-0.0125783436676851,0.000272202289629708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0237101253535475,0.0065135847250616,-0.0364767514146682,-0.0109434992924267,0.000273555991016656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0204173065231565,0.00561929443423299,-0.0314311236142531,-0.00940348943205979,0.00028072542222938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0360535515920686,0.00992462137552295,-0.0555058094880935,-0.0166012936960436,0.000281712422246871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42794,-0.0314702256619323,0.00867045884529545,-0.0484643249987114,-0.0144761263251533,0.000284911037593906
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0148610783387098,0.00409950661504313,-0.0228961113041943,-0.00682604537322528,0.000290126679623823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42495,-0.0118921711558708,0.00328369562963826,-0.0183282145899617,-0.00545612772177977,0.000293896673438463
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0202626118497165,0.00560842149552237,-0.0312551179809404,-0.0092701057184927,0.000304136368087754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0131451202099618,0.00363899701002433,-0.0202775543496094,-0.00601268607031408,0.000304820097717777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,40285,-0.00777238993786533,0.00215463553441923,-0.011995475585327,-0.00354930429040364,0.0003107748793507
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0164622251305474,0.00460094695677909,-0.0254800811658344,-0.0074443690952604,0.000347721907686445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.00987316408457292,0.0027654920472983,-0.0152935284972776,-0.00445279967186825,0.000358287568030493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0300611516659859,0.00842629069709943,-0.0465766814323008,-0.013545621899671,0.00036162487915387
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0336131051719676,0.00943755839192187,-0.0521107196201345,-0.0151154907238007,0.000370079313227074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42794,-0.00903177859200336,0.00253619727152924,-0.0140027252442007,-0.00406083193980605,0.000370495304030104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0162664326920059,0.00457094450937554,-0.025225483930382,-0.00730738145362986,0.000374308148227733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0214504137917091,0.00603721391836412,-0.0332833530717028,-0.00961747451171548,0.0003824244405703
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0252060723175763,0.0071043892840082,-0.0391306753142323,-0.0112814693209202,0.000389806345002381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,40482,-0.0271157886974192,0.00765543705837736,-0.0421204453318388,-0.0121111320629995,0.000398661758877048
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0316894141409323,0.00895677023258821,-0.0492446837968052,-0.0141341444850595,0.000404723551359137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,40532,-0.00850649329096213,0.00240961367409537,-0.0132293360921891,-0.00378365048973522,0.000416843448293883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0222350599541866,0.00631982125148559,-0.0346219096070984,-0.00984821030127487,0.000436064976166736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,40532,0.0206080924515649,0.00586177436841969,0.00911901468946231,0.0320971702136675,0.000440350930056259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0102804172669976,0.00292750420292692,-0.0160183255047344,-0.00454250902926089,0.000446771913664266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0172155654174415,0.00490451754671208,-0.0268284198089972,-0.0076027110258858,0.00044961452340948
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0134627903640863,0.0038386152216313,-0.0209864761984837,-0.00593910452968895,0.000454638060392744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.010918491081901,0.00311715609247061,-0.0170281170231434,-0.00480886514065858,0.000462375823504625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,42292,-0.021362203324925,0.0061116074534093,-0.0333409539336073,-0.00938345271624283,0.000475007539247308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0260685608208294,0.00746257527864195,-0.0406952083669676,-0.0114419132746911,0.000478751767252336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0252367942581409,0.00722773174286347,-0.0394031484741533,-0.0110704400421285,0.000481607264983819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0151369439851466,0.00433860831636411,-0.0236406162852203,-0.00663327168507297,0.000486584341730675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00964091446461412,0.00276412021801665,0.00422323883730149,0.0150585900919268,0.000488421606554639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.00940822507492135,0.00269955082576651,0.00411710545641899,0.0146993446934237,0.000493489145101823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0120333250576377,0.00345520398655182,-0.0188055248712793,-0.00526112524399617,0.000498330551496339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.016397651618055,0.00471312278715646,-0.0256353722808816,-0.00715993095522829,0.000504645907375488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),40324,0.0636648083529158,0.0183069685841723,0.0277831499279381,0.0995464667778936,0.000507805767209931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0168135300571772,0.00483947628525315,-0.0262989035762733,-0.007328156538081,0.000513941337506652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.012667561882515,0.00364771761469396,-0.0198170884073152,-0.00551803535771486,0.000516841831716513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42652,0.0159211200500304,0.00459471360580431,0.00691548138265396,0.0249267587174069,0.000531695596646212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0168819098167001,0.00488306078632528,-0.0264527089578976,-0.00731111067550252,0.000547433598239241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0194943338241097,0.00563956464576575,-0.0305478805298106,-0.00844078711840884,0.000548886805281302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0103249163702238,0.00298815829798581,-0.016181706634276,-0.00446812610617162,0.000551753811709537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0316953355524394,0.00917796691904962,-0.0496841507137767,-0.0137065203911021,0.000555244681207921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0195611354261562,0.00566462757647878,-0.0306638054760546,-0.00845846537625781,0.000555703200961903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0319222756066857,0.00926067676350044,-0.0500732020631465,-0.0137713491502248,0.000568455672971263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,40527,-0.0152637624762082,0.00442886746267719,-0.0239443427030555,-0.00658318224936088,0.000570115448419756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.00979167290977376,0.00284606280857462,-0.01536995601458,-0.0042133898049675,0.00058255513725655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,40283,0.0319625043903806,0.00933106204162806,0.0136736227887896,0.0502513859919716,0.000616147587764663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,40539,0.00792853753742168,0.00231661422761551,0.00338797365129528,0.0124691014235481,0.000622745530985882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.00817648899752006,0.00239030578340285,-0.0128614883329897,-0.00349148966205047,0.000626894982578059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42587,-0.0263677647994984,0.00771935617584471,-0.041497702904154,-0.0112378266948428,0.000637840933974785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.024905258004961,0.00730246316203725,-0.039218085802554,-0.010592430207368,0.000650325391482709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,42370,-0.0163849840875225,0.00480583362963006,-0.0258044180015974,-0.00696555017344756,0.000653022889002053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0275304394812506,0.00807735775473829,-0.0433620606805377,-0.0116988182819636,0.000655860665867515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0203668559710638,0.00597941640590666,-0.0320865121266409,-0.00864719981548677,0.000660742027399302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0111882065983725,0.00328538153009448,-0.0176275543973577,-0.00474885879938736,0.0006625189881519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.0123416648516124,0.00363406451492806,0.00521889840235339,0.0194644313008714,0.000685877914760758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,40199,-0.0139236382938007,0.0041012167663182,-0.0219620231557843,-0.00588525343181702,0.00068870570503855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,42461,0.0230278761986476,0.00678561665827541,0.00972806754842781,0.0363276848488674,0.000691744235611059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.0385418116388058,0.0113653525073516,0.0162657207243967,0.0608179025532149,0.000698487256564315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0213403507931042,0.00629451974988664,-0.033677609502882,-0.00900309208332642,0.000700569286482537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.0135629435199551,0.00400207505098645,0.00571887642002165,0.0214070106198885,0.000703551957694815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0252951050699928,0.00746599308491819,-0.0399284515164325,-0.0106617586235532,0.000706377206645757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00922597461233091,0.00273918246932826,0.00385717697244751,0.0145947722522143,0.00075884666579169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.0105969519281375,0.00315992175823976,0.00440350528198753,0.0167903985742874,0.000800519939262622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0117299354768314,0.00350711010747749,-0.0186038712874873,-0.00485599966617556,0.000826694282433611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0125129840034622,0.00374441526732737,-0.0198520379274239,-0.00517393007950057,0.00083519967340769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0176430457320615,0.00528102267616579,-0.0279938501773464,-0.00729224128677654,0.000837974380812075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.02544579304663,0.00762161681850707,-0.0403841620109038,-0.0105074240823561,0.000844723234116621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0103224761618301,0.00309597765254208,-0.0163905923608126,-0.00425435996284759,0.000857873010431512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0314739237277602,0.00944033854344847,-0.0499769872729192,-0.0129708601826012,0.000858926014798447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0289519532466745,0.00868571762433375,-0.0459759597903687,-0.0119279467029804,0.000861108523537861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0200853399528039,0.00603532242752726,-0.0319145719107573,-0.00825610799485044,0.000877635296825711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0167424164692063,0.00503286827774349,-0.0266068382935835,-0.00687799464482904,0.000881891676849373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.0147433241222302,0.00443796577129004,0.00604491121050177,0.0234417370339587,0.000896368491310088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42681,-0.0230449540041312,0.00694457877371289,-0.0366563284006085,-0.00943357960765393,0.000907714506499201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0349772639660856,0.0105507435399059,-0.0556567213043011,-0.0142978066278701,0.000918884279683054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.0072150008857186,0.00217650964785059,-0.0114809597955057,-0.00294904197593145,0.000919588226231574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0136591483985964,0.0041243734057049,-0.021742920273778,-0.00557537652341484,0.000929838525929375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.0125479109118535,0.00379038242445483,-0.019977060463785,-0.00511876135992208,0.000934355226640175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0189732107095491,0.00573245166596155,-0.0302088159748338,-0.00773760544426448,0.000936661181470654
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.0131614379580742,0.003979791226265,0.00536104715459475,0.0209618287615536,0.000945715492394608
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.00833944023884976,0.00252277085039436,-0.0132840711056227,-0.00339480937207681,0.000949980418658929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,40527,-0.0325020892408237,0.00983804895193429,-0.0517846651866149,-0.0132195132950324,0.000957092640222035
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0197934124833515,0.00599510483330215,-0.0315438179566237,-0.00804300701007933,0.000964338325873926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0248990933340313,0.0075525142250039,-0.0397020212150389,-0.0100961654530236,0.000980539249688141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.00779344594660457,0.00236403438129185,-0.0124269533339366,-0.00315993855927254,0.000980922134651531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.026507163496758,0.00804148024550818,-0.042268464777954,-0.010745862215562,0.000982794943591186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0119470940930316,0.00362950475137554,-0.0190609234057276,-0.00483326478033551,0.000998600459550326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0222720615753185,0.00676788609230222,-0.0355371183162308,-0.00900700483440611,0.00100147995248664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0127278939126211,0.00388087926367457,-0.0203344172694233,-0.00512137055581896,0.00104264360533318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,42370,0.0102665083990581,0.00313196628642902,0.00412785447765721,0.016405162320459,0.00104825294013215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0232570910324059,0.0071059392124997,0.00932945017590644,0.0371847318889053,0.00106766783753251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0217427638839533,0.00665219036877731,-0.0347810570067568,-0.00870447076114973,0.00108392130918916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,40532,0.0161687799560667,0.00495607953206887,0.0064548640732117,0.0258826958389217,0.001107946579635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0234240283271804,0.00718904454750501,-0.0375145556402903,-0.00933350101407062,0.00112361281459629
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0102202936243777,0.00313979960894633,-0.0163743008579125,-0.0040662863908429,0.0011370106457539
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0168857888261997,0.00519012085444841,-0.0270584257009185,-0.00671315195148077,0.00114350699608609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.016226566163675,0.00498918715075887,-0.0260053729791623,-0.00644775934818759,0.00114744804506151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0154951972933172,0.00476679800899073,-0.0248381213909391,-0.0061522731956954,0.00115424926273555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.00802882091791761,0.00247268852095871,-0.0128752904189967,-0.00318235141683854,0.00116913117807885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.0243545349383487,0.00751320103013586,-0.039080408957415,-0.00962866091928241,0.00119225477583578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0111153544254453,0.00343097866816893,0.00439063623583424,0.0178400726150564,0.00119946183960549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0143167499737715,0.00441980079255228,-0.0229795595271739,-0.00565394042036902,0.00120144612899952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00701701427691118,0.00217194206310789,0.00276000783321972,0.0112740207206026,0.00123762165390222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0167131790177217,0.00517379612090168,-0.026853819414689,-0.00657253862075438,0.00123942907052237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0132981566119003,0.00412780683686636,-0.0213886580121583,-0.00520765521164219,0.0012783791660222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0288296778547163,0.00894979951514156,0.0112880708050389,0.0463712849043938,0.00127938456845045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0185533514842048,0.00576244231121795,-0.029847738414192,-0.00725896455421762,0.00128635160858416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0122210911105428,0.00379869537821793,-0.0196665340518499,-0.00477564816923565,0.0012982863240668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,42434,-0.0242403241542684,0.00754615281954508,-0.0390307836805767,-0.00944986462796003,0.0013200282037681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0195792558020778,0.00611278278344278,-0.0315603100576256,-0.00759820154652995,0.00136390825493217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0133181969265642,0.00416093096762027,-0.0214736216230999,-0.0051627722300285,0.0013744057990773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0174898864256205,0.00546546263274508,-0.0282021931858009,-0.00677757966544014,0.00137784988422195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.021088584365856,0.00659163831818113,-0.034008195469491,-0.00816897326222096,0.00138091093541033
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,40511,-0.0096175728033617,0.00300987759138667,-0.0155169328824796,-0.00371821272424382,0.00140050994541983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.0114267414429908,0.00357755235676014,0.00441473882374088,0.0184387440622406,0.00140642446889643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0247460994132189,0.00774789549281214,-0.0399319745791307,-0.00956022424730712,0.00140753293254986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.023397843060644,0.00733108418441176,-0.0377667680620911,-0.00902891805919694,0.0014182365826842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,40527,0.010472660051766,0.0032825313771457,0.00403889855256042,0.0169064215509715,0.00142452323170473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.013024235045651,0.0040838264535665,-0.0210285348946414,-0.0050199351966607,0.00142983820387153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0203177535627697,0.0063863229189971,0.00780056064153534,0.032834946484004,0.00146948471040918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0211524924069607,0.00664902886596532,0.00812039582966863,0.0341845889842527,0.00146954019680999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42594,-0.0211108037240576,0.00664357667754495,-0.0341322140120457,-0.0080893934360695,0.00148823133746404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0128615524602765,0.00405033626949559,-0.0208002115484879,-0.00492289337206514,0.00150028090717988
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42594,-0.0114010360904767,0.00359212848343359,-0.0184416079180065,-0.00436046426294685,0.00150748460153863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00709283668010076,0.00223550643121832,0.00271124407491287,0.0114744292852887,0.00151311915800523
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00902814035724353,0.0028501113827615,0.00344192204703099,0.0146143586674561,0.00154022989376812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.00963127582779378,0.00304332904787284,-0.0155962007616245,-0.00366635089396302,0.00155655626857002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0271142358162464,0.0085762191715793,-0.0439236253925418,-0.010304846239951,0.00157274805963118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.00934742880466033,0.00295750623168426,-0.0151441410187615,-0.00355071659055918,0.00157812928276782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,40199,-0.0130377695544038,0.00413310276339514,-0.0211386509706583,-0.00493688813814932,0.00161219859130706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0201829705916412,0.00639884949203683,-0.0327247155960334,-0.00764122558724901,0.00161384024684166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.00920124869858292,0.00291899033920933,0.00348002763373264,0.0149224697634332,0.00162408613584001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0232929503008481,0.00739247314318472,-0.0377821976614901,-0.00880370294020602,0.00163132686608312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0223001189166274,0.00709380457941098,-0.0362039758922729,-0.00839626194098186,0.00167320687153605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0127263844845882,0.00405787369142035,-0.0206798169197721,-0.00477295204940435,0.00171581558391395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.01159392433989,0.00370302989753548,-0.0188518629390595,-0.00433598574072041,0.00174636905019867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,40509,0.011410541277843,0.00364533227044809,0.00426569002776475,0.0185553925279212,0.00175144481758225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.0125956973847456,0.00402790522563502,-0.0204903916269902,-0.00470100314250093,0.00176993785033368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.0117817148325165,0.00378597822752194,0.00436119750657346,0.0192022321584595,0.0018627129463179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,42311,-0.0216206136956889,0.00695261431872644,-0.0352477377603927,-0.0079934896309851,0.00187672327294344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0146516152589735,0.00471404778921344,-0.0238911489258318,-0.0054120815921151,0.00188777966033055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.012666840710179,0.00407629225461575,-0.0206563735292258,-0.00467730789113209,0.0018911639927221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0252449698642946,0.00812421364304553,-0.0411684286046638,-0.00932151112392532,0.00189152174511276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0218897845086459,0.00704663880172117,-0.0357011965600194,-0.0080783724572724,0.00189856093615885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0154593922690938,0.00498206105692953,-0.0252242319406757,-0.00569455259751197,0.00192046510412535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42611,-0.0120103722984125,0.00387275562220816,-0.0196009733179405,-0.00441977127888451,0.00193106936595535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.0074847121114924,0.00241878903115313,0.00274388561043227,0.0122255386125525,0.00197608416126399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0104414525902606,0.00337600898341933,-0.0170584301977625,-0.00382447498275871,0.00198746747539248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00914866450072539,0.00296720016932505,-0.0149643768326025,-0.0033329521688483,0.00205236705644752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,40539,-0.00823549620988612,0.0026764786556333,-0.0134813943749274,-0.00298959804484485,0.00209601023213206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0324913203265189,0.0105623118450795,-0.0531934515428746,-0.0117891891101631,0.00210189613720211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0167151877152978,0.00543559696942882,-0.0273689577753783,-0.00606141765521734,0.00210910879000155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.013232320759054,0.00430663760938322,-0.0216733304734452,-0.00479131104466294,0.00212679692330163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0223277737907428,0.00727476334841155,-0.0365863099536295,-0.00806923762785619,0.00215058654049152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0129700177939639,0.00424693917033708,0.00464601702010321,0.0212940185678246,0.0022627637310362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.0180574804354075,0.00591602369141556,-0.029652886870582,-0.006462074000233,0.00227539018320238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,40235,-0.0127790085479841,0.00418681967677887,-0.0209851751144707,-0.00457284198149751,0.00227711071725069
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0131989667897282,0.00432959175027525,-0.0216849666202677,-0.00471296695918876,0.0023040637174524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0122770981536832,0.00402795217630937,-0.0201718844192496,-0.00438231188811686,0.00230939735250756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0186849850654331,0.00613129646754479,-0.0307023261418209,-0.00666764398904531,0.00231319202585288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0256935383473644,0.00843901060347206,-0.0422339991301696,-0.00915307756455913,0.00233438934220961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0269211548135308,0.00884365259437443,-0.0442547138985047,-0.0095875957285569,0.00233918606273004
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00923302483865667,0.00303472453169705,0.00328496475653047,0.0151810849207829,0.00235104758892375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42689,-0.0146191554766864,0.00481263330942221,-0.024051916763154,-0.0051863941902189,0.0023887640606539
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0132460625460057,0.00436440559888859,-0.0218002975198273,-0.00469182757218402,0.00241068182555841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.0085445837931028,0.0028189665593985,0.00301940933668173,0.0140697582495239,0.00244122687245049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.00745140779881703,0.00246145533139174,-0.0122758602483448,-0.00262695534928921,0.00247268088927376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0255018655416551,0.00842797352297025,-0.0420206936466768,-0.00898303743663339,0.00248393211888642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0195990045648654,0.00648259968788653,0.00689310917660777,0.032304899953123,0.00250592842461178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.0112389541932557,0.00371819571101124,0.00395129059967369,0.0185266177868378,0.00251109696841967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0184631685535581,0.00611388617153885,-0.0304463854497743,-0.00647995165734196,0.00253458207263395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0157342919363045,0.00521330711636294,0.00551620998823314,0.0259523738843759,0.00254844973998079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0164450428241823,0.00545335780603601,0.00575646152435173,0.0271336241240129,0.00257071242223188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42679,0.0112409450611784,0.0037335188579422,0.00392324809961167,0.0185586420227451,0.0026102741281454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,40199,-0.0151108796358683,0.00501868176657673,-0.0249474958983587,-0.00527426337337791,0.00261043174802327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0105165331097809,0.00349528220691666,-0.0173672862353376,-0.00366577998422428,0.00262795184022697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.0100933668372485,0.00335928113596071,-0.0166775578637315,-0.00350917581076547,0.00266511521209941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0163970552780841,0.0054593615910019,-0.0270974039964478,-0.00569670655972033,0.00267419030352704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0104546279669957,0.00348597998866924,-0.0172871487447874,-0.00362210718920398,0.00271319628911741
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0190751830656903,0.00637408677861355,-0.0315683931517729,-0.00658197297960778,0.00277195022470052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.01667529974714,0.00558254691293389,-0.0276170916964904,-0.00573350779778954,0.00282210347568793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0373001727847744,0.0124894131505779,-0.061779422559907,-0.0128209230096418,0.00282767590186512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0129553794080718,0.00434237156575489,-0.0214664276769514,-0.00444433113919225,0.00285500383703921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42721,0.0133468671339684,0.00447421691895695,0.00457740197281283,0.0221163322951241,0.00285889138393031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0125548587919411,0.00421334740700544,-0.0208130197096718,-0.00429669787421045,0.0028898168071844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.00696692693545757,0.00233802302588955,-0.0115494520662011,-0.00238440180471404,0.00289013766144108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00621305766131781,0.00208522430050929,-0.010300097290316,-0.00212601803231961,0.00289289966816222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.013235444314596,0.00444502700734349,0.00452319138020279,0.0219476972489893,0.00291160869322039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0179955044836639,0.00604610117112421,0.00614514618826045,0.0298458627790673,0.00292187735252989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.0136087529995295,0.00457514056027465,-0.0225760284976678,-0.00464147750139118,0.00293990249491021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0257529107337925,0.00869843157469892,-0.0428018366202023,-0.00870398484738259,0.00307540150618247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0170583693101726,0.00576240723233739,-0.0283526874855539,-0.00576405113479128,0.00307887870374984
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,40460,-0.0273120264245277,0.00923984420769889,-0.0454221210716176,-0.00920193177743792,0.00312407264913591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42754,-0.0228950254913958,0.00775418732386369,-0.0380932326461687,-0.00769681833662301,0.00315648579470474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,40483,0.0231947698632067,0.00785997508273623,0.00778921870104368,0.0386003210253697,0.00317400066894923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0203800808341389,0.00691034559005246,0.00683580347763604,0.0339243581906417,0.00319138797934312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0268439395234824,0.00913330591539859,-0.0447452191176636,-0.00894265992930112,0.00329816389057433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,42311,-0.0180114122758903,0.00612849635639285,-0.0300232651344203,-0.00599955941736035,0.00329888264003167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.00679599780260475,0.00231535580117866,-0.0113340951729149,-0.00225790043229458,0.00333906408796039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.013977668776036,0.00476345226543321,-0.023314035216285,-0.00464130233578688,0.00334912682669833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0111360315230393,0.00380783502285215,-0.0185993881678295,-0.00367267487824913,0.00345593760547501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,40199,-0.0183496951022459,0.0062872117826341,-0.0306726301962087,-0.00602676000828304,0.00352348124989099
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,40451,-0.0205589864450026,0.00705146101003926,-0.0343798500246796,-0.00673812286532569,0.00355746483259964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42495,-0.0128112266041151,0.00439486530323079,-0.0214251625984474,-0.00419729060978273,0.00356231411430294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0270943797610572,0.00931345811298542,-0.0453487576625086,-0.00884000185960576,0.00362992331733634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0341939000651823,0.0117686500512967,-0.0572604541657238,-0.0111273459646409,0.00367387101674815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42794,0.00506789782525668,0.00174519333873004,0.00164731888134581,0.00848847676916756,0.00369117938082247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42611,-0.034899644748265,0.0120206551370341,-0.0584601288168518,-0.0113391606796782,0.00369846934434343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0122386907110345,0.0042163417478367,-0.0205027205367944,-0.00397466088527453,0.00370588050922845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0154693318104368,0.00533636004065257,-0.0259285974901158,-0.00501006613075775,0.00375251999489432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0132435268166641,0.00457081344260744,-0.0222023211641747,-0.00428473246915352,0.00376865769088613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,40283,0.0159316995393249,0.00549914526448699,0.00515337482093039,0.0267100242577194,0.00377339109172417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,40483,-0.0112989534394381,0.00390068578151404,-0.0189442975712056,-0.00365360930767059,0.00377884910378685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00797073607311879,0.00275676994732857,0.0025674669763548,0.0133740051698828,0.00384347945893014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0178854070166054,0.00619256241455622,-0.0300228293491356,-0.00574798468407521,0.00388204965601109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.00841953749079012,0.00291543966649994,0.00270527574445024,0.01413379923713,0.00388434480953192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.00953458898211748,0.00330168594138919,0.00306328453699466,0.0160058934272403,0.00388687912949558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42664,-0.0124348728114475,0.00430878062716,-0.0208800828406811,-0.00398966278221394,0.00390869093404309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00815900793279072,0.00284026615807188,0.00259208626296983,0.0137259296026116,0.00407717351082342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0293559090474936,0.0102198638494715,-0.0493868421924578,-0.00932497590252935,0.0040809687212555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0153960328898229,0.00536055839671005,-0.0259027273473746,-0.00488933843227122,0.00408411648522725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0115848113026971,0.00404422935061578,0.00365812177549017,0.019511500829904,0.00418426525682698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0162272065750132,0.0056676966664367,-0.0273358920412292,-0.00511852110879728,0.00420313565007527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42679,-0.00989462706970605,0.00346653769983975,-0.016689040961392,-0.00310021317802013,0.00431940556585491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0316477815695637,0.01110242661544,-0.0534085377358261,-0.00988702540330125,0.00437147333921819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0187403234247434,0.00657741882421626,-0.0316320643202073,-0.00584858252927958,0.00439127736024088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0201207866591011,0.00706869621686741,0.00626614207404096,0.0339754312441612,0.00442767596856742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0111901401278535,0.00393364832441897,-0.0189000908437147,-0.00348018941199232,0.00445300191516978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0111609347541532,0.00393031548015942,0.00345751641304076,0.0188643530952657,0.00452387611654459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.010714295946269,0.00377828311752636,0.00330886103591733,0.0181197308566206,0.0045785381318875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,40136,0.026233840705196,0.00925151280240047,0.00810087561249109,0.0443668057979009,0.00458197154169754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.00744452823797155,0.00262572530377016,-0.0125909498333611,-0.00229810664258203,0.0045874067516132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.0212458709486788,0.00749402972477609,-0.0359341692092399,-0.00655757268811769,0.00458884695897642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0123144495972635,0.00434503242181767,-0.0208307131440261,-0.00379818605050087,0.00460176144352568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0103324012227956,0.00364580532170958,-0.0174781796533464,-0.00318662279224482,0.00460436889920731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0172079257768808,0.00607227050795659,-0.0291095759724757,-0.00530627558128585,0.00460747305232754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.0102436737671061,0.0036176599602773,-0.0173342872892496,-0.00315306024496254,0.0046404133107315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,40449,-0.00979434363093915,0.00346187774589214,-0.0165796240128877,-0.00300906324899055,0.00467471133084068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0135391176581632,0.00478668744512448,0.00415721026571926,0.0229210250506072,0.00468530085872886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42636,0.0224842834652026,0.00795783903263941,0.00688691896122939,0.0380816479691759,0.00472874234433447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0245731672945972,0.00869871115803401,-0.0416226411643439,-0.00752369342485053,0.00473766557834157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.00899325789243668,0.00318612417625597,0.00274845450697499,0.0152380612778984,0.00477167089658324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0117807442349585,0.00418415684897811,-0.0199816916589556,-0.00357979681096139,0.00487638200525437
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.00642314370020143,0.00228408068559314,-0.010899941843964,-0.00194634555643888,0.00492987309993738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0156421141120908,0.00559069786993722,-0.0265998819371677,-0.00468434628701381,0.00515135272639108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.0143109690564231,0.00511787989286935,0.00427992446639915,0.024342013646447,0.00517837531664968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00816175020120456,0.00292353088986246,0.00243162965707413,0.013891870745335,0.00525157026316108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42721,0.0128857960104355,0.0046236939778061,0.00382335581393553,0.0219482362069354,0.00532882434010775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0109903350182248,0.00394730252908788,-0.018727047975237,-0.00325362206121252,0.00537415396722002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00445421832156786,0.00160053986638777,0.00131716018344784,0.00759127645968788,0.00539418300018309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0300559064615956,0.0108297323101934,-0.0512821817895747,-0.0088296311336166,0.00552265907736125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,40182,-0.0139277872479859,0.00502821924021113,-0.0237830969587997,-0.00407247753717212,0.00561634229593815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.015063881600619,0.00544228334554806,-0.0257307569578932,-0.00439700624334483,0.00565071697014077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.00744184246680176,0.00269643199918272,-0.0127268491851999,-0.00215683574840362,0.00579173492152758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.011692736506363,0.00423860461138834,0.00338507146804185,0.0200004015446841,0.00581408532289843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.0132145915591554,0.00480627586354444,0.00379429086660827,0.0226348922517025,0.00597944213893118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0167202203405025,0.00608702101662906,0.00478965914790956,0.0286507815330955,0.00602484428033143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0107168984289416,0.0039059109704417,-0.0183724839310073,-0.00306131292687586,0.00608375456763713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0118459555096463,0.00432251679941655,-0.0203180884365028,-0.00337382258278989,0.00614246631457268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00866378456535379,0.0031653501127041,-0.0148678707862538,-0.00245969834445376,0.0062072394089569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.0119137239291746,0.00436211244394453,-0.0204634643193059,-0.00336398353904335,0.00632088780065046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.01571474503394,0.0057539182716269,-0.0269924248463287,-0.00443706522155126,0.00632158205347126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,40136,-0.0121836915842231,0.0044617308692314,-0.0209286840879166,-0.00343869908052953,0.00632993262146169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,42201,0.00747421473582394,0.00274047606177059,0.00210288165475358,0.0128455478168943,0.00639325042732388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0120709430680793,0.00443398723364104,-0.0207615580460157,-0.00338032809014285,0.00649171318985041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,42357,-0.0317198806357415,0.0116642665544739,-0.0545818430825104,-0.00885791818897254,0.00654849759296098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0308741883245384,0.0113543239453931,-0.053128663257509,-0.00861971339156786,0.00655489079116982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00943016477305903,0.0034698977868807,0.00262916511077287,0.0162311644353452,0.00658193138029089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0258519891685401,0.00951483657372038,-0.044501068853032,-0.00720290948404813,0.00659756640803171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.011140211531523,0.00410364281574085,-0.0191833514503751,-0.00309707161267096,0.00664184922897857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0132131527748158,0.00486886999338226,-0.022756137961845,-0.00367016758778658,0.00666026495158223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0178846258388658,0.00659078131101262,-0.0308025572084506,-0.0049666944692811,0.00666621087076625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0130226364497462,0.00480703123201738,0.00360085523499212,0.0224444176645003,0.00675754329138238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.0140884258094683,0.0052236797256082,-0.0243268380716603,-0.0038500135472762,0.00700643731948705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.0121686673347296,0.00452282681213511,-0.0210334078865144,-0.00330392678294482,0.00714327793340238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00828215445234561,0.00308277164919235,0.0022399220199286,0.0143243868847626,0.00722754372696112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0135955990014074,0.00508093442039501,-0.0235542304653817,-0.00363696753743321,0.00746421862233348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0140073339648201,0.00523633508655349,0.00374411719517529,0.024270550734465,0.00748158506570791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.00928996099062927,0.00347409524830463,-0.0160991876773063,-0.0024807343039522,0.00750304883257185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0130984555576358,0.00489912440878987,-0.022700739398864,-0.00349617171640771,0.00751430258424359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,40199,-0.0133748212108444,0.00500479710243798,-0.0231842235316228,-0.00356541889006594,0.00754217325414229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0217311795292474,0.00814370993762433,-0.0376928510069911,-0.0057695080515037,0.00762911537343634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00852607323201039,0.00320308154168157,0.00224803341031452,0.0148041130537063,0.00778298301086585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.0159485993246425,0.00599248752503039,0.00420332377558295,0.0276938748737021,0.00779228519802571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0264562724963465,0.00995566726692705,-0.0459693803395235,-0.00694316465316948,0.00788548921750517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.00894192963683368,0.00337280439426018,-0.0155526262495836,-0.00233123302408373,0.008030584651616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00553417482526284,0.00209339727841416,0.00143111615957109,0.00963723349095459,0.00821386186032511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0192586098835635,0.00729077422172155,-0.0335485273581377,-0.00496869240898925,0.00826364378420803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.0140516743585674,0.0053436311550314,-0.0245251914224289,-0.00357815729470584,0.00855987201297556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0102369486913007,0.00390004727496786,-0.0178810413502377,-0.00259285603236365,0.00868128594324138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,42322,-0.0225070143879756,0.0086160228809626,-0.0393944192346623,-0.00561960954128888,0.00900567332239812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.00745955010460187,0.00285759417346114,-0.0130604346845857,-0.00185866552461804,0.00905475934420754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.0127419080041789,0.00489447846828659,0.00314873020633723,0.0223350858020207,0.00924267029406117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0149462169996769,0.00574365347499458,0.00368865618868751,0.0262037778106663,0.0092749027624741
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,42209,0.0180389753871017,0.00693839603396573,0.00443971916052887,0.0316382316136745,0.00933625414781238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.010237225903674,0.00393854852596039,-0.0179567810145564,-0.00251767079279163,0.00935528078537688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.0165203426607496,0.00638098661912977,-0.029027076434244,-0.00401360888725526,0.00963841170383027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.0151759328772577,0.00587393446224477,-0.0266888444232574,-0.00366302133125791,0.00978780802325018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0142777725931671,0.00554191821302741,-0.0251399322907008,-0.00341561289563339,0.0099983497237196
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0118073247191796,0.00458608145047607,-0.0207960443621127,-0.00281860507624651,0.0100464730935069
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0133067106124887,0.00516895696299583,-0.0234378662599605,-0.00317555496501688,0.0100558778755077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,39042,-0.0285361751793679,0.0110890665108546,-0.0502707455406429,-0.00680160481809289,0.0100860952334623
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,40511,0.00996481766597904,0.003876961198507,0.00236597371690532,0.0175636616150528,0.0101747476517036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0206787875130773,0.00807428535288365,-0.0365043868047292,-0.00485318822142532,0.0104483296327215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,42292,-0.00940997925311026,0.00367999256046265,-0.0166227646716171,-0.00219719383460346,0.0105671244040654
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42570,-0.0169903091284382,0.00664857745487909,-0.0300215209400012,-0.00395909731687515,0.0106150957529077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00725646480480394,0.00284452691077063,-0.0128317375499144,-0.00168119205969349,0.010753676315425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.00772043326683485,0.00303327459004626,-0.0136656514633255,-0.00177521507034417,0.0109335707780906
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0131141340349685,0.0051677939761193,-0.0232430102281623,-0.00298525784177468,0.0111708938685665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0147512874098186,0.00582216640112579,-0.0261627335560252,-0.00333984126361209,0.0112998786077463
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42652,-0.00973101251075342,0.00384589716305718,-0.0172689709503455,-0.00219305407116135,0.0114100149935579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0185712718327259,0.0073576521952008,-0.0329922701353195,-0.00415027353013237,0.0116141122321753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00820650685132501,0.00326304073989035,-0.0146020667015101,-0.00181094700113992,0.0119152490991179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.0158954542769559,0.00632301384367502,0.00350234714335288,0.0282885614105589,0.0119518793541143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0120327399583587,0.00479035987233907,-0.0214218453081432,-0.00264363460857409,0.0120213519984793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0120846759995674,0.00482916496794335,0.00261951266239839,0.0215498393367363,0.0123486916636428
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0216960712394361,0.00867034198964821,-0.0386899415391466,-0.00470220093972558,0.0123495743292537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0246986106436977,0.00987244488916791,0.00534861866092861,0.0440486026264668,0.0123713166617626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.00999787687954395,0.00400491636903883,-0.0178475129628601,-0.00214824079622784,0.0125580770556407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.00603021601980771,0.00241748391067216,-0.0107684844847251,-0.00129194755489028,0.0126283280349144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.010432180344359,0.00419459531650352,0.00221077352401208,0.0186535871647059,0.0128928615848158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,42370,-0.0211918898639138,0.00852658283875484,-0.0379039922278733,-0.00447978749995433,0.0129532386571299
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.00991127388249755,0.0039906637402072,0.00208957295169144,0.0177329748133037,0.013020359176787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,40182,-0.0189706426120624,0.00764216746435774,-0.0339492908422035,-0.00399199438192122,0.0130662027515832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.0183231066553166,0.00739758506445658,-0.0328223733816515,-0.00382383992898173,0.0132650122900969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.0140157972176154,0.00566287106653886,0.00291656992719928,0.0251150245080316,0.0133349165425944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0295606721171512,0.0119519459783663,-0.0529864862347491,-0.00613485799955331,0.013399714642395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.00843568823046285,0.00342750194803513,0.001717784412314,0.0151535920486117,0.0138635329579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42636,0.00956246393066695,0.00388644856979542,0.00194502473386793,0.017179903127466,0.0138882615677735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00889492737873733,0.00361528319291532,0.00180897232062331,0.0159808824368513,0.0138918950430565
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0225835110608914,0.00919221857452612,-0.0406002594669626,-0.00456676265482023,0.0140330709997858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00896449761762673,0.00366541303686399,0.00178028806537331,0.0161487071698801,0.0144697809164895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0213995242701347,0.00880599436104913,-0.038659273217791,-0.00413977532247841,0.0151098183430979
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00966860072199536,0.00398195417275148,0.00186397054340245,0.0174732309005883,0.0151913280872097
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0135820474539363,0.00560075548624302,0.00260456670090002,0.0245595282069726,0.0153198999332186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0141816638564352,0.00585344040269867,-0.0256544070457246,-0.0027089206671458,0.0154151802406465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.00809751942243034,0.00334778397309523,-0.014659176009697,-0.00153586283516369,0.0155863025569231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0304757682253437,0.0126060826471439,-0.0551836902137457,-0.00576784623694166,0.0156413523834787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0175431902198261,0.00726866605300221,-0.0317897756837104,-0.00329660475594173,0.0158119095926305
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0287758737937013,0.0119301468872123,-0.0521589616926375,-0.00539278589476514,0.015877321908565
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.00808526849056316,0.003352756196955,-0.014656670636595,-0.00151386634453136,0.0159020607649953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.00947709341256479,0.00393391380491822,-0.0171875644702045,-0.00176662235492508,0.0160094546703666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0211851334046569,0.00880799928039154,-0.0384488119942243,-0.00392145481508945,0.0161766580274773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0139857627153871,0.00585506109760865,-0.0254616824667,-0.00250984296407415,0.01692677730657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42638,0.0081967298598622,0.00343261478808545,0.00146880487521472,0.0149246548445097,0.016958822448381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0134721407108615,0.00566400554874288,-0.0245735915863976,-0.00237068983532549,0.0173948771339162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0173477944331262,0.00729668335992839,-0.0316492938185859,-0.00304629504766658,0.017447456389986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,42459,0.0159475037846628,0.00670957920065667,0.00279672855137575,0.0290982790179499,0.0174764145100134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42569,0.00681648514089976,0.00286925149715224,0.00119275220648138,0.0124402180753182,0.01752963039739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00820439027963266,0.00345750256406458,0.00142768525406607,0.0149810953051992,0.0176619117101765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0191645451179307,0.00808058275918254,-0.0350024873259285,-0.00332660290993296,0.0177218007237089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.014969778918469,0.0063153325705358,-0.0273478307567192,-0.00259172708021887,0.0177835272830915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.0075504156784531,0.00319063714995171,-0.0138040644923585,-0.00129676686454775,0.0179778456756896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,40199,0.0133419889398272,0.00567697397348204,0.00221511995180243,0.024468857927852,0.0187812002216379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0224664191464406,0.00957980406726814,-0.0412428351182861,-0.00369000317459504,0.0190321014766188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0164837665478406,0.00703553855520734,-0.0302734221160469,-0.00269411097963416,0.0191507049568425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0123314400343252,0.005263576269005,-0.022648049521575,-0.00201483054707538,0.01915755888668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.018320038814871,0.00782322002643486,-0.0336535500666833,-0.00298652756305866,0.0192080473556501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0125106340984509,0.00534931328413992,0.00202598006153669,0.0229952881353652,0.0193640122049764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.00882358703527284,0.00377411869762206,-0.0162208596826121,-0.00142631438793361,0.0194059951476298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0151887609189009,0.00649945328255422,-0.0279276893527071,-0.00244983248509459,0.019460744407809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0144083611792885,0.00617835624958314,-0.0265179394284715,-0.00229878293010558,0.0197151326563121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0130489291422712,0.00559836487625017,-0.0240217242997216,-0.00207613398482091,0.0197761560617482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.0098932092784026,0.00425011093530624,0.00156299184520237,0.0182234267116028,0.0199434454228868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0331463459245548,0.0142476269720778,-0.0610716947898274,-0.00522099705928231,0.0200098295053359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,40182,-0.00963801485638983,0.00415183578227032,-0.0177756129896397,-0.00150041672314001,0.0202842001812145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0234764286359546,0.0101217047623616,-0.0433149699701833,-0.00363788730172596,0.0203876461292348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.00510797884939295,0.00220246725446712,-0.00942481466814851,-0.000791143030637393,0.0203986466624831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.0109069355870592,0.00471484354253158,-0.0201480289304211,-0.00166584224369728,0.0207229344299478
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0130913016154315,0.0056603608621238,0.00199699432566886,0.0241856089051941,0.0207488490987714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42611,0.0152792255101567,0.00661436227011133,0.00231507546073854,0.0282433755595749,0.0209028470249475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.00776957776913208,0.00336428110113983,-0.0143635687273661,-0.00117558681089802,0.0209348957573526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0103695825364862,0.00450496697648676,0.00153984726257217,0.0191993178104003,0.0213639504105863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.0153025399079274,0.00666343287803283,-0.0283628683488717,-0.00224221146698305,0.0216633057405187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00813053303587714,0.00355678860685002,-0.0151018387053032,-0.00115922736645111,0.0222747883782876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00587316622406217,0.00257038307545896,0.000835215396162608,0.0109111170519617,0.0223348485343312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0149899755805649,0.0065656128098145,-0.0278585766878013,-0.00212137447332843,0.0224397200893663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0113659041378312,0.00499921755374745,-0.0211643705431762,-0.00156743773248618,0.0230095024680238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42711,-0.00648317452191569,0.00285737700714053,-0.0120836334559111,-0.00088271558792025,0.0232885721866029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.014071486260396,0.0062074490254224,0.00190488617056807,0.0262380863502239,0.0234175369411148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.0102174575866823,0.00451069517034904,0.00137649505279816,0.0190584201205664,0.023521578701431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.00931366074859367,0.00412327296891051,0.00123204572952908,0.0173952757676583,0.0239116642650083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.012039581885217,0.00533101559862118,-0.0224883724585146,-0.00159079131191951,0.0239400698133674
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.015002562254378,0.00664608616987774,-0.0280288911473383,-0.00197623336141761,0.024002331324044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0222927004506263,0.00987621754957143,-0.0416500868477863,-0.00293531405346628,0.0240109664886684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.00840981286009255,0.00372575667431989,-0.0157122959417595,-0.00110732977842557,0.0240145173425293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0228097991547397,0.0101153821395184,-0.0426359481481959,-0.00298365016128359,0.0241554515311527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00804277949940616,0.00357036590251403,-0.0150406966683337,-0.00104486233047867,0.02430093603675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,42154,-0.00842585805011945,0.00374423808463306,-0.0157645646960003,-0.00108715140423864,0.0244432337124314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0147366324961675,0.00655153403078956,-0.027577639196515,-0.00189562579581991,0.024506941946886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0118031300778964,0.00524904447423336,-0.0220912572473937,-0.00151500290839897,0.0245525464460954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.00537172426695182,0.00239397565912381,-0.0100639165588345,-0.00067953197506915,0.024858042290968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0155634276520589,0.00693673486590475,-0.0291594279892322,-0.0019674273148856,0.0248759797083274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.00815337022328477,0.00363642004816457,-0.0152807535176873,-0.00102598692888222,0.0249718810634182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0264418163142176,0.0117991354113099,-0.049568121720385,-0.00331551090805023,0.0250425398542706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0276717586096207,0.0123827203339923,-0.0519418904642456,-0.00340162675499576,0.0254565465312492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0207293349665476,0.00931197813204078,-0.0389808121053476,-0.00247785782774769,0.0260244013457927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42543,0.0111826868273829,0.00503016025892457,0.00132357271989075,0.0210418009348751,0.0262238935913333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00723823548971397,0.00327078975839012,0.00082748756326933,0.0136489834161586,0.0269186744019853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0215470747907438,0.00977280585688166,-0.0407017742702318,-0.00239237531125571,0.0274882788914811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.010302762410078,0.00467523408421738,-0.0194662212151441,-0.00113930360501198,0.0275634812215846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.011181481743729,0.00508388142047142,-0.021145889327853,-0.00121707415960501,0.0278666093133209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.011222863068113,0.00510584351555006,-0.0212303163585911,-0.00121540977763493,0.0279633970416582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0131046848051562,0.00596594393987998,0.00141143468299147,0.024797934927321,0.0280712156644392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0218139993491509,0.00993256740178171,-0.041281831456643,-0.00234616724165872,0.0280978785771214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0208670612930795,0.00951449473942645,-0.0395154709823554,-0.00221865160380371,0.0283143320391324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00612831380226171,0.00279871091099536,0.000642840416710808,0.0116137871878126,0.0285671043819955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.014250499771127,0.00652094392735046,-0.0270315498687339,-0.00146944967352007,0.0288846640056404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0320366067955728,0.0146636847446533,0.00329578469605231,0.0607774288950933,0.0289269780254691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00968273832926101,0.00443835262298798,-0.0183819094703174,-0.000983567188204568,0.0291598429050156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0131720617714928,0.00604254746359057,-0.0250154548001303,-0.0013286687428553,0.0292833493863985
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0155281646806521,0.00712414839973404,-0.0294914955441309,-0.00156483381717342,0.0293041929673917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.017746665075357,0.00817525230184583,-0.0337701595869748,-0.00172317056373918,0.0299687231457783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,40482,-0.00562407890248817,0.00259803084199613,-0.0107162193528006,-0.000531938452175755,0.0304279726178242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0182227939336884,0.00844650331431466,-0.0347779404297451,-0.00166764743763167,0.0309894030150362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.0166446138653351,0.00775265826855725,0.00144940365896284,0.0318398240717073,0.0318147083629293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00605232923688045,0.00282412850317597,-0.0115876211031053,-0.00051703737065555,0.0321251322700177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0369620169003814,0.0172583119069246,0.00313572556280915,0.0707883082379537,0.0322363487578682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0140446764818236,0.00658137455452828,-0.026944170608699,-0.00114518235494816,0.0328647748748312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.00979648367836371,0.00459107605158376,-0.0187949927394679,-0.000797974617259545,0.0328803398227782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.00955630772181336,0.00450573409718131,-0.0183875465522887,-0.000725068891337987,0.033950888407561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0206590786621268,0.00974677292492292,-0.0397627535949757,-0.00155540372927789,0.0340631909251366
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00749372610154152,0.00354371116861208,0.000548052211061846,0.0144393999920212,0.0344819230931789
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42711,-0.0135834352791104,0.00645052886284613,-0.0262264718502888,-0.00094039870793196,0.0352413139886795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,40482,-0.0132774179127005,0.00630584317313888,-0.0256368705320527,-0.000917965293348266,0.0352634247578676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,40116,0.00780205293100931,0.00371468008526049,0.000521279963898745,0.0150828258981199,0.0357227187591928
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42654,0.00681595913612883,0.00324672519184012,0.000452377760122194,0.0131795405121355,0.0358060813587071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.0103231990186841,0.00491893117011143,0.000682093925265696,0.0199643041121025,0.0358649270224939
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.006489731245358,0.00309266309859419,0.000428111572113391,0.0125513509186026,0.0358863499235669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,40199,0.00823802394980926,0.00392623657014978,0.000542600272315696,0.0159334476273028,0.0359103474176762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.00448131387730408,0.00213905524726565,0.000288765592663397,0.00867386216194476,0.0361900129248522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0130963967792602,0.00625667623944772,-0.0253594822085777,-0.000833311349942656,0.0363552514924976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0147172707025805,0.00703853102946651,0.000921749884826151,0.0285127915203349,0.0365545211872631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42710,0.00931124300416068,0.00446852277257803,0.000552938369907737,0.0180695476384136,0.0372024944079784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0109866773994031,0.00527837350694511,-0.0213322894730155,-0.000641065325790665,0.0374150400568289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.00846908108497918,0.00406903938482961,-0.0164443982792452,-0.000493763890713143,0.0374254330424163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0166578208274414,0.00800949158250198,-0.0323564243291453,-0.000959217325737536,0.0375668655473155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0115266756989646,0.00554376074161311,-0.0223924467525263,-0.000660904645402865,0.0376206437681167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0177751090878869,0.00855712502182735,-0.0345470741306685,-0.00100314404510526,0.0378036909391298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42495,0.0070572995238573,0.00340023632592799,0.000392836325038446,0.0137217627226762,0.0379564206005103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0104308678266175,0.00503519897505458,-0.0202998578177245,-0.000561877835510542,0.038326417388558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00753867462477822,0.00367220632081422,0.000341150235982342,0.0147361990135741,0.0401058443015758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00813714411532735,0.00396581501762589,0.000364146680780613,0.0159101415498741,0.0402106699444702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,40539,-0.0105174731143027,0.00512919888452425,-0.0205707029279702,-0.000464243300635136,0.0403376244660651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,42311,0.00687564122543484,0.00335699298499561,0.000295934974843445,0.0134553474760262,0.0405647008428398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00990893302425889,0.00487781397573961,-0.0194694484167085,-0.000348417631809256,0.0422348685357282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00463245121099198,0.00228391076904389,0.000155986103665957,0.00910891631831801,0.0425493118552461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,42370,-0.010015849784561,0.00493940236580952,-0.0196970784215476,-0.000334621147574338,0.0426063363628865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,42017,-0.00570886121151536,0.00282714996051966,-0.0112500751341339,-0.000167647288896825,0.0434769122279595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0105658368743397,0.00523609706070059,-0.0208285871133128,-0.000303086635366507,0.0436275938269557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0105903743848159,0.00525196311100724,-0.0208842220823901,-0.000296526687241717,0.0437755826217473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42721,-0.00604332837226036,0.00299922594062174,-0.011921811215879,-0.00016484552864175,0.0439283046763426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.010972937240085,0.0054512723336795,-0.0216574310140968,-0.000288443466073131,0.0441441163680938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00641117759160274,0.00318912764202572,0.000160487413232333,0.0126618677699732,0.0444214758299539
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,42311,-0.0131489225235484,0.00655421965146402,-0.0259951930404178,-0.000302652006678878,0.0448578944984274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.0116676505492033,0.00581876484373873,-0.0230724296429312,-0.000262871455475417,0.0449680758507705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42654,0.016614339828504,0.00830455377185382,0.000337414435670511,0.0328912652213375,0.0454523206615784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42679,-0.011332455444042,0.00567135860734487,-0.0224483183144379,-0.00021659257364603,0.0457160454455462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.00763533235941627,0.00382569328678577,-0.0151336912015164,-0.000136973517316165,0.0459792931723334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.00754607184136925,0.00378162251188039,-0.0149580519646548,-0.000134091718083693,0.0460129486407395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,40532,0.0044931585365148,0.00225173910834174,7.97498841649865e-05,0.00890656718886462,0.0460213032432924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42618,-0.00488030845574826,0.00244587163675347,-0.00967421686378507,-8.64000477114567e-05,0.046027637512674
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0114636556610672,0.00575457467196629,-0.0227426220181211,-0.000184689304013256,0.0463848256174351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.010465781563738,0.00525392950822339,-0.0207634833998558,-0.000168079727620157,0.0463920579005211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0102765324457609,0.00516034929951365,-0.0203908170728077,-0.000162247818714175,0.0464571138247972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.00907586407301826,0.00457965026705937,9.97495495818901e-05,0.0180519785964546,0.0475238701068108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,40136,0.0101745290437079,0.00515012992232732,8.02743959464076e-05,0.0202687836914695,0.0482266736174187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.00928794487378696,0.00470541203273851,-0.0185105524579544,-6.53372896194816e-05,0.0484191687917192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.00569193649503548,0.00288537607840121,3.65993813691168e-05,0.0113472736087018,0.04855223522169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00813542324121291,0.00413011674314786,4.0394424643108e-05,0.0162304520577827,0.0488837981909191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.0151702191426163,0.00770324788664306,-0.0302685850004368,-7.1853284795944e-05,0.048939894701543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0174620119414102,0.00886829811162316,-0.0348438762401916,-8.01476426287966e-05,0.0489736407015109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42591,-0.00490610126809308,0.00249619367708253,-0.00979864087517484,-1.35616610113139e-05,0.0493847766749494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42638,0.00583625753557087,0.00296981801694297,1.54142223626535e-05,0.0116571008487791,0.0494127744015837
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.00817674363901023,0.00416668407281857,1.00428562858322e-05,0.0163434444217346,0.0497356094910053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42611,-0.0105290517143829,0.00537162787495766,-0.0210574423492999,-6.61079465837447e-07,0.050002073456245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,40116,0.00861184500930277,0.00439800134715563,-8.23763112226157e-06,0.0172319276497278,0.0502405362961558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00638316577394297,0.00326046689802224,-0.0127736808940666,7.34934618062781e-06,0.0502843112976087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00576923935565346,0.00295198050979362,-1.66424435420406e-05,0.011555121154849,0.0506836763652655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.00546085225742938,0.00280728175607918,-0.0109631244993446,4.14199844858028e-05,0.051766215406934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0118097763236368,0.00607904043675337,-0.0237246955796734,0.000105142932399854,0.052077595448825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0150775925494615,0.00776295461004666,-0.030292983585153,0.000137798486229945,0.0521324556853897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00532873839404842,0.0027491414893648,-0.0107170557132034,5.95789251065897e-05,0.0526079878214743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00831351415943856,0.00430487273497766,-0.0167510647199948,0.00012403640111765,0.0534850101806347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0229147093928484,0.011910033304856,-0.0462583746703661,0.000428955884669253,0.0543777612712557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00711510767985635,0.00370733973271284,-0.0143814935559735,0.000151278196260814,0.0549857809570568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.00744888892385865,0.00389546359417919,-0.0150839975684499,0.000186219720732557,0.0558770668756914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,42370,0.0120179712022689,0.00629159672115292,-0.000313558371190801,0.0243495007757286,0.0561339996591904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00561485072323194,0.00294038461595943,-0.0113780045705124,0.000148303124048536,0.0562152340860526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.00912023399615349,0.00478126460198831,-0.0184915126160506,0.000251044623743592,0.0564819874005736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.0101276385800132,0.00531232158786842,-0.000284511732208857,0.0205397888922354,0.0566190517777908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42611,0.00385441261019153,0.00202774171292274,-0.000119961147137031,0.0078287863675201,0.0573443780598662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00617776252386489,0.00326672179914926,-0.0125805372501974,0.000225012202467671,0.058634733798534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00753358030866423,0.0039882623311814,-0.000283413860451302,0.0153505744777798,0.0589263479419794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.00596937507103323,0.00317516995963238,-0.0121927081919127,0.000253958049846238,0.0601314249423795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00676235128083283,0.0035984928590986,-0.000290694723000436,0.0138153972846661,0.0602364656889061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00532540248135849,0.00283423377805448,-0.000229695723628299,0.0108805006863453,0.0602769684104573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.00843819852765303,0.00449166597121768,-0.0172418638312397,0.000365466775933614,0.0603208327437357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,40136,0.00940812493979997,0.00501227334111095,-0.000415930808777498,0.0192321806883774,0.0605422769583661
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,40539,0.00366086572246549,0.00195489935316476,-0.00017073700973744,0.00749246845466842,0.0611407733430493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0118387148334424,0.0063431042937652,-0.0242711992492222,0.000593769582337381,0.0620124429706018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.00275430538603462,0.00147949690726191,-0.00565411932426796,0.000145508552198725,0.0626783364558036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,40136,0.0176902522695699,0.00956188535090479,-0.00105104301820346,0.0364315475573433,0.0643289706287722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.0050163384149626,0.0027128906441317,-0.0103336040774607,0.000300927247535531,0.0644740691562168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00582368331865897,0.00315108892332616,-0.0119998176083782,0.000352450971060301,0.0646075766058944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42636,-0.00752799771621252,0.00408269283031016,-0.0155300756636204,0.0004740802311954,0.0652225515888447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42531,-0.00841403861804796,0.00457047827988391,-0.0173721760466204,0.000544098810524507,0.0656505508324892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.00931094370680222,0.00505894158649779,-0.000604581802733451,0.0192264692163379,0.0657226681731932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0113775899492623,0.00618249381857555,-0.0234952778336703,0.00074009793514581,0.0657526773866587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.00429948249568114,0.00233743598308543,-0.00888085702252857,0.0002818920311663,0.0658781190995626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.0234859926844066,0.0127868851205329,-0.048548287520651,0.00157630215183792,0.0662724342962997
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00450042841650283,0.00245088589533543,-0.00930416477136027,0.00030330793835461,0.0663483022390925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00722896726666499,0.00394691987220709,-0.000506995682860903,0.0149649302161909,0.0670462357180301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0153311760996533,0.00838704543063544,-0.0317697851436987,0.00110743294439219,0.0675827476935418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.00900868259102071,0.00492948212196289,-0.018670467550068,0.000653102368026549,0.0676451378401531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0126663054343307,0.0069311169145736,-0.0262512945868949,0.000918683718233615,0.0676585369580043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.0123016657614893,0.00673794339922053,-0.0255080348239615,0.000904703300982924,0.0679182251141893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.00839591993810208,0.00462856084334595,-0.0174678991910601,0.000676059314855983,0.0697139658378665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.00952110831001288,0.00525052842207801,-0.0198121440172858,0.000769927397260024,0.0698032889620283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00475271539050008,0.00262603566838753,-0.000394314519539466,0.00989974530053964,0.0703423593000692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.014287324429595,0.00789769703372042,-0.029766810615687,0.001192161756497,0.0704703924101246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,40302,0.00645480864575531,0.0035709885963406,-0.000544329003072266,0.0134539462945829,0.0707006311873379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00958641864010305,0.00530919486507241,-0.000819603295438877,0.019992440575645,0.0710035304629877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,42334,-0.0106599383328799,0.00591003014087814,-0.0222435974090011,0.000923720743241249,0.071300793610994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.00828615453294927,0.00460159629794224,-0.0173052832769161,0.000732974211017513,0.0717748745714304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.0052235972688978,0.00290405784840559,-0.000468356113977156,0.0109155506517728,0.072084844618607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00570534316709045,0.00318613589744225,-0.000539483191896365,0.0119501695260773,0.0733679677044303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.00790811870376812,0.00441668090444235,-0.000748575868938886,0.0165648132764751,0.0733993788726813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.00565346347974335,0.00318033250704987,-0.000579988234074393,0.0118869151935611,0.0754866923752211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.0076670105813539,0.00431557700987286,-0.000791520357996897,0.0161255415207047,0.0756633983107454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0265450970061333,0.0150244895146932,-0.0559930964549321,0.00290290244266541,0.0772868880895161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0140302266233102,0.00794151181358663,-0.00153513653131955,0.02959558977794,0.0773071337887186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42754,-0.00769416678766176,0.00436585091880658,-0.0162512345885227,0.000862901013199129,0.07803234267764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.00581355678497734,0.00331119206300932,-0.0123034932284756,0.000676379658520929,0.0791574936391082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,42370,0.00865480011177064,0.00493687392781726,-0.00102147278675119,0.0183310730102925,0.0796092639748113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42734,-0.006054785761158,0.00346091656811378,-0.012838182234661,0.000728610712345015,0.080231663396722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.00976576593342695,0.00558250721554011,-0.0207074800758856,0.00117594820903168,0.0802582404629834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00486405291239419,0.00278218427978938,-0.000589028275993003,0.0103171341007814,0.0804373115089402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.00143722582835217,0.000822473548271304,-0.00017482232625959,0.00304927398296392,0.0805880553628679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00718146367116651,0.00411418508541979,-0.000882339096256276,0.0152452664385893,0.0809185869532354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,40449,-0.010667311474281,0.0061160103663995,-0.022654691792424,0.00132006884386201,0.0811581841923074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,40511,0.00529227793299049,0.00303843307616641,-0.000663050896295672,0.0112476067622766,0.0815743489794591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.0107418091689615,0.0061745120848401,-0.00136023451732506,0.0228438528552481,0.0819348662779237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.00638921321687814,0.00367561415838853,-0.000814990533563387,0.0135934169673197,0.0821902851296418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0140352946910489,0.00808314855887256,-0.00180767648434134,0.0298782658664391,0.0825276414795204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0110779987130509,0.00640279929685355,-0.0236274853348839,0.00147148790878204,0.0836258853481319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.00378793195845482,0.0021912228173591,-0.000506864763569018,0.00808272868047867,0.0838889434409407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,40449,-0.00538791739511909,0.00311747782809649,-0.0114981739381882,0.00072233914795003,0.0839630030270014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42794,-0.0124612657719211,0.00721168816866361,-0.0265961745825018,0.00167364303865952,0.0840241358048441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.00446487856024583,0.00258442101839657,-0.000600586635811452,0.0095303437563031,0.0840806852144075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00646384296506217,0.00374655176565,-0.00087939849561184,0.0138070844257362,0.0845055198852384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.00838756177831949,0.00486332494625271,-0.0179196786729748,0.00114455511633581,0.0846131053298562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.00543852897970494,0.00315605095718141,-0.0116243888557805,0.000747330896370619,0.0848738354302697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42638,-0.00586062246903159,0.00340542305905902,-0.0125352516647873,0.000814006726724097,0.0852797262378501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.00828504169691774,0.0048251719598839,-0.0177423787382902,0.00117229534445471,0.0859989671889755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.00934670730005409,0.00544706331695087,-0.0200229514012778,0.00132953680116962,0.086205160661119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,42346,-0.0128481715852964,0.0074903262965018,-0.0275292111264399,0.00183286795584717,0.086313428602057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,40182,-0.0105145824108528,0.00613521338235965,-0.0225396006402777,0.00151043581857215,0.086592058973144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0134684282067384,0.0079048716053809,-0.0020251201398082,0.0289619765532849,0.0884442995016006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0074665604340394,0.00438780481861488,-0.0160666578785246,0.00113353701044577,0.0888423952175889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0147349619172006,0.00867539840823786,-0.0317387427973468,0.00226881896294564,0.0894455185931838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.00624254132815435,0.00368096536932505,-0.0134572334520314,0.00097215079572275,0.089933293465689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00672902391517898,0.00397383949995987,-0.00105970150474236,0.0145177493351003,0.0904200828646206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,42346,0.00916199685500303,0.00541875788661543,-0.00145876860276321,0.0197827623127693,0.0909000762409123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,40116,-0.0121856941483887,0.00721033384139702,-0.0263179484775268,0.00194656018074948,0.0910503906669708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,42370,0.02363230494748,0.0139964718016045,-0.00380077978366479,0.0510653896786248,0.0913490620449682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.00734406271586481,0.00436487713183745,-0.0012110964625366,0.0158992218942662,0.0924931118648175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.00501857509011704,0.0029865836848282,-0.0108722791123803,0.000835128932146227,0.0929082785093149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00587787472452447,0.00349837135280054,-0.0127346825760135,0.000978933126964588,0.0929465185655306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.00731077568557631,0.00436413460438093,-0.0158644795101629,0.00124292813901031,0.0939237928270071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.0113509902356656,0.00678543639488672,-0.00194846509831238,0.0246504455696435,0.0943860810509559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00899834493666977,0.00537948823976414,-0.00154545201326794,0.0195421418866075,0.0944122650812762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00369474375029266,0.00220962463861144,-0.00802560804197108,0.000636120541385753,0.0945250546114261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00781353490729478,0.00468733675659496,-0.00137364513563135,0.0170007149502209,0.0955530658551608
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00630769468297555,0.00378573349094445,-0.0137277323252267,0.00111234295927558,0.0957018973304791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00495783234181939,0.00297804683300841,-0.0107948041345159,0.000879139450877088,0.0959816877016601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42588,-0.0131034090720231,0.00789803445330361,-0.0285835566004982,0.002376738456452,0.0971246654430352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.0125343272050994,0.0075582439237971,-0.0273484852957417,0.00227983088554296,0.0972671480490367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00807293349714605,0.00487782538670105,-0.001487604260788,0.0176334712550801,0.0979477201225857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0119455054625038,0.0072228515325291,-0.00221128354125326,0.0261022944662608,0.0981869431877541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0119884635704093,0.00725177349963945,-0.0262019396297026,0.00222501248888406,0.098322576196155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.0142990107909769,0.0086541400816996,-0.00266310376915427,0.0312611253511082,0.0985028924949968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42721,0.00412115656822374,0.00249739174438417,-0.000773731250769231,0.00901604438721672,0.098928470028659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42711,-0.00492209660305265,0.00299166894740475,-0.0107857677399659,0.000941574533860652,0.0999378473410126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,40116,0.00833155404391882,0.00507903098083922,-0.00162334667852605,0.0182864547663637,0.10095443709804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.00326378387781302,0.00199359101255627,-0.00717122226242331,0.000643654506797257,0.101629393375676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.00709241179871224,0.00433939041502452,-0.0155976170121603,0.00141279341473581,0.102193400551426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00496743210106402,0.00304103114570699,-0.000992988944521668,0.0109278531466497,0.102399028031005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.0056407224244078,0.00346311957119687,-0.00114699193513807,0.0124284367839537,0.103384564071195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,40199,-0.00545978070994487,0.00335321497347712,-0.01203208205796,0.00111252063807029,0.103506299779861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.013950813943833,0.00860260203415417,-0.0308119139307751,0.00291028604310921,0.104896755200814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0147914067646075,0.00912480418389698,-0.00309320943583061,0.0326760229650456,0.105043956443068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00665141303272339,0.00410331534107754,-0.00139108503578858,0.0146939111012354,0.105049700681067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39926,0.0114006489094807,0.00703649767437682,-0.00239088653229784,0.0251921843512593,0.105215180526506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00551077418528486,0.00340566169185251,-0.0121858711013158,0.00116432273074607,0.105664366688343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0174880409276933,0.0108226045321685,-0.0387003458107436,0.00372426395535708,0.106148755228017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.00775474179958719,0.00481529545312311,-0.0171927208877085,0.00168323728853411,0.107330632044764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00526135518503153,0.00327279648771561,-0.0116760363009541,0.00115332593089106,0.107950274442913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,40136,0.00778084666589263,0.00484292781555846,-0.00171129185260194,0.0172729851843872,0.108161985152003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.00464192977094809,0.00289086753834792,-0.01030803014611,0.00102417060421384,0.108362962635957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.00757406360432172,0.00471724442044655,-0.016819862668397,0.00167173545975352,0.108382707499054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00466350619901752,0.00291741116565739,-0.010381632083706,0.00105461968567097,0.109958903754697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.00873445790965019,0.00546721576481976,-0.0194502008086969,0.00198128498939654,0.110158629241454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.0188453319001775,0.0118477979822537,-0.00437635214503983,0.0420670159453949,0.111718874781144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00427632856924158,0.00269460938948634,-0.00100510583415164,0.0095577629726348,0.112542545974524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00713478744681513,0.00451408685211501,-0.0159823976769606,0.00171282278333029,0.114002563031744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42603,-0.00639546113527374,0.00404686624142079,-0.0143273189684585,0.001536396697911,0.114050544045186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.00524881453476359,0.00332499817931419,-0.0117658109662194,0.00126818189669223,0.114453355699195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0145400798570939,0.00921964229761218,-0.0326105787604138,0.00353041904622596,0.114805979528359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.022776726005602,0.0144540119849279,-0.0511065894960608,0.0055531374848568,0.115099462753796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0136789062106808,0.00869505895202057,-0.0307212217566411,0.00336340933527955,0.115705580193717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.013237948661929,0.00842230795552291,-0.0297456722547539,0.00326977493089591,0.116032380543867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00877886623809651,0.00560072233634032,-0.0197562820173235,0.00219854954113052,0.117038025713669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00934756392167433,0.00597420937176047,-0.0023618864469762,0.0210570142903249,0.117693118969809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,40182,0.011009287256878,0.00704094163023488,-0.00279095833838235,0.0248095328521384,0.117937965620979
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00614527307474787,0.00393960567352874,-0.00157635404536846,0.0138669001948642,0.11881421058119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0132081281161084,0.00849400872709111,-0.029856385221207,0.00344012898899015,0.119971665511861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.00962082005941969,0.00619153712372295,-0.0217562328219167,0.00251459270307729,0.12024013533156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.00735043577245882,0.00473359907384663,-0.0166282899571982,0.00192741841228058,0.120493748375244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0175287391298302,0.0112931366563596,-0.039663286976295,0.00460580871663461,0.120652397230567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.00676333305152753,0.00436456081848679,-0.0153178722557616,0.00179120615270657,0.121265410631033
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.00976904752175362,0.00630463201356005,-0.0221261262683313,0.00258803122482408,0.121288912701807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,40337,0.00534389728843844,0.00345093552838369,-0.00141993634719359,0.0121077309240705,0.121521742615698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00525280048188644,0.00340566038089158,-0.00142229386466105,0.0119278948284339,0.123006471836731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.00694777511482154,0.0045141447821054,-0.0157954988877481,0.00189994865810505,0.123805450175509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.0087183386723223,0.00566937073479251,-0.0198303053125156,0.00239362796787102,0.124122517330665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00571486206106527,0.00371705095511779,-0.00157055781096559,0.0130002819330961,0.124205664392572
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42651,0.00541698136325001,0.00352790574642553,-0.00149771389974402,0.012331676626244,0.124692770226685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00787498828483674,0.00513001446323852,-0.00217984006311076,0.0179298166327842,0.124792871959755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.00828060992488916,0.0054052283665102,-0.0188748575232491,0.00231363767347082,0.125560306875234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0368725531627741,0.0240978282067368,-0.0841042964479782,0.0103591901224299,0.126015209284865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00613757605550179,0.00401256115421404,-0.0140021959177613,0.00172704380675773,0.126147043311834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.0122186268909891,0.00799719859666838,-0.00345588235848089,0.0278931361404591,0.126575515295666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42656,-0.00486103948328117,0.00318508934937193,-0.0111038146080502,0.00138173564148781,0.126986986066239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,40136,0.0118335122399579,0.00775909570843597,-0.0033743153485766,0.0270413398284924,0.127259350374605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.00626241449854259,0.00411826453665631,-0.014334212990389,0.00180938399330378,0.128377222994423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,40199,-0.00544218176321226,0.00358282507842004,-0.0124645189169155,0.00158015539049102,0.12880032300694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.00502252442167374,0.00330704883187134,-0.0115043401321416,0.00145929128879408,0.128853310577576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00525452974345928,0.00346007579737181,-0.00152721881938946,0.012036278306308,0.128887982899133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00690203901738808,0.00454673766913486,-0.00200956681411625,0.0158136448488924,0.129038065169602
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.010599772125262,0.00699519694042524,-0.0243103581284955,0.00311081387797143,0.129722045140444
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,42353,-0.0135059158706819,0.00892330232834522,-0.0309955884342385,0.00398375669287472,0.130162558414074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00686438911094297,0.00456154062867409,-0.0158050087431442,0.00207623052125824,0.132394211555826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,40383,0.00454319682434324,0.00302945377674325,-0.00139453257807353,0.01048092622676,0.133726760709343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00776373849865501,0.00517873495447872,-0.00238658201212327,0.0179140590094333,0.133861722283276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00395748293831502,0.00264415602873935,-0.00914002875464414,0.00122506287801409,0.13450251352585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,42332,-0.00759110777729388,0.00508392483210087,-0.0175556004482116,0.00237338489362383,0.135419602488774
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00554719169476633,0.00372221991593733,-0.0128427427300035,0.00174835934047084,0.136171614621063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42636,-0.00451258715734864,0.00303105896289508,-0.010453462724623,0.00142828840992571,0.136568144865159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,42370,-0.0057906955085692,0.00389122704557236,-0.013417500517891,0.00183610950075263,0.136737576462156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,40511,0.00400841342519596,0.00270070692153745,-0.00128497214101744,0.00930179899140935,0.137781342284391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00384637314493481,0.00260679887254362,-0.00126295264525069,0.0089556989351203,0.140102727176782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.0049327893442591,0.00334976908480885,-0.00163275806196625,0.0114983367504845,0.140889326874917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00728209091684928,0.0049491567043208,-0.00241825622361948,0.016982438057318,0.141217149766904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42611,0.00493612478078721,0.00337633761027013,-0.00168149693534225,0.0115537464969167,0.143771189007327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0098285199273851,0.0067256364919308,-0.0230107674515695,0.00335372759679926,0.143942339408075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.00884492681137765,0.0060555057600619,-0.020713718101099,0.00302386447834366,0.144136930188508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42495,0.00175428020266308,0.00120343890653627,-0.000604460054148016,0.00411302045947417,0.144940603641775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42721,-0.00316446274343928,0.00217522443029158,-0.00742790262681079,0.00109897713993222,0.14575468556889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42636,0.0123414006085329,0.00851614813145884,-0.00435024972912644,0.0290330509461922,0.147311663491316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.00909693479830046,0.00627772859633233,-0.0214012828471118,0.00320741325051092,0.147343348865288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.00481353484482991,0.00332311672601753,-0.0113268436278243,0.00169977393816444,0.147500499343363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.0086923124751841,0.00603719075313982,-0.00314058140096994,0.0205252063513381,0.149954281742882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0106295251049987,0.00739062903491077,-0.00385610780342638,0.0251151580134239,0.15039354044683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00697479324026331,0.00485170398064351,-0.00253454656179798,0.0164841330423246,0.150577136738629
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.00759844454840102,0.00528721892729757,-0.0179613936459043,0.00276450454910222,0.150707582999502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0155482071285576,0.0108903054478812,-0.0368932058064046,0.0057967915492895,0.153398393024685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0105195557763861,0.00742450305878339,-0.0250715817716015,0.00403247021882938,0.156544620017235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.00752567931643323,0.00531196238290706,-0.0028857669540646,0.0179371255869311,0.156582087381187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00768801280911483,0.00543398035948722,-0.00296258869548012,0.0183386143137098,0.157154713451657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00473422989219426,0.00335179914013936,-0.00183529642247889,0.0113037562068674,0.157847594083819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.037787972353758,0.0267904260800681,-0.0902972074706914,0.0147212627631754,0.158418891773839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.00970861460181766,0.00688586740066823,-0.0232049147071274,0.00378768550349208,0.158587646240187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.0144919354117556,0.0103005363112554,-0.0346809865818162,0.00569711575830493,0.159477237244671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,40302,-0.00626114912619554,0.00448588659136785,-0.0150534868452765,0.00253118859288545,0.162819507618832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00484422427009524,0.00347617899132683,-0.00196908655290534,0.0116575350930958,0.16348232300651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.00895866366162994,0.00643011060703056,-0.0215616804514098,0.00364435312814996,0.163576478114508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,40182,-0.00762961013324777,0.0054977239529948,-0.0184051490811176,0.00314592881462204,0.165233362181913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0153987231849811,0.011143338446518,-0.0372396665401563,0.00644222017019407,0.16703730554417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,42357,0.00333887447226252,0.00242095373343347,-0.00140619484526708,0.00808394378979212,0.167869888514147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00618523177627503,0.00449412750013217,-0.0149937216765341,0.00262325812398403,0.16875924793115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.00796146418766827,0.00578901206538276,-0.00338499946048194,0.0193079278358185,0.169070665873982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00528687424479619,0.00384508739866597,-0.00224949705658912,0.0128232455461815,0.169168927190367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.0124226872015757,0.00903608053074021,-0.0301334050418265,0.00528803063867506,0.169220437278185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.00538327748818723,0.00391576330251689,-0.0130581735611203,0.00229161858474588,0.169225961876878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00377211990257904,0.00274503075639508,-0.00160814037995531,0.0091523801851134,0.169418342258012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42488,-0.00712763749961249,0.00519027235687817,-0.0173005713190937,0.00304529631986872,0.169692053433658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.0120539716539831,0.00883153675294596,-0.00525584038179102,0.0293637836897571,0.172314275171315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.00435683037156716,0.00319895195406639,-0.00191311545840295,0.0106267762015373,0.173235239441975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00532198760923833,0.00391876994602423,-0.0130027767034458,0.00235880148496916,0.174462850381048
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00555974046646107,0.00409381638947225,-0.00246413965690455,0.0135836205898267,0.174465503786182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00674309492795347,0.00496547540685846,-0.00298923686948912,0.0164754267253961,0.174488363347687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00829016643012582,0.00614677603639873,-0.00375751460121568,0.0203378474614673,0.177460756389777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,0.00296726142189857,0.00220053091711836,-0.00134577917565342,0.00728030201945056,0.177542842375976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0074713214254111,0.00554677795726299,-0.0183430062216466,0.00340036337082435,0.178018109746644
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00796066268578718,0.00592197006545205,-0.00364639864249883,0.0195677240140732,0.178892598930683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42594,-0.00741471900410498,0.00552172711792109,-0.0182373041552303,0.00340786614702036,0.179351051621289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,40080,-0.00989633967056543,0.00737267883314942,-0.0243467901835383,0.00455411084240743,0.179527048766257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,40419,-0.00460627320488347,0.00343207172550392,-0.0113331337868712,0.00212058737710421,0.179582241916782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.00919891623856336,0.00686376401634571,-0.022651893710601,0.00425406123347423,0.180202585093642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.0044427086840904,0.00331743682178052,-0.0109448848547802,0.00205946748659942,0.180528939099058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00430052213223463,0.00321503326711671,-0.00200094307131413,0.0106019873357834,0.181039870960983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00563472434327377,0.00422410713681633,-0.00264452564488623,0.0139139743314338,0.182249820160862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.00652088684812174,0.00490251140706957,-0.0161298092059781,0.00308803550973462,0.183504556492545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00350637751345985,0.00263992442790207,-0.0016678743652282,0.0086806293921479,0.184136150448931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.00390265176989018,0.00294778406194977,-0.00968030853131172,0.00187500499153136,0.185553883802748
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,42247,0.00887740839749661,0.00671393426776919,-0.00428190276733101,0.0220367195623242,0.186112605974268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00335377695864264,0.00254181778359229,-0.00833573981448353,0.00162818589719824,0.187048592769556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00574413655547937,0.0043648077003537,-0.00281088653721387,0.0142991596481726,0.188197846428355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.00327237430171101,0.0024919659963075,-0.00815662765447372,0.00161187905105169,0.189152935068195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42594,0.0122472511985796,0.00933118145477081,-0.00604186445277121,0.0305363668499303,0.189371236106884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00790325764069332,0.0060247009125166,-0.00390515614783921,0.0197116714292259,0.189611951050508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00396627139765317,0.00303778006016413,-0.00992032031557487,0.00198777752026853,0.19169475805218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00675748076454141,0.00517595377926592,-0.00338738864281979,0.0169023501719026,0.19173214172212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42636,0.00529689604198127,0.00407544723323392,-0.00269098053515721,0.0132847726191198,0.193722962504455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.00606881687864918,0.00467060843103707,-0.00308557564618347,0.0152232094034818,0.193841857369186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.00772730280376143,0.00596023120629212,-0.019409355968094,0.00395475036057111,0.194837694696507
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.00788348084661189,0.00608147740157615,-0.00403621486047736,0.0198031765537011,0.194890769939737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0126246028251496,0.00977801085061025,-0.00654029844204653,0.0317895040923456,0.196683583302236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00661280248414855,0.00513305858841384,-0.00344799234914258,0.0166735973174397,0.197676604132659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,40136,0.00678423117511008,0.0052800695818134,-0.00356470520524419,0.0171331675554643,0.198863049253306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00566077940696126,0.00441520162309144,-0.0143145745882205,0.00299301577429796,0.199825796648244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,42357,0.00501690041442104,0.00391633050885915,-0.00265910738294289,0.012692908211785,0.200208967050193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.00485965098944899,0.00379578402657312,-0.00258008570263432,0.0122993876815323,0.200474409439093
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,0.00301445854636145,0.0023560341206336,-0.00160336833008041,0.00763228542280332,0.200756216270095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,42370,-0.00665936389048589,0.00520566068193057,-0.0168624588270698,0.00354373104609802,0.200830042033153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0100409047796014,0.00785187465248652,-0.00534876953927218,0.025430579098475,0.200997868183725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,42249,-0.0131693525293192,0.0103699529040926,-0.0334944602213407,0.00715575516270234,0.204124016387582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.00748086880424404,0.00589721250490496,-0.00407766770536968,0.0190394053138578,0.204625916260856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42587,-0.0244320105541968,0.0192798155366257,-0.0622204490059831,0.0133564278975895,0.205094170270627
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,0.00580649162494852,0.00460548509433864,-0.00322025915995521,0.0148332424098523,0.207410933337299
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.00325074298593875,0.00258300540631069,-0.00181194761043021,0.00831343358230771,0.208233333771425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00663334829893274,0.00527460052204475,-0.0169715653221404,0.00370486872427496,0.208562158514568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,40539,0.00187942475791431,0.00149565719439504,-0.00105206334309997,0.00481091285892859,0.208928764656541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00548426895830078,0.00438418476231094,-0.00310873317582866,0.0140772710924302,0.210989880308666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00409401681543281,0.00327306327798422,-0.00232118720941626,0.0105092208402819,0.211026525871442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,40451,-0.0138615804813559,0.0110901207145382,-0.0355982170818508,0.00787505611913896,0.211360791843047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00443307243622126,0.00356840568441387,-0.00256100270522992,0.0114271475776724,0.214143261729568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,40116,0.00756126538881321,0.00608722512271254,-0.00436969585170337,0.0194922266293298,0.214206760785818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0115440131035578,0.0093030947279096,-0.0297780787702606,0.00669005256314502,0.21467717447578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0108309546138098,0.00873212758402799,-0.0279459246785046,0.00628401545088508,0.214870151603291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0108260569040951,0.00874610953791626,-0.0279684315984109,0.0063163177902208,0.215811440142116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.00810855297860139,0.00656673593945621,-0.0209793554199356,0.00476224946273277,0.216934045694055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.00687224314864833,0.00557169957561164,-0.0177927743168471,0.0040482880195505,0.217441378761955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,40116,-0.0104751563565063,0.00854055247143119,-0.0272146392005115,0.0062643264874988,0.220029585069695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00652469594932223,0.00532677412952877,-0.0169651732431986,0.00391578134455415,0.220639825502416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0035897132202344,0.00293154875403451,-0.00933554877814205,0.00215612233767324,0.220780790423281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00315135330948998,0.00258309228324507,-0.00821421418465032,0.00191150756567036,0.22249378992529
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.0118193570464402,0.00970970121231678,-0.0308503714225811,0.0072116573297007,0.223525748609312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00781946961053105,0.00642728469147369,-0.00477800838475737,0.0204169476058195,0.223780608233935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,40527,0.0110535552030653,0.00908871609385155,-0.00676032834088378,0.0288674387470143,0.223939995147495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.00978292412494869,0.00804941263491957,-0.00599392463949368,0.0255597728893911,0.224250568854896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,40182,0.00592350782183807,0.00488911661553756,-0.00365916074461554,0.0155061763882917,0.225703015256273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.0054591074885288,0.00450670054658455,-0.0142922405598345,0.00337402558277691,0.225794221596871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00784741313330051,0.00648806744165588,-0.020564025318946,0.00486919905234501,0.226491137846804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,42293,-0.00688783065345547,0.00570468708686963,-0.0180690173437199,0.00429335603680899,0.227300512276369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00541286832065334,0.00448670911769414,-0.0142068181913338,0.00338108155002716,0.227679849905376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.00600297575867047,0.00497982011163317,-0.0157634231774715,0.00375747166013054,0.228050899557899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00560271937275318,0.0046714953638386,-0.0147588502858768,0.00355341154037047,0.230416114637123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.00375189355554973,0.0031285547981347,-0.00988386095989374,0.00238007384879427,0.23045977447371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.00868563556370814,0.00728992292075582,-0.0229738844883896,0.00560261336097327,0.233495024947581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.00893288170029015,0.00749866589403908,-0.0236302668526067,0.00576450345202643,0.233575417335713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.00352370177068974,0.00296003054170405,-0.00932536163242968,0.00227795809105021,0.233899321657036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00538464287609519,0.0045241456900609,-0.00348268267642417,0.0142519684286145,0.233992486413758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,40479,0.00570804177272492,0.00480561498389971,-0.00371096359571852,0.0151270471411683,0.234942764972175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00990964360802512,0.00837104513971238,-0.00649760486581114,0.0263168920818614,0.236517599919854
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00721352394714362,0.00610174042894924,-0.0191729351878841,0.00474588729359689,0.237149024887536
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0130029862622332,0.0110307409030034,-0.0346232384321198,0.00861726590765345,0.23850062567443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00621783356594311,0.00529680282643283,-0.00416389997386524,0.0165995671057515,0.240467061140208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00634153312643477,0.00540963990948672,-0.0169444273490287,0.0042613610961592,0.24111536809385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,0.00371418481468589,0.00317999913134066,-0.00251861348274181,0.0099469831121136,0.242834351829419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0106482853577293,0.00912865561055049,-0.0285404503544082,0.00724387963894971,0.243449959046124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.00671054161330848,0.00577415846788536,-0.0180278922103638,0.00460680898374681,0.245192240392488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00552307079016075,0.00476948392122932,-0.0148712592757702,0.00382511769544873,0.246888447130149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.00615223532326682,0.0053133158777619,-0.0042618637971465,0.0165663344436801,0.246929955093233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00441709829843906,0.00381837523513408,-0.00306691716242374,0.0119011137593019,0.247379034468229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00360741186733442,0.00311887848663254,-0.0097204137011342,0.00250558996646536,0.247445594105179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00299810366355695,0.00260402291421906,-0.00810198857542631,0.00210578124831241,0.249618558211813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00329173550981164,0.00286251845739493,-0.00890227168630569,0.00231880066668242,0.250191985020223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00474219700332476,0.00413656854501029,-0.00336547734489541,0.0128498713515449,0.251651315932272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00376217828970723,0.00328273206744057,-0.00267197656247628,0.0101963331418907,0.251799168887003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.00825121475325521,0.00721673415905969,-0.0223960137050122,0.00589358419850178,0.252919687673189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.00679147284115496,0.00596818367649274,-0.0184891128470807,0.00490616716477081,0.255167928601122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00562235449198819,0.00494342075803754,-0.00406675019376538,0.0153114591777418,0.255420613854761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00331733711835396,0.00291926581306879,-0.00240442387526086,0.00903909811196879,0.255830412682952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,42370,-0.00365558177448521,0.00322143160997508,-0.00996958773003637,0.00265842418106596,0.256492624901423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.00479732745723645,0.00422955670861694,-0.00349260369165276,0.0130872586061257,0.256718532252241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00561745710913032,0.00496419213823377,-0.0153472737000685,0.00411235948180786,0.257829260012818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.00866772172191369,0.00766090084890244,-0.0236830873857625,0.0063476439419351,0.257901661251785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.00329109373963497,0.00290909953680737,-0.00241074135250748,0.00899292883177742,0.257944983940294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.0045886861672864,0.00405782418471632,-0.0125420215693304,0.00336464923475758,0.25815388300822
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00556025747142959,0.00491805698169244,-0.0151996491555468,0.0040791342126876,0.258255816457998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.0024626188373563,0.00218111475545569,-0.00673760375804946,0.00181236608333685,0.258890926121268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00654480665084575,0.00579860743805576,-0.00482046392774354,0.017910077229435,0.259055090448261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42711,-0.00847761317378051,0.00751115830432282,-0.0231994834502532,0.00624425710269222,0.259057430130758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,40199,-0.0063018986257407,0.00558469623169444,-0.0172479032398618,0.00464410598838039,0.259165997013806
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00309621511317379,0.00274526482389229,-0.0022845039416551,0.00847693416800268,0.259412943597102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.00212078012718516,0.00188625358909525,-0.00581783716181185,0.00157627690744153,0.260894904028527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,40483,0.0117007239739048,0.0104123596727172,-0.00870750098462099,0.0321089489324305,0.261149726611571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.00982109857385661,0.00875014360957816,-0.0269713800486298,0.00732918290091659,0.261719705437723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00603157589884671,0.00540009029954882,-0.00455260108826897,0.0166157528859624,0.264044581371942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.00568864254101746,0.00509508888858104,-0.00429773168060138,0.0156750167626363,0.264234616398094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00336806053114273,0.00301991518449686,-0.00928709429275658,0.00255097323047112,0.264753455527336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00643183294031755,0.00577173948560874,-0.0177444423321107,0.00488077645147558,0.26514186787838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00406453280574239,0.00365548644990353,-0.00310022063606851,0.0112292862475533,0.266205778872606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.00304631492660025,0.00275113928831314,-0.008438547931694,0.0023459180784935,0.268191173216977
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.00836081722358635,0.00755153346054418,-0.0231618228062529,0.00644018835908025,0.268245579769419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00554692396923936,0.00501149546538374,-0.0153694550813915,0.00427560714291277,0.268387586977758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.00250809535581159,0.00228140333897292,-0.00697964590019851,0.00196345518857533,0.271632815826073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00741027726894292,0.00674298230151567,-0.00580596804202779,0.0206265225799136,0.271805073233856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,40302,-0.00918825207052278,0.00837108230366478,-0.0255955733857057,0.00721906924466018,0.272395045929468
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.00821586352678473,0.00750753840069216,-0.0064989117385719,0.0229306387921414,0.273826286791808
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,40384,-0.00346815233075137,0.00317067755526227,-0.00968268033906542,0.00274637567756268,0.27405722579076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00315482830610126,0.0028854847525667,-0.008810378421132,0.00250072180892947,0.274266591094239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.0041523996438944,0.0038039463179293,-0.0116081344270358,0.00330333513924702,0.275027098426728
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0101598999855553,0.00933140056354206,-0.0284494450900977,0.00812964511898714,0.276267729805194
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,40182,-0.00444461805136514,0.0040880796737618,-0.0124572542119383,0.00356801810920799,0.276966028530436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00415101599521327,0.00381897870325927,-0.0116362142536014,0.00333418226317489,0.277085545088007
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.00381965128493388,0.00352133091177306,-0.0107214598720091,0.00308215730214131,0.278066107747473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00346862209353915,0.00319794806502856,-0.00973660030099513,0.00279935611391682,0.278104277787121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.00271567249682487,0.00251518629363484,-0.00764543763234915,0.00221409263869941,0.280290658076643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.00673412833859153,0.00623847367971102,-0.0189615367508251,0.00549328007364207,0.280410398992374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,40451,-0.00473091450749473,0.00438529948717606,-0.0133261015023598,0.00386427248737034,0.280694578233117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,40182,-0.00251745913361184,0.00233464418283288,-0.00709336173196429,0.00205844346474061,0.280921215251813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00923820743152766,0.00859531302102175,-0.00760860608967496,0.0260850209527303,0.282485821312538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.00349809490425894,0.00325537982927707,-0.009878639369642,0.00288244956112412,0.282591664047999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,40136,0.0059079818037357,0.00550633015087018,-0.00488442529196985,0.0167003888994412,0.28332007526869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00431055954568185,0.00402378052866008,-0.0121971693818556,0.00357605029049191,0.284071107147535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42636,0.00506141570437113,0.00472517511086574,-0.00419992751292572,0.014322758921668,0.284116998309989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,42370,0.0050690422662879,0.00473271860539042,-0.00420708620027733,0.0143451707328531,0.284160486366379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0129920686902721,0.0121625321511446,-0.0368306317065155,0.0108464943259713,0.285451947898688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00658333891129491,0.00618340020156313,-0.0187028033063586,0.00553612548376882,0.287044170732399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00279680021202965,0.00262783115269994,-0.00794734927132154,0.00235374884726224,0.287215665196999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00569343934859089,0.00535147650419332,-0.0161823332968098,0.004795454599628,0.287397305367554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00427227507388528,0.00402467708704076,-0.00361609201671462,0.0121606421644852,0.288476743814546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00621315076905523,0.00585369335286431,-0.0176863897406693,0.00526008820255881,0.288524457209638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,40483,0.00451646471346358,0.0042613145229414,-0.00383571175150156,0.0128686411784287,0.289223720786113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,42346,0.00893159872419642,0.00845844095921396,-0.00764694555586293,0.0255101430042558,0.291015424667978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00393086420607866,0.00373908288619611,-0.00339773825086572,0.011259466663023,0.293148076326645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00362116816760005,0.00344663425802173,-0.0103765713133226,0.00313423497812254,0.293447771266535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00471864194153552,0.00449441426675927,-0.0135276939043837,0.00409041002131264,0.29379173925873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.0038605204042491,0.00367720622895538,-0.0110678446130017,0.00334680380450345,0.293805657254297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.00624056149784224,0.00595860854782247,-0.0179194342515743,0.0054383112558898,0.29497591779024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00271748496611886,0.00259894838005535,-0.00781142379102734,0.00237645385878962,0.295760187142676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00622257648698037,0.00596630679146647,-0.0054713848242939,0.0179165377982546,0.296992842303515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,40302,-0.00429671576162627,0.00412823133697126,-0.0123880491820899,0.00379461765883739,0.297985119815056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00477544137343556,0.00459494132401844,-0.0137815263685117,0.00423064362164058,0.298695705678083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00655607516430584,0.00631458921748918,-0.00582051970197296,0.0189326700305846,0.299179912220804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.00760381724415997,0.00732536655290443,-0.0219615356878527,0.00675390119953272,0.299287596188265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.00686411687723319,0.00661304816575656,-0.00609745752764968,0.0198256912821161,0.299308980833182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.00295202256212201,0.00284660672795495,-0.00853137174891372,0.00262732662466971,0.299743631558624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.00687806517577293,0.00664082487155185,-0.0198940819240146,0.0061379515724687,0.300352926247707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00258314299302755,0.00249578290996072,-0.00230859151049546,0.00747487749655057,0.30068634874108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00734849261306793,0.00710591187664576,-0.00657909466515776,0.0212760798912936,0.301094225120574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,42549,-0.00381564147538716,0.00369829767646936,-0.0110643049212671,0.00343302197049279,0.302217706584542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00731752321210253,0.0071339802946213,-0.0213001245895603,0.00666507816535521,0.305042156733342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00316568570835142,0.00308926859026816,-0.00288928072857418,0.00922065214527701,0.305510393454253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00628465091528198,0.0061478288817255,-0.0183343955234639,0.00576509369289999,0.306678850481697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.0069411833137881,0.00680075353669498,-0.0202706602457103,0.00638829361813407,0.307443165193763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42721,0.00647987833974825,0.00638120186624915,-0.00602727731810008,0.0189870339975966,0.30990304240892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.00297671073467652,0.00294651148550237,-0.00875187324626116,0.00279845177690812,0.312394143639279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00347196356523473,0.00344060784818049,-0.00327162781719902,0.0102155549476685,0.312938625118426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.00392620964168357,0.00389830944047685,-0.0115668961450182,0.00371447686165106,0.313877519067888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.00665981010306415,0.00662679911529738,-0.019648336369047,0.00632871616291872,0.314924243442032
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,40182,-0.00614080652629961,0.00611438698504512,-0.0181250050169881,0.00584339196438883,0.31524608762218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.0076283542315103,0.00761949055883938,-0.00730584726381489,0.0225625557268355,0.316770010488538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00365945101979512,0.00365558597741218,-0.010824399535523,0.00350549749593275,0.316817161568751
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,40482,-0.00366100749309865,0.00366534786746083,-0.0108450893133219,0.00352307432712457,0.317905323617845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,40136,-0.00483500941268522,0.00485009176320753,-0.014341189268572,0.00467117044320155,0.318839807077644
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,40116,0.00739654005927759,0.00742085405259957,-0.00714833388381757,0.0219414140023728,0.318920792444734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0115330107395659,0.0116124093145458,-0.0342933329960758,0.0112273115169439,0.320652005029616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00291592157364652,0.0029531420139591,-0.00287223677371331,0.00870407992100636,0.323470092978236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00477185723255628,0.00486015164098518,-0.00475403998377468,0.0142977544488872,0.326203879048219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0055361312227476,0.00565032493523296,-0.0166107680958042,0.005538505650309,0.327210905439226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.00840745364643879,0.00861069730722596,-0.0252844203686017,0.0084695130757241,0.328886083023672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00490898800911112,0.00503444854473861,-0.00495853113857654,0.0147765071567988,0.329542378428555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.00592526983449873,0.00608090055721567,-0.0178438349266414,0.00599329525764397,0.329875615349044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00525566846936815,0.00539414565641745,-0.00531685701721005,0.0158281939559463,0.329914836119543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.00756937520131758,0.00777662047045579,-0.0228115513234109,0.00767280092077576,0.330396736541465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,42460,-0.00550859933533198,0.00569491795104787,-0.0166706385193858,0.00565343984872184,0.333420036403348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00386075976524623,0.00401487956815076,-0.0117299237188217,0.00400840418832926,0.336265404593596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.00634539957757432,0.00660698760861845,-0.0192950952904665,0.00660429613531784,0.336867355862571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00433820312955947,0.00452153942527847,-0.0132004204031053,0.00452401414398633,0.33735198455518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0056288536567305,0.0058905273665053,-0.0171742872950809,0.00591657998161988,0.339306874028849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42584,-0.00681441836224459,0.00715157929139955,-0.0208315137733877,0.00720267704889853,0.3406807232202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,40136,0.00598516963353916,0.0062859826725302,-0.00633535640462003,0.0183056956716983,0.341044266630955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00497795570709084,0.00523829112502754,-0.00528909489796314,0.0152450063121448,0.341980124355552
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00977584160788582,0.0103669566476645,-0.0300950766373083,0.0105433934215367,0.345711429559086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,40539,0.00196728800773407,0.0020913690616939,-0.00213179535318598,0.00606637136865411,0.3468940566398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0035956170627575,0.0038228786090103,-0.0110884591364177,0.00389722501090268,0.346955126495222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,40527,-0.00878056532344559,0.00934790334767974,-0.0271024558848979,0.00954132523800671,0.347592380547347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0041571579973644,0.00442734769425864,-0.0128347594781113,0.00452044348338254,0.347761932179267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.00335681221872813,0.00358001556509136,-0.0103736427263072,0.00366001828885094,0.348439481258684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.00524183773986032,0.00560377428444862,-0.00574155985765898,0.0162252353373796,0.349596081372275
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,40539,-0.00197263836003861,0.00211126988524994,-0.00611072733512849,0.00216545061505128,0.350149776937399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,40302,0.0161592417305882,0.0174093255049106,-0.0179630362590365,0.050281519720213,0.353326808905576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.0033528765218303,0.00362439859652038,-0.00375094472734965,0.0104566977710102,0.354938704338537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.0037255764672291,0.00403041289480986,-0.00417403280659821,0.0116251857410564,0.355316036909777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.00930772749797033,0.0100734395765337,-0.0104362140720358,0.0290516690679764,0.355513482094126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00507306446265196,0.00549590086003997,-0.0158450301483303,0.00569890122302638,0.355994260523182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.0087602375822334,0.00949812643121061,-0.0098560902229394,0.0273765653874062,0.356386104524307
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00317943507086709,0.00345120091361309,-0.00994378886154873,0.00358491871981456,0.356937152812115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00648576534353095,0.00704600590381036,-0.0202959369149993,0.00732440622793735,0.357338022631166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.00663944213753379,0.00721577560256456,-0.00750347804349276,0.0207823623185603,0.357525835832849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,40302,0.00325815279495887,0.003547456246866,-0.0036948614488985,0.0102111670388162,0.358404504700042
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.00440804228023929,0.00480343503821377,-0.0050066903946597,0.0138227749551383,0.3588001015826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,40199,0.00969694676933382,0.0105836318841946,-0.0110469717236877,0.0304408652623553,0.359571021006846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.0038708840035606,0.00422694686274475,-0.0121556998545403,0.00441393184741912,0.359807667411743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,40483,0.00240372295125901,0.00262658126233638,-0.0027443763229203,0.00755182222543831,0.360131015336633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,42381,-0.00422354283180799,0.00462872869852671,-0.0132958510809203,0.00484876541730436,0.361541814785868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00430422275040237,0.00471787003911979,-0.00494280252627241,0.0135512480270772,0.36161853833046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,40434,0.00548362044184282,0.00601284091153506,-0.0063015477447659,0.0172687886284515,0.361796197052471
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00368583937857612,0.00404303348163945,-0.0116101850025894,0.0042385062454372,0.361971931760953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00343624492479276,0.00380501353081544,-0.00402158159560549,0.010894071445191,0.366501198536112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.00736580252397301,0.00817639194092597,-0.00865992568024188,0.0233915307281879,0.367681116051223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00418020482656098,0.00464224957714153,-0.0132790139977584,0.00491860434463642,0.367886860180312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,0.00365175821888469,0.004064279611303,-0.00431422981926919,0.0116177462570386,0.368934942161582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00413821422642844,0.00464402923303334,-0.00496408307031691,0.0132405115231738,0.372904302494279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00413079042310166,0.00465008041020579,-0.013244948027105,0.00498336718090167,0.374384622840506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.0058564511314382,0.00663223255937707,-0.00714272468494086,0.0188556269478173,0.377239920539163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0132003554074795,0.0149580835139047,-0.0161174882797737,0.0425181990947326,0.377530866560095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42594,-0.00557544973926369,0.00633659974256448,-0.0179951852346901,0.0068442857561627,0.378939897708908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00461697874079791,0.00525245179438988,-0.00567782677620625,0.0149117842578021,0.379413014741994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,40182,-0.00314315044696344,0.00358205612759889,-0.0101639804570573,0.00387767956313039,0.380250037045083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.00463162369882239,0.00529953494497633,-0.015018712190976,0.00575546479333121,0.382151377748945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00966789014948885,0.0111103355200353,-0.0121083674697804,0.0314441477687581,0.38422616489686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42711,-0.00258351829275833,0.00297038109232965,-0.00840546523372445,0.00323842864820779,0.38444708687531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.00191544620092579,0.00221773299187721,-0.00626220286500512,0.00243131046315354,0.387773961035199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00355921231343125,0.00412923401797,-0.0116525109886524,0.00453408636178994,0.388728209027521
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00386911671416537,0.00449480162593833,-0.00494069447267376,0.0126789279010045,0.38936782911809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00314531501156034,0.00365416462152991,-0.00401684764663829,0.010307477669759,0.389395726300341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00595197548633654,0.00696240180077018,-0.00769433204317301,0.0195982830158461,0.39263978173805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.00258785170979355,0.00302797699302893,-0.00334698319654316,0.00852268661613025,0.392761821713051
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42594,-0.00509114996405205,0.00595727390099199,-0.0167674068099964,0.00658510688189225,0.392781985488176
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00241002787223313,0.00284037585649747,-0.00797716455096817,0.00315710880650191,0.396184111067634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.00215475927198567,0.00256164713675304,-0.00717558766002164,0.00286606911605029,0.400272227569068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00334652177292957,0.00397859905849287,-0.00445153238171646,0.0111445759275756,0.400292625075713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00410588657768804,0.00489042635194408,-0.0136911222274984,0.00547934907212235,0.401161180877562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0072573380662888,0.00866035938314116,-0.00971696632466787,0.0242316424572455,0.402048471716809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.00458520734738638,0.00547240282087975,-0.0153111168763107,0.00614070218153792,0.402117108064829
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.0059078581806406,0.00707098961152504,-0.0197669978192297,0.00795128145794848,0.403450799975435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00461786628006454,0.00554083713488177,-0.00624217450430374,0.0154779070644328,0.404623364126873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,40080,0.00558052845033555,0.00669649378631317,-0.00754459937083826,0.0187056562715094,0.404665197829185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00413602284901359,0.00499360758694,-0.0056514480213888,0.013923493719416,0.407539392584999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.00880200254504777,0.0107066129675275,-0.0121829588713061,0.0297869639614017,0.411029772527028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.00636367800878713,0.00775611996624792,-0.0215656731426331,0.0088383171250588,0.411962046823018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00228323237654617,0.00279190562868948,-0.00775536740877755,0.00318890265568521,0.413483755734615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,0.00237878645427175,0.00291021113344312,-0.00332522736727676,0.00808280027582026,0.413718270898041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,0.00336564026321962,0.00412421407061194,-0.00471781931517978,0.011449099841619,0.414478305945178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.00484828622778434,0.00596037613237834,-0.0165306234472459,0.00683405099167719,0.415991831425991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.00343092376122407,0.00422696810355366,-0.0117157812441892,0.00485393372174111,0.416995383186689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.00428631098486941,0.00528456929355172,-0.0146440668002308,0.00607144483049197,0.417325615960971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.00384505702146083,0.00475502916015341,-0.0131649141753615,0.00547480013243986,0.418745750761396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.00785632919411213,0.00973685590593501,-0.0269405667697448,0.0112279083815205,0.41976125550622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00351154423510737,0.00436331902555098,-0.0120636495251873,0.00504056105497256,0.420959751555955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00486146022601896,0.00604368093274183,-0.0167070748541929,0.00698415440215503,0.421190837763465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.00494345341441652,0.00614654925725836,-0.0169906899586429,0.00710378312980986,0.42126141565558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00600214233370696,0.00746369193459277,-0.00862669385809486,0.0206309785255088,0.421310968154874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42587,-0.00337363332935669,0.00420511314800447,-0.0116156550994454,0.00486838844073206,0.422411411642418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.00716197405251348,0.00892918226415827,-0.0246631712902637,0.0103392231852367,0.422520404673985
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.00710411252377866,0.00886643419165389,-0.0244823235394203,0.010274098491863,0.423008768611846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,40421,0.00579960968694856,0.00724614137517347,-0.00840282740839145,0.0200020467822886,0.423512152519291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00915073476001541,0.0114418418620114,-0.0315767448095577,0.0132752752895269,0.423863909971367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.00372453613882686,0.00465718983384194,-0.0128526282131571,0.00540355593550333,0.423876593610479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42553,-0.00478384878676491,0.00598880919493557,-0.0165219148088386,0.00695421723530882,0.424421753263189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00625071944481738,0.00783919996890943,-0.0216155513838799,0.00911411249424511,0.425255303948841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.00246571572832948,0.00309384304480451,-0.00852964809614631,0.00359821663948735,0.425479540418734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00369766175329,0.00464606094146133,-0.00540861769197421,0.0128039411985542,0.426124612075388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,0.00216079422750134,0.00271825685577642,-0.00316698920982044,0.00748857766482313,0.426677216485765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,40199,-0.00261508577937034,0.00329480260364554,-0.0090728988825156,0.00384272732377492,0.427387044657262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,40080,0.00758320828670614,0.00955974793982337,-0.0111538976753477,0.0263203142487599,0.427653233739495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.00157706381352064,0.00199091439487757,-0.0023251284004394,0.00547925602748068,0.428301209099375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00313734524382052,0.00397098398796423,-0.0109204738602304,0.00464578337258937,0.429502614978769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00297359261765434,0.00376392557657885,-0.0103508867477489,0.0044037015124402,0.429530226162961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42794,0.00247558920457669,0.00313644552930628,-0.00367184403286362,0.00862302244201701,0.429951797413303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,40199,0.00266654374026426,0.0033848463656705,-0.00396775513644991,0.00930084261697843,0.430837275073743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00236999438425761,0.00302223029138217,-0.00355357698685144,0.00829356575536666,0.432946649983462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,40198,0.00550382054156941,0.00701918417386535,-0.00825378043920668,0.0192614215223455,0.432991774080942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,40116,0.00357849009312606,0.00457047037260718,-0.005379631837184,0.0125366120234361,0.433668270115104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.00590655641468587,0.00754726249311449,-0.0206991909011903,0.00888607807181853,0.433873104750589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00406762106001029,0.00520126670246374,-0.00612686167681863,0.0142621037968392,0.434205914487929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,40283,0.00273559353367104,0.00351444657283345,-0.00415272174908252,0.00962390881642459,0.436358513107525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.00532815079086756,0.00686463001774946,-0.0187828256256565,0.00812652404392139,0.43765956126248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00451590571575518,0.00584118760247903,-0.00693282198510371,0.0159646334166141,0.439471519875202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.00408313421235543,0.00528287707435527,-0.00627130485338089,0.0144375732780917,0.439598455964938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0141686007400537,0.0183987297674273,-0.0218929096041039,0.0502301110842112,0.441262591891981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.00559788815488474,0.0073243703483411,-0.0199536540376333,0.00875787772786381,0.444712237098726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.00460191850625212,0.00604870180629903,-0.0164573740465982,0.00725353703409398,0.446783486009874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0045834378548828,0.00603188434492878,-0.00723905546117761,0.0164059311709432,0.4473469054905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00482368604150937,0.0063688613477355,-0.0173066542830709,0.00765928220005221,0.448835069906491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,40302,0.0021443758223914,0.00283253994079147,-0.00340740246155988,0.00769615410634267,0.449035656139754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,42346,0.00596990993224017,0.00789787539764564,-0.00950992584714528,0.0214497457116256,0.449729834330027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.00640092568085886,0.00847104829056575,-0.0230041803303677,0.01020232896865,0.449890980813292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00499148147204904,0.00660846836838292,-0.0179440794740796,0.00796111652998148,0.450073001005539
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.00428983466843691,0.00568888889030387,-0.0154400568934325,0.00686038755655868,0.450821945570913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,40080,0.00311148317323352,0.00413006741864694,-0.00498344896731448,0.0112064153137815,0.451241820458547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,42357,0.0054233844132816,0.00720281513168273,-0.00869413324481655,0.0195409020713797,0.451491360483389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.00796569940434897,0.0106127697447494,-0.0287667281040579,0.0128353292953599,0.452920778655136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,0.00182240015098278,0.00242970644516591,-0.00293982448154241,0.00658462478350796,0.453238033005704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00583736877782932,0.00781397379890218,-0.0211527574236776,0.00947801986801896,0.455053644385155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.0120240453364246,0.0161139417978385,-0.0195592805873389,0.043607371260188,0.45556882050028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.0033231983365173,0.0044646749848774,-0.012073961306877,0.0054275646338424,0.456692030384248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00480895751643033,0.00646523577841379,-0.0174808196421214,0.0078629046092607,0.45700258421114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.00327106160206303,0.0044271880149675,-0.0119483501113993,0.00540622690727326,0.460006632768762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.0021984005146852,0.00298041415991528,-0.00804001226811914,0.00364321123874874,0.460761099075372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,40080,0.00425761411803348,0.00580241037024338,-0.00711511020764355,0.0156303384437105,0.463106887522177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.00214108704162734,0.00293085152316652,-0.00788555602703372,0.00360338194377905,0.465079315579075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00571029910896671,0.00783098917385536,-0.0210590378897232,0.00963843967178979,0.465896850625981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00200595169657458,0.00275203940915408,-0.00338804554536741,0.00739994893851657,0.46607757095764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00469692554825104,0.00645711456769363,-0.0173528701009306,0.00795901900442849,0.466994661716594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.00409331573547875,0.00563811333723079,-0.00695738640549359,0.0151440178764511,0.467849267918271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,40482,0.00240600092985974,0.00334257546969414,-0.00414544699074077,0.00895744885046025,0.47166026466366
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00658091160672298,0.00915446484537371,-0.0113618394902095,0.0245236627036554,0.472233582306497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.00420851239135633,0.00587929085522135,-0.0157319224675902,0.00731489768487751,0.474115193551157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00295317773539734,0.00413960269510157,-0.00516044354700174,0.0110667990177964,0.475615616493226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,40302,0.00293341425905552,0.00412862474711833,-0.0051586902452964,0.0110255187634074,0.477405087204784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00276890260177431,0.00391638497907961,-0.00490721195722173,0.0104450171607704,0.479578638132721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.00457424932620046,0.0064745387141932,-0.00811584655361823,0.0172643452060191,0.479890924057777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.0046846335006723,0.00665725062448219,-0.00836357772331279,0.0177328447246574,0.481641572622415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00479162778590042,0.00681273131096376,-0.00856132558358855,0.0181445811553894,0.481862415661041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00576412160809839,0.00821296145476663,-0.021861526059441,0.0103332828432442,0.482798222876511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.00250338643478899,0.00357766701010903,-0.00951561377460269,0.00450884090502471,0.484110834688107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,42357,-0.0034267191802099,0.00490289269174941,-0.0130363888560387,0.00618295049561893,0.484615725027392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,40080,0.0022355544885456,0.00320314542227673,-0.00404261053911679,0.008513719516208,0.485239157925755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.00831559871161201,0.0119169369045496,-0.0150415976213051,0.0316727950445291,0.485319274674448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.00183387573570785,0.00263739008011978,-0.00700316029274263,0.00333540882132692,0.48685877693944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,40429,0.00372300937810201,0.00537912693506738,-0.00682007941463006,0.0142660981708341,0.488875337128431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00490584799178301,0.00715385379992706,-0.0189274014396401,0.00911570545607404,0.492877039679995
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,40302,0.00388461712890065,0.00566904491992897,-0.00722671091416012,0.0149959451719614,0.493211149293504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00375275355263927,0.00548561423246395,-0.00699905034299007,0.0145045574482686,0.493921130031758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.00276783635372255,0.004113894143019,-0.0108310688740398,0.00529539616659469,0.501087279948606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.00686516676567084,0.010237584182678,-0.0269308317637196,0.013200498232378,0.502498926002341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00237809726242687,0.00355589230828259,-0.004591451661807,0.00934764618666075,0.503652078339084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00223632466959196,0.00336766561656096,-0.00883694927805144,0.00436429993886751,0.506667326378827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,42346,-0.00926987398542289,0.014019851196722,-0.036748782330998,0.0182090343601522,0.508498004667
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.00210839450364671,0.00319478944966933,-0.00415339281770517,0.00837018182499859,0.509301113466343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,40451,-0.00302343484005444,0.00458584605202051,-0.0120116931020147,0.00596482342190576,0.509718513529756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00567538111065432,0.00862596702267071,-0.0225822764750889,0.0112315142537803,0.510589606250154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00166675520963934,0.00254366960227659,-0.00331883721082278,0.00665234763010145,0.512316679065636
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.0039868515207068,0.00608647952913523,-0.00794264835639825,0.0159163513978118,0.512459581637409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00507748468477852,0.00775609832147245,-0.0202794373948645,0.0101244680253075,0.512710698073249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00404115542233052,0.00617501024667904,-0.0161441755058214,0.00806186466116039,0.512843975383012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.00284745336263967,0.00436600221539846,-0.0114048177048206,0.0057099109795413,0.514293388312825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,40116,-0.00435305703178271,0.00668852116858548,-0.0174625585222102,0.00875644445864483,0.515173127815797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.00131136919438534,0.00202024013258204,-0.00527103985424613,0.00264830146547546,0.516276925743494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.0049252811204989,0.0076032854796964,-0.0198277206607038,0.00997715841970604,0.517138313075448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42674,-0.00396666672349029,0.00613495911827148,-0.0159911865953024,0.00805785314832182,0.517922742945062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,42292,0.00227198773261078,0.00352689199653473,-0.00464072058059729,0.00918469604581885,0.519463666228941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.00353149004750459,0.00548951479313716,-0.00722795894704424,0.0142909390420534,0.520032694834112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00236350375539869,0.00368947848037897,-0.00959488157694148,0.00486787406614409,0.521791439806181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00274772576550497,0.00429427378788123,-0.0111645023897522,0.00566905085874225,0.522278337132835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00215315355428299,0.00339220986318058,-0.00880188488611693,0.00449557777755095,0.525614706616717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00311074380996282,0.00490194224025074,-0.00649706298092862,0.0127185506008543,0.525706444322884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.00649367773119965,0.0102359100662327,-0.0265560614610158,0.0135687059986165,0.525831952161018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.00534829357687795,0.00848243188137974,-0.0219738600643822,0.0112772729106263,0.528369213024453
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42495,-0.00567887898567049,0.0090324916907872,-0.0233825626996134,0.0120248047282724,0.529545294515803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,40451,0.00166036661479354,0.00266170464685683,-0.00355657449304584,0.00687730772263293,0.532772750035553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.00305920232491292,0.00491217482537501,-0.0065686603328221,0.0126870649826479,0.533440350606841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00384103358535448,0.00617753442018461,-0.00826693387820736,0.0159490010489163,0.534103111698852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.00211164329101074,0.00342175380120017,-0.00881828074136307,0.00459499415934159,0.53716403231407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00230916653424784,0.00374406247844795,-0.00964752899200582,0.00502919592351014,0.537409672188545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00230865786625612,0.0037605990387149,-0.00506211624962509,0.00967943198213733,0.539289430049484
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00307201789726977,0.00501226893142737,-0.0128960650028674,0.00675202920832786,0.53995545296254
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.00251615507879561,0.00411145107940212,-0.00554228903683253,0.0105745991944238,0.540559022613781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.00173040255816423,0.00285168453055009,-0.0073197042380424,0.00385889912171395,0.543993741704604
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00223480148030637,0.00371449851909659,-0.00504561561712295,0.0095152185777357,0.547424311002356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.00300868859144019,0.00502746477633652,-0.00684514237017939,0.0128625195530598,0.549551742750397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41779,0.00300518464432347,0.00502636480783014,-0.00684649037902361,0.0128568596676706,0.549927889408304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.00213197968714859,0.00357294113755452,-0.00913494431675546,0.00487098494245827,0.550718627154631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00333963183982681,0.00560431375763462,-0.00764482312513704,0.0143240868047907,0.551251886674109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.00140935573151519,0.00241097616143829,-0.00331615754490386,0.00613486900793423,0.558856568169844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00171465356104056,0.00293577380185379,-0.00403946309059287,0.00746877021267399,0.559195254362689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00459907103912859,0.00788455643421992,-0.0200528016501996,0.0108546595719424,0.559702592927833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42794,-0.00115037133709235,0.00197274463873019,-0.00501695082900351,0.00271620815481882,0.559813835779454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00417172810230496,0.00718620704889076,-0.00991323771352093,0.0182566939181309,0.561576735238615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42618,0.00213316952609099,0.0036872880373289,-0.00509391502707365,0.00936025407925563,0.562922867894782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.00651660890800351,0.0112873379367517,-0.0286397912640369,0.0156065734480299,0.56372303879785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,40483,-0.001307534914222,0.00227510635724203,-0.00576674337441638,0.00315167354597239,0.565496356624445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,40451,0.00220812089739411,0.00385276279286113,-0.00534329417661371,0.00975953597140193,0.566570415773213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00207898925683139,0.00364805913341704,-0.00922918515832879,0.00507120664466601,0.568764546830852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00288513245073256,0.00506888875572001,-0.00704988951047865,0.0128201544119438,0.56924268322559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00312739690129946,0.00550521843294601,-0.0139176250298737,0.00766283122727473,0.569993801473882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00211609720554891,0.00373555677076195,-0.00520559406514451,0.00943778847624233,0.571082871098236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.00296152300484279,0.00522923284486187,-0.0132108193807721,0.00728777337108647,0.571172431256302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.00868544541343705,0.0154933388237713,-0.0390523895080288,0.0216814986811548,0.575084846999611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42590,0.0040886906266035,0.00731213725151168,-0.0102430983863594,0.0184204796395664,0.576058520820365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.0029490607566482,0.00535797578125827,-0.007552571774618,0.0134506932879144,0.582052182495019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.00215715225155849,0.00393248058152405,-0.00986481419134564,0.00555050968822866,0.583327296919168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00148724591840309,0.00275009246205949,-0.00687742714403969,0.00390293530723352,0.588657169039853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00364975501536774,0.0067561496159612,-0.0168918082626517,0.0095922982319162,0.589061472332537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.00555079183141051,0.0103200115464133,-0.0257780144623805,0.0146764307995595,0.59067978534841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,42370,-0.0040726411522372,0.00758895119748068,-0.0189469854992993,0.0108017031948249,0.591515684415272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.0038419919273129,0.00716080055950997,-0.0178771610239524,0.0101931771693266,0.591600404185145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.00574917409075562,0.0107185923974767,-0.02675761518981,0.0152592670082988,0.591711211833259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00261854947221551,0.00493865404064582,-0.00706121244745029,0.0122983113918813,0.595973543412579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00485188699773202,0.00917405841502324,-0.0131292674957135,0.0228330414911776,0.596906155861592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.00177856667618623,0.00337554394522697,-0.00483749945645864,0.00839463280883109,0.598275159155414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00395482548450488,0.00753465527573352,-0.0187227498249426,0.0108130988559328,0.599674015375175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00344188273690892,0.00656275934067529,-0.00942112557081465,0.0163048910446325,0.599969790661239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,42370,0.00264480848344726,0.00507501794324612,-0.00730222668531513,0.0125918436522097,0.602276134974199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00215406319531868,0.0041579181377778,-0.00599545635472582,0.0103035827453632,0.604424915814451
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,40527,0.00224775628426151,0.00435819199995305,-0.00629430003564647,0.0107898126041695,0.606036082384108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.00248202001472762,0.00482820023094086,-0.00698125243791647,0.0119452924673717,0.607214978833227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.000696432000770948,0.00135604782929369,-0.00335428574618658,0.00196142174464468,0.607559498820408
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.00205547998896372,0.00401565737994033,-0.00992616845364675,0.00581520847571932,0.608754544689655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00219688268967292,0.00431269093185532,-0.0106497569161094,0.00625599153676352,0.610482404497563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.0035511103883717,0.00701063335677424,-0.0101897309909058,0.0172919517676492,0.612493430696778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00446425499361707,0.00883379003214895,-0.0128499734693949,0.021778483456629,0.613313612973249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,40080,-0.003147824263523,0.00623342752972027,-0.0153653422217747,0.00906969369472873,0.613575440524318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,40080,-0.00227517561279137,0.00452477492120183,-0.011143734458347,0.00659338323276422,0.615096607371574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.01370840190017,0.0273039366799188,-0.0672241177928109,0.039807313992471,0.615630509853611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00492566602601388,0.00982516471503538,-0.0143316568154555,0.0241829888674832,0.616147820635347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00211054932616296,0.00423488604935953,-0.00618982733058172,0.0104109259829077,0.61823172768459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00204952779428,0.00413029230486279,-0.00604584512325107,0.0101449007118111,0.619750127169923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.00188176338656216,0.00379815750454447,-0.00932615209546932,0.005562625322345,0.620296907432973
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42595,0.00654278717577081,0.0132322844692935,-0.0193924903840445,0.0324780647355862,0.620992026349014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00166217450934935,0.0033722157160861,-0.0082717173128781,0.0049473682941794,0.622090895346796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.00205283134883112,0.00420115247069189,-0.00618142749372498,0.0102870901913872,0.62510966190784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,40199,0.0008367895125822,0.00174905945801224,-0.0025913670251218,0.00426494605028619,0.63235898006789
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.00424010406062935,0.00888377569260039,-0.0216523044181261,0.0131720962968674,0.633167876605403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,40199,0.00139127290666551,0.00293172105384006,-0.00435490035886101,0.00713744617219203,0.635111166336114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00232509145433082,0.00493261196542579,-0.00734282799790373,0.0119930109065654,0.637384989126586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00194039669117748,0.00411956507071304,-0.00613395084742007,0.010014744229775,0.637634432690938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.0017023610295141,0.00362873655261493,-0.00540996261361116,0.00881468467263935,0.638983442988796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00335717136312329,0.00722592763224012,-0.0108056467960673,0.0175199895223139,0.642226603928406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0032755523832809,0.00705448952044443,-0.0105512470767902,0.017102351843352,0.642424730169952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,40251,-0.00153450180474385,0.00331365200273303,-0.00802925973010059,0.00496025612061288,0.643312713912809
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00187655774080124,0.00406798583625629,-0.00984980997986357,0.00609669449826109,0.64459176140812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.00651637578141889,0.0142814733759896,-0.0345080635983584,0.0214753120355206,0.64819612343943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.00399829227452438,0.00885306809000233,-0.0133537211818802,0.0213503057309289,0.651546084449658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,42370,0.0021496125069866,0.00476782042203414,-0.00719531552020032,0.0114945405341735,0.652098932940856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,40223,0.000824244166250236,0.00183413261542778,-0.00277065575998821,0.00441914409248869,0.653157872859656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,40182,0.00155268982436079,0.00348383767217633,-0.00527563201310482,0.00838101166182641,0.655834488035982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.00166444353649365,0.00373986837025772,-0.00566569846921148,0.00899458554219877,0.656289233570769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00380096211971866,0.00854498888091296,-0.0205491403263081,0.0129472160868707,0.656460246283835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00189923394225954,0.00427806807864146,-0.00648577949187772,0.0102842473763968,0.657089892898199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00168878177706058,0.00380812834746271,-0.00577514978396632,0.00915271333808749,0.657435966101039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.00404592558974568,0.00916588491646991,-0.0220110600260267,0.0139192088465353,0.658923916031977
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00133611479411068,0.00302819702856314,-0.00727138097009444,0.00459915138187308,0.659057732726239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.00314894345143253,0.00726483632979942,-0.0173880226578394,0.0110901357549743,0.664696151176415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,40199,0.00250752374867785,0.00580060809868703,-0.00886166812474874,0.0138767156221044,0.665541770936707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,0.00322552712419231,0.00746925160514625,-0.0114142060218943,0.017865260270279,0.665865677775072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00131892310270521,0.00307287969003774,-0.00470392108976875,0.00734176729517918,0.667774446314063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.00101170088264801,0.00237714887205866,-0.00364751090658696,0.00567091267188299,0.670411837782347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,0.00238542679018829,0.00560884779864326,-0.00860791489515251,0.0133787684755291,0.670628393744827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00263014707986248,0.00619774820693958,-0.0147777335654641,0.00951743940573911,0.671303270968184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.000961758954048307,0.00226786758136635,-0.00540677941352635,0.00348326150542973,0.671515009275397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00270849337514853,0.00638772175122483,-0.0152284280075492,0.00981144125725214,0.671562680899105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.00143253246601232,0.00340793222023942,-0.00524701468565695,0.00811207961768159,0.674234717314016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00166629759789855,0.00397336243280515,-0.00945408796619664,0.00612149277039954,0.674956090817398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.0014401630090995,0.00343807280783139,-0.00817878571244902,0.00529845969425002,0.67530692187717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.00353471061250878,0.00847078916238643,-0.0130680361457686,0.0201374573707862,0.676480100540775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00354303845621775,0.00853189123549105,-0.0131794683653447,0.0202655452777802,0.677952445995332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42495,0.00233940681278348,0.00563398661627587,-0.00870320695511722,0.0133820205806842,0.677979385876685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,42276,-0.00202947979350582,0.00489030331164309,-0.0116144742843263,0.00755551469731464,0.678148121990674
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00233543393972722,0.0056381106718777,-0.0133861308566075,0.00871526297715308,0.678719037441495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,40136,0.00155173121941407,0.00374974390014173,-0.00579776682486373,0.00890122926369186,0.679011663694422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42587,-0.00117342502247953,0.00285413711549684,-0.00676753376885334,0.00442068372389427,0.680982858646676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.00458742568579154,0.0112786889270348,-0.0266936559827797,0.0175188046111967,0.684211373201743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00260731595069802,0.00642131041437329,-0.0151930843628697,0.00997845246147363,0.684720119095711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.00192524793801987,0.00476421798139085,-0.00741261930550619,0.0112631151815459,0.686142845746424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.000960209697647169,0.00239160259337327,-0.00564775078065878,0.00372733138536444,0.68806540754942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,40223,0.00345287447428856,0.00863948149788907,-0.013480509261574,0.0203862582101511,0.689413051325887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,42311,-0.00232940303306992,0.00586398461839925,-0.0138228128851324,0.0091640068189926,0.691197733012781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.00166324100188464,0.00419121666868892,-0.00655154366874564,0.00987802567251492,0.691492021584039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,0.00102326304213677,0.00258252453091773,-0.00403848503846198,0.00608501112273551,0.691945915779702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.00351031772784404,0.00886805540822033,-0.0138710708722678,0.0208917063279559,0.69223190653781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00113228611974815,0.0028779519504525,-0.00677307194263505,0.00450849970313875,0.69400585357128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,40080,-0.00165116263094357,0.00426499851084674,-0.0100105597122032,0.00670823445031605,0.698658206398179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00375107272384587,0.00971190056417499,-0.0152842523819371,0.0227863978296288,0.699330426397848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00108677354132888,0.00281497551504101,-0.00660412555080925,0.00443057846815149,0.699453141400992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00119244413777996,0.00310168436517837,-0.00488685721796965,0.00727174549352957,0.700652079142052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.00221997678003862,0.00578165432676625,-0.0135520192605005,0.00911206570042324,0.701007420189993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,40116,0.00148277109516424,0.00387040963833054,-0.00610323179596361,0.00906877398629209,0.701649787689032
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00189070102248601,0.00495053309598922,-0.0115937458906249,0.00781234384565287,0.702527716100249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,40293,-0.000941946512490548,0.00247198091414828,-0.00578702910422118,0.00390313607924008,0.703173985667066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00299627981417727,0.00791794755860031,-0.0125228974006793,0.0185154570290339,0.705128728563293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.00319554968457351,0.00846915203412392,-0.0197950876714564,0.0134039883023094,0.705945796853159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,40539,-0.000844272025539247,0.00224148960652989,-0.00523759165433784,0.00354904760325935,0.706435806795159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.00291312889103538,0.00777801668233387,-0.0181580415884098,0.012331783806339,0.708013389053113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00112840452267654,0.00303085099138827,-0.00706887246579755,0.00481206342044447,0.70967208587359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,42357,0.00124231003673089,0.00334251867799691,-0.00530902657214305,0.00779364664560483,0.710145410784708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,40036,-0.00130873784897552,0.00352722967781634,-0.00822210801749554,0.00560463231954451,0.71061613953033
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.00163924022985938,0.00442179946764534,-0.0103059671864442,0.00702748672672548,0.710854630522769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,40116,-0.0012428945686029,0.00339779772374686,-0.00790257810714674,0.00541678896994094,0.714525761233475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.00112734275392224,0.00308193833063797,-0.00716794188197266,0.00491325637412819,0.71452850741188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.00114225321735601,0.00312675715038874,-0.00498619079740593,0.00727069723211794,0.71488169187168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00173443408542064,0.00477181589974935,-0.0110871932489294,0.00761832507808808,0.7162572677167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.00242068564370197,0.00667198123914061,-0.0154977688724176,0.0106563975850136,0.71675093231418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00209129704196164,0.00585433330217175,-0.0135657903142183,0.00938319623029498,0.720931314179411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.00150436521804871,0.00430213514081088,-0.0069278196579406,0.00993655009403803,0.726586570971338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,42346,0.00585095697887379,0.0167525490113195,-0.0269840390833125,0.03868595304106,0.726901432431209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,0.000911656041765895,0.00262506513509513,-0.00423347162302057,0.00605678370655236,0.728379738188733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00153532217914659,0.00442384511957118,-0.0102060586135061,0.00713541425521293,0.728555791175561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00199372420197821,0.00581753279845298,-0.00940864008298962,0.013396088486946,0.731823574448337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00223098523913903,0.00652826238559957,-0.0150263795149142,0.0105644090366361,0.732551159325712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00122196663572384,0.00360568632709784,-0.00828911183683561,0.00584517856538792,0.734691706334836
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.0016214368901882,0.00478747175292652,-0.0110048815259242,0.00776200774554778,0.734853704355436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,40449,0.00387173424551562,0.0114368248742159,-0.0185444425079476,0.0262879109989788,0.734968430692953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,42311,0.00130626734177337,0.00385983661406242,-0.00625901242178897,0.00887154710533572,0.73504793682422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,40539,0.000508497971752917,0.00151501702338208,-0.00246093539407596,0.00347793133758179,0.737149728672938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00158626073226938,0.00475543685652767,-0.00773439550652485,0.0109069169710636,0.738710958490089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00191084292687978,0.00577598851296181,-0.00941009455852537,0.0132317804122849,0.740782822371579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00185760459538067,0.00566269670438215,-0.00924128094520834,0.0129564901359697,0.742885883848406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.00228159774104911,0.00696483886059168,-0.0159326819078088,0.0113694864257106,0.743229402328062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00161302644761918,0.00493393133377713,-0.00805747896658399,0.0112835318618223,0.743730684446717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,40286,-0.00325522627863883,0.0100493643387397,-0.0229519803825686,0.016441527825291,0.746001983338023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00412681561006272,0.0127405377979214,-0.0290982696939888,0.0208446384738633,0.746009658900465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42636,0.00120711394505927,0.003765955101023,-0.00617415805294582,0.00858838594306435,0.748569087936682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00135650091235539,0.00423304447217561,-0.00694026625310881,0.0096532680778196,0.74862941588035
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00280107160000969,0.00882978956687499,-0.0201074591510847,0.0145053159510653,0.751075324486055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42594,-0.00174492435180638,0.00553393677622167,-0.0125914404332009,0.00910159172958809,0.752528631304744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.000853350609079588,0.00271625051629003,-0.00447050040284888,0.00617720162100805,0.753400684470702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00120081561391387,0.00385887645995585,-0.00876421347542734,0.00636258224759959,0.755667653542422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,42370,0.00144350405661909,0.00469151463671071,-0.00775186463133391,0.0106388727445721,0.758327647962825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,40482,-0.00117814762804334,0.00386947358595973,-0.0087623158565244,0.00640602060043772,0.760773685000443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,42311,0.0013708879911792,0.00452113809941146,-0.00749054268366725,0.0102323186660257,0.761728955866203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,40136,-0.0033591965254737,0.0111199398518503,-0.0251542786351003,0.0184358855841529,0.762590986356056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00146943507188347,0.00486661012288496,-0.011007990912738,0.00806912076897105,0.762701857798558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42721,-0.000983321300554997,0.00326299262111949,-0.00737878683794919,0.0054121442368392,0.763147932626543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.000856021582128055,0.00286503502874049,-0.00647149023845942,0.00475944707420331,0.765111844567315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.00126709951927632,0.00428272612458425,-0.00712704368490881,0.00966124272346145,0.767340472985786
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00119347875839395,0.00404420845323134,-0.00912012732672737,0.00673316980993947,0.767916728396363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00116004253907718,0.00394202282954311,-0.0065663222068273,0.00888640728498167,0.768551679187669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,40223,-0.00214226610746583,0.00739209314764043,-0.0166307686768411,0.0123462364619094,0.771970813212424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,40482,0.000639750311237576,0.00223861239281106,-0.0037479299786721,0.00502743060114725,0.775051986891429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.0010275402298913,0.00360372670434932,-0.00603576411063337,0.00809084457041597,0.775547895282314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00127438056108735,0.00447225368291519,-0.0100399977796011,0.00749123665742642,0.775685656541361
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.00107898578162221,0.0038422643437446,-0.00860982389536161,0.0064518523321172,0.77885347162326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.000941510741288599,0.00337283583861553,-0.00566924750239784,0.00755226898497504,0.780138694180412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,0.00098678553675539,0.0035355483008886,-0.00594288913298627,0.00791646020649705,0.780169427871025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,40302,0.000654721247808689,0.00236017021936893,-0.00397121238215442,0.0052806548777718,0.781474881431906
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42636,0.000730030155885225,0.0026320604357006,-0.00442880829808794,0.00588886860985839,0.781507411254515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.00126263495454486,0.00459663463616564,-0.0102720388414295,0.0077467689323398,0.783561040124956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.000539334454230048,0.00200963697889996,-0.00447822293287396,0.00339955402441386,0.788415530532135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,40199,0.00114126581867973,0.00425636837618493,-0.00720121619864273,0.00948374783600219,0.788603237082272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.000926942308273859,0.00346245081297837,-0.00585946128516375,0.00771334590171147,0.788925475209889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.00119024544499696,0.00447532518029612,-0.00996188279837734,0.00758139190838343,0.790277098017082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00138245647271968,0.0052200933318786,-0.0116138394032017,0.00884892645776238,0.791142565602746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.00108760168052885,0.00413960049900394,-0.00920121865857656,0.00702601529751887,0.792762737662006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00150748736639328,0.00573974671884914,-0.0127573909353376,0.00974241620255104,0.792832972392909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.0016763265487661,0.00641463022499905,-0.0142490017897642,0.010896348692232,0.79384393240775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,40116,-0.00100139898465496,0.00387250725863122,-0.00859151321157215,0.00658871524226223,0.795955011394228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,40080,0.00173758182284532,0.00672468876484651,-0.0114428081562538,0.0149179718019445,0.79611202405372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.00156820544698734,0.00609426212299662,-0.0135129592080607,0.010376548314086,0.796931983304954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,42357,0.000708760820343002,0.0027797644493997,-0.00473957750048041,0.00615709914116641,0.798749064651103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00124972999809573,0.00490203995770024,-0.0108577283151882,0.00835826831899674,0.798773621852061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,0.00168683094983748,0.00662671729905851,-0.0113015349563172,0.0146751968559922,0.799075290685954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,42311,0.00189373167712045,0.00750230957045148,-0.0128107950809645,0.0165982584352054,0.800720532256483
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,0.000741963157103806,0.00295584149848632,-0.00505148617992939,0.006535412494137,0.801805874885972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.0011513361472582,0.00462935417794683,-0.00792219804151759,0.010224870336034,0.803593999317417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00178314087059256,0.00717532782643346,-0.012280501669217,0.0158467834104021,0.803744481164062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,0.00155331029856653,0.00630922542590256,-0.0108127715362025,0.0139193921333356,0.805534633934382
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00134112040910083,0.00549284087839038,-0.012107088530746,0.00942484771254431,0.807113101917867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.0015005850604356,0.00618231191405234,-0.0136179164119782,0.010616746291107,0.80822423427435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.000860530070616184,0.00354901699708559,-0.00609554324367157,0.00781660338490394,0.808420494050549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.000710177239652338,0.00295623117739142,-0.00650439034733952,0.00508403586803485,0.810155824653964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.000619394966377947,0.00260369521553442,-0.00572263758882542,0.00448384765606952,0.811970161170137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00103652652584619,0.00437709892139086,-0.00961564041177227,0.00754258736007988,0.812811089253473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,40302,-0.00166296344724453,0.00713991215459086,-0.0156571912702426,0.0123312643757536,0.815834876689089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.000518678929641828,0.00223087243786198,-0.00385383104856765,0.0048911889078513,0.8161535109575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.00173628804495956,0.00756249817816174,-0.0165587844741566,0.0130862083842374,0.818413157707778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,-0.0013010059810591,0.00568595086937528,-0.0124454696850346,0.00984345772291645,0.819019664645693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.000641528523039307,0.00280383785943766,-0.00485399368145851,0.00613705072753712,0.819025612246676
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,0.00112548779343901,0.00495060212614175,-0.00857769237379882,0.0108286679606769,0.820160014884651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.000721163022342845,0.00318194790835222,-0.00551545487802751,0.0069577809227132,0.82070638995688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,40080,0.00105240529055707,0.00465973836593809,-0.00808068190668158,0.0101854924877957,0.821321762869815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.000668909986197019,0.00297945215961393,-0.00517081624664629,0.00650863621904033,0.822366435063121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.00108351352157093,0.0048501503332066,-0.00842278113151401,0.0105898081746559,0.823229288522228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.00208215154325629,0.00932057103200039,-0.0203504707659771,0.0161861676794645,0.823233741814166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.000745307423794347,0.00334985505030782,-0.00582040847480899,0.00731102332239768,0.823936896434799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,42445,-0.000849454326616262,0.00385856497075878,-0.00841224166930346,0.00671333301607094,0.825759493216173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,40527,0.001047489705812,0.00482113989525705,-0.00840194448889181,0.0104969239005158,0.828001742837736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,42370,0.000706055420387985,0.00328751102068541,-0.00573746618015542,0.00714957702093139,0.829950755161458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,40080,-0.00073317581015558,0.00344390924556785,-0.00748323793146857,0.00601688631115741,0.831416302379912
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42629,0.00396197965022319,0.0186346782806424,-0.0325619897798359,0.0404859490802822,0.831631855564499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,40080,0.000658689016577324,0.00315238636510233,-0.00551998825902325,0.0068373662921779,0.834491704338919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.00099569896116777,0.00476649141480935,-0.0103380221341941,0.00834662421185855,0.834532994294086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,0.000679346205442251,0.00326112837113201,-0.0057124654019765,0.007071157812861,0.834985237395633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.00112766516853301,0.00544376690906925,-0.00954211797324271,0.0117974483103087,0.83589816825226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.00129112791910423,0.00628835940947638,-0.0136163123616779,0.0110340565234695,0.837325046808824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,42332,0.0015111192570303,0.00749313164807131,-0.0131754187731895,0.0161976572872501,0.840179989073214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,40182,-0.000848653689312376,0.00421566846420306,-0.00911136387915037,0.00741405650052562,0.840460379111783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,42311,-0.00107359803085336,0.00535971213992015,-0.0115786338250969,0.00943143776339014,0.84124210956635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.000612637025008737,0.00308261618484754,-0.00542929069729244,0.00665456474730992,0.842470306716398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,40199,0.000825113216459983,0.00417889235863271,-0.00736551580646012,0.00901574223938009,0.843480752028118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,40302,0.0012221267190475,0.00620990396921689,-0.0109492850606176,0.0133935384987126,0.843985431384667
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,40451,-0.000702582246436236,0.00360696497412866,-0.0077722335957284,0.00636706910285593,0.845564873240966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.00110171200392103,0.00568688111244552,-0.0122479989843142,0.0100445749764722,0.846391265768858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.00110457185607558,0.00570541053281008,-0.0100780327882322,0.0122871765003833,0.846491481743166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.000833813416788506,0.00431426545906455,-0.00928977371655503,0.00762214688297802,0.846751939494029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.000960934053288604,0.00503253518931725,-0.0089028349177732,0.0108247030243504,0.84857275237493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,40302,-0.00104086801639996,0.00548384823875033,-0.0117892105643506,0.00970747453155068,0.849464519648417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,0.000610060095790801,0.00326128004006726,-0.00578204878274103,0.00700216897432263,0.851615260871487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,42370,-0.000640027646037395,0.00345668197799769,-0.00741512432291287,0.00613506903083808,0.853109021358347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,40199,0.000596829266673738,0.00323368935015281,-0.00574120185962576,0.00693486039297324,0.853572818298199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,0.00209903670081502,0.0115778011901759,-0.0205934536319297,0.0247915270335597,0.856136104146866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.000602774178409987,0.00342086786694991,-0.00730767519763181,0.00610212684081184,0.860136123852975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,42370,0.00163942467675289,0.00940535892476444,-0.0167950788157854,0.0200739281692912,0.86162647697234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.000787494565865078,0.00459126559870817,-0.00821138600760294,0.0097863751393331,0.863817433333438
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,0.00124385307396381,0.00749470777181978,-0.013445774158803,0.0159334803067306,0.868188201035575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000626898167723914,0.00380339125912512,-0.00808154503560915,0.00682774870016132,0.869083906387141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,40199,0.000438412580560463,0.00267899210116443,-0.00481241193772181,0.00568923709884274,0.870011001655037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.000832285887674815,0.00509961243691799,-0.00916295448868444,0.0108275262640341,0.870359497121879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00101328169430403,0.00630856918247932,-0.0133780772919635,0.0113515139033554,0.872395752666053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.000795419235674876,0.004961216602449,-0.00892856530512517,0.0105194037764749,0.872625600822029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.000541331178274861,0.00348428356204303,-0.0073705269598792,0.00628786460332948,0.876536917007021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.001862213091704,0.0123292180333186,-0.0260274804370084,0.0223030542536004,0.87994596698828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42654,-0.00166259728434831,0.0110089643893022,-0.0232401674873805,0.0199149729186839,0.879960519669519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.000526157154812248,0.00349894438295757,-0.00738408814540909,0.0063317738357846,0.880470775860561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00093732883153304,0.00638819694055889,-0.0115835371719624,0.0134581948350285,0.883349252290219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,42370,0.000653328104131407,0.00448917335159028,-0.00814545166498554,0.00945210787324835,0.884291367738133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,40199,0.00131461615343381,0.00985543146762585,-0.0180020295231129,0.0206312618299805,0.89388738050317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,42370,-0.000655890164107961,0.00516974842547267,-0.0107885970780344,0.00947681674981847,0.899044587045207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.000627483107575722,0.0049474627794181,-0.0103245101552352,0.00906954394008375,0.89907786100141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,40136,-0.000642719829827332,0.0050713782812829,-0.0105826212611418,0.00929718160148715,0.899152674222402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000607250385109605,0.00479584158575076,-0.00879259912296189,0.0100070998931811,0.899243345005295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.000600791328600254,0.00481145132008038,-0.00882965325875729,0.0100312359159578,0.90063117654304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,-0.0013366310103004,0.0107087517965718,-0.0223257845315811,0.0196525225109803,0.900670886705524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,42311,-0.000590382205735235,0.00477641655694559,-0.00995215865734859,0.00877139424587812,0.901631048351345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.000928449486132234,0.00768518839261621,-0.0141345197633955,0.01599141873566,0.903843536600707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.000835156366941653,0.00691773156817635,-0.0143939102405673,0.012723597506684,0.903909493029879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.000796994484096299,0.00673137686877459,-0.0123965041787019,0.0139904931468945,0.905752601992709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.000906807684938565,0.00812115771511696,-0.0168242768065678,0.0150106614366907,0.911095090484175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,0.000504951627901583,0.00452729427561412,-0.00836854515230209,0.00937844840810525,0.911193839129879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,40116,0.000720894569960923,0.00661521761055626,-0.0122449319467293,0.0136867210866512,0.913224173683929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,42370,0.000302321534875478,0.00287670271990559,-0.00533601579613949,0.00594065886589044,0.916303553875193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.000446057150631021,0.00439856137290929,-0.00817512314027118,0.00906723744153322,0.919226714528361
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,40199,0.00074558903205601,0.00739535688539927,-0.0137493104633266,0.0152404885274386,0.91969635119149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.000477713131274869,0.00477948040600591,-0.00889006846449671,0.00984549472704645,0.920384827901596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000291024627530283,0.00293952796830759,-0.00605249944541315,0.00547045019035259,0.92113671493026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.000524467663866758,0.00529810455830429,-0.00985981727040965,0.0109087525981432,0.921146753307976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,40283,-0.000393590879774944,0.00407564280313294,-0.00838185077391551,0.00759466901436562,0.923068447090195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.000703643017571755,0.00741723555175294,-0.013834138663864,0.0152414246990075,0.924423038134216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.000690963107899888,0.0073387286752797,-0.0136929450956483,0.0150748713114481,0.924989366413076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.000584793213837604,0.00623011112930949,-0.011626224599609,0.0127958110272842,0.925217626935765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.000392450272779068,0.00420410012029107,-0.00863248650854957,0.00784758596299144,0.925627696482595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,40136,-0.00067037032129007,0.00734855455307487,-0.0150735372453168,0.0137327966027367,0.927315650040157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.000740002404723102,0.00814669429006832,-0.016707523213257,0.0152275184038108,0.927625623330217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.000498228126952032,0.00553162379435403,-0.0103437545099819,0.0113402107638859,0.928233988442199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000262203088597627,0.00298787674155451,-0.0055940353248492,0.00611844150204446,0.930072215364383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.000443368577539119,0.00519843023987437,-0.0106322918476929,0.00974555469261464,0.932033248679933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.000470957319119228,0.0057910273695088,-0.010879456325118,0.0118213709633565,0.935184710612438
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.000506470916664894,0.006342789913811,-0.0129383391477344,0.0119253973144047,0.9363581030124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,40199,-0.000300547362938201,0.00377217528928131,-0.00769401092992958,0.00709291620405317,0.936497340303601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,40136,-0.00036444104536362,0.00461100687108,-0.00940201451268041,0.00867313242195317,0.937004484220029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.000212363730921757,0.00273830552378111,-0.00557944255753273,0.00515471509568922,0.938185027292034
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.000190747201896401,0.00279048399121924,-0.00566009582468611,0.00527860142089331,0.945503240044318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.000352247028029222,0.00525143667000339,-0.00994056884517742,0.0106450629012359,0.946522181661162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.000437951549470068,0.00669977309535479,-0.0135695068163654,0.0126936037174253,0.947881915800156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.000169822627992014,0.00267086416999703,-0.00506507114520217,0.00540471640118619,0.949303118612574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,40080,0.000238785400813725,0.00383490489247189,-0.00727762818843117,0.00775519899005862,0.950351895284763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.0010917406302156,0.017632466735859,-0.033467894172068,0.0356513754324992,0.950630426872247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.000226715336659549,0.00371321191416131,-0.00750461068841572,0.00705118001509662,0.951315393804817
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.000469371211464002,0.007721903760886,-0.0156043025828006,0.0146655601598726,0.951532001186003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,40482,-0.000222261359518424,0.00366238499139101,-0.00740053594264481,0.00695601322360796,0.951609080723038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,40116,-0.000310285544658499,0.00520128124268403,-0.0105047967803192,0.00988422569100219,0.952431027532544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.000253168374365918,0.00435766354219098,-0.00879418891706024,0.0082878521683284,0.953672206351952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,40199,-0.000317533327600836,0.00557294971415513,-0.0112405147673449,0.0106054481121432,0.954564069168348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,42357,0.000337788617338443,0.00621257644820426,-0.0118388612211419,0.0125144384558188,0.956639815574771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000294142119282044,0.0054267921577919,-0.0109306547485542,0.0103423705099901,0.956775344404479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.000218987151545987,0.00416163559364884,-0.00837579291509771,0.00793781861200573,0.958035285661717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,0.000274666477538733,0.00552368059053879,-0.0105517474799173,0.0111010804349948,0.960342225718513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.000193351349310506,0.00437836204824722,-0.00877494096387506,0.00838823826525405,0.964777149047499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,0.000146547786545706,0.00348929115084224,-0.00669246286910508,0.00698555844219649,0.966500026231151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.000148968874098874,0.0038295976412487,-0.00735704250274859,0.00765498025094633,0.968971338669405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.000156451965478688,0.00408409148917756,-0.00816127128426672,0.00784836735330934,0.969443076308394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.000412690467622214,0.011065350578024,-0.0221007776005493,0.0212753966653049,0.970249857580768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.000219349611911672,0.00589258944012304,-0.0117688249145528,0.0113301256907295,0.970306559049026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.000118049407345451,0.00319501881280218,-0.00638028628043772,0.00614418746574682,0.970527065012325
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.000150779942750722,0.00484089846903321,-0.00963894094205581,0.00933738105655437,0.975152797602245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42608,0.00018019735085974,0.0058965750072829,-0.0113770896634147,0.0117374843651342,0.975621165235019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,40080,-0.000146290413342447,0.00482269514283835,-0.00959877289330561,0.00930619206662072,0.975801438970572
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00027940487267871,0.00964090105903157,-0.0191755709483806,0.0186167612030232,0.976880114781941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,40116,-0.000133252101111815,0.00477061175478487,-0.00948365114049016,0.00921714693826653,0.977717001133249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.000157583026583537,0.00584843336961711,-0.011305346377866,0.0116205124310331,0.978504503662847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-9.75362249973097e-05,0.00381035406195985,-0.00756583018643861,0.00737075773644399,0.979578703985089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.000171073785312091,0.00718236178662,-0.0142485028870873,0.0139063553164631,0.98099773801643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.00013993676749054,0.00596699104200593,-0.0115553656748411,0.0118352392098222,0.981290302718375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,40199,0.000125584153330806,0.00595546309393557,-0.0115471235107829,0.0117982918174445,0.983176462844578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,40009,-7.56337186516149e-05,0.00394946929802358,-0.00781659354277782,0.0076653261054746,0.984721518703446
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,7.94858146536193e-05,0.00511341394975953,-0.00994280552687507,0.0101017771561823,0.987597964478895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-6.30319836754858e-05,0.00414563634713811,-0.00818847922406619,0.00806241525671522,0.987869322440716
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.000101202227400027,0.00805311113225042,-0.0156828955918108,0.0158853000466109,0.989973595213713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,40136,-6.18411179286808e-05,0.00574581590309944,-0.0113236402880036,0.0111999580521462,0.991412883036215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,5.98563086553778e-05,0.00611302470279208,-0.0119216721088171,0.0120413847261279,0.992187700680457
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-2.39849518842346e-05,0.00490112191717083,-0.00963018390953906,0.00958221400577059,0.996095443309843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,8.72328804659347e-06,0.00519549509374202,-0.0101744470956878,0.010191893671781,0.998660375264484
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42587,-1.78028270892028e-06,0.0019439151863076,-0.00381185404787182,0.00380829348245398,0.999269292516455
